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2 Glossary 
The glossary contains units and measurements used in the text of this work following the 
International System of Units (SI-System and Units) and abbreviations used and not explained 
in the text. All other abbreviations are explained in the text, at least once when first used.  
Units and Measurements 
µl microlitre 
µM micromolar 
g gram 
h hour 
kDa kilo dalton 
M molar 
min minutes 
ml milliliter 
mM Milli molar 
nM nono molar 
rpm rounds per minute 
s seconds 
xg (x) fold earth acceleration  
pmol Pico molar  
mT Milli Tesla 
mW Milli Watt 
mA Milli Ampere  
V Volt 
 
Miscellaneous abbreviations  
Approx. approximately 
ATP  Adenosine triphosphate 
BRAF proto-oncogene B-Raf; serine/threonine-protein kinase  
CC(R), CXC(R), CX3C(R) Classification of chemokine ligands and receptor (R) families  
CD Cluster of differentiation  
CDK2 Cyclin-dependent kinase 2 
cDNA Copy DNA 
CREB cAMP response element-binding protein (transcription factor)  
C-term/ N-term Carboxy-terminus/ Amino-terminus of proteins  
DEPC Diethylpyrocarbonate (or diethyl dicarbonate) 
DNA Deoxyribonucleic acid 
dNTPs Desoxynucleotide-5’-triphosphates 
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(dGTP, dATP, dTTP, dCTP)  Desoxyguanosine-, adenosine-, thymidine-, cytidine- 5'-triphosphate 
EF-hand Ca
2+
-binding domain 
ER/SR Endoplasmic/ sarcoplasmic reticulum 
ERK (1/2) Members of the extracellular signal-regulated kinase family 
Ero1p ER oxidoreductin 1 
ERp57 Protein disulfide isomerase family A, member 3 
FAD
+
/FADH + H
+
 flavin adenine dinucleotide (reduced/ oxidized) 
FC Flow cytometer/ cytometry 
Fcγ Fragment crystallizable receptor type γ (antibody binding receptor)  
GAPDH Glycerinaldehyd-3-phosphat-dehydrogenase  
HEK (cell line) Human embryonic kidney (cell line)  
HIF1-α Hypoxia-inducible factor 1-α 
HLA-DR Human leukocyte antigen (type DR, MHC class II) 
IgG Immunoglobulin G (antibody) 
IL Interleukin  
LBP Lipopolysaccharide binding protein 
LPS Lipopolysaccharide 
MEK Dual specificity mitogen-activated protein kinase kinase 1 
MHC II Major histocompatibility complex class II molecule 
NAD
+
/NADH + H
+
 Nicotinamide adenine dinucleotide (reduced/oxidized) 
NADP
+
/NADPH + H
+
 Nicotinamide adenine dinucleotide phosphate (reduced/ oxidzed) 
NFAT Nuclear factor of activated T cells  
NfκB Nuclear factor 'kappa-light-chain-enhancer' of activated B-cells  
N-Ras Member of the Ras superfamily of small GTPases 
p16/ p21 Cell cycle regulators (cyclin-dependent kinase inhibitor 2A/ 1) 
PCR Polymerase chain reaction  
Pdi1p Protein disulfide isomerase  
PI3Kγ Phosphatidylinositol-4,5-bisphosphate 3-kinase 
RNA Ribonucleic acid 
RNAPol RNA Polymerase 
SDS Sodium-dodecyl-sulfate 
SEM Standard error of the mean 
TBP TATA-Box binding protein 
TLR-4 Toll-like receptor 4 
TM Trans-membrane region  
TRP channel Transient receptor potential channel  
UV (radiation) Ultraviolet (radiation)  
∆ Delta/ difference 
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3 Summary 
3.1 Zusammenfassung 
Die Funktion von Zellen wird maßgeblich durch das Zusammenspiel des extra- und 
intrazellulären Milieus bestimmt. Ca2+ Signalwegen kommt dabei eine wichtige Rolle zu. Die 
Haut und das Immunsystem stellen zwei Zellsysteme da, die unter physiologischen und 
pathologischen Bedingungen nicht nur durch Ca2+, sondern auch durch das oxidative Milieu 
stark beeinflusst werden. Die Rolle und Regulation eines zentralen Ca2+ Signalwegs wurde in 
Melanom-Zelllinen und primären humanen Monozyten untersucht, da diese Zellen in der 
Tumor- und Entzündungsumgebung in der sie agieren, mit einem charakteristischem Ca2+ und 
oxidativen Milieu konfrontiert werden. Durch UV Strahlung kommt es in der Haut zur 
Freisetzung verschiedenster Hormone, die zu einer Produktion von reaktiven Sauerstoff 
Spezies (RSS) und der Aktivierung von Ca2+ Signalwegen führen können. Es konnte kürzlich 
gezeigt werden, dass Ca2+ Signalwege in Melanozyten essentielle Funktionen, wie z.B. die 
Pigment-Synthese, regulieren. Dagegen gab es wenige Informationen über die Rolle von Ca2+ 
Signalwegen in pathologischen Hautveränderungen, wie Melanomen. Wie in der Haut, konnte 
auch im erworbenen Immunsystem eine essentielle Funktion für Ca2+ Signalwege 
nachgewiesen werden, wie z.B. in Proliferation und Differenzierung von T-Zellen. Auch der 
angeborenen Immunantwort gegen schädliche Pathogene, konnte eine wichtige Rolle für die 
Produktion RSS, sowie Ca2+ Signalwegen zugeschrieben werden. Unter den verschiedenen 
Zellarten der angeborenen Immunität, gab es über die Rolle von Redox und Ca2+ Signalwegen 
in einer zentralen Zellart, den Monozyten, allerdings nur geringe Informationen.  
Der in dieser Arbeit untersuchte Signalweg, ist der Speicher-gesteuerte Ca2+-Einstrom (SGCE), 
der durch die Calcium-realease activated Ca2+ (CRAC) Kanäle vermittelt wird. Zudem wurde 
die Rolle der molekularen Komponenten des SGCE, Orai und STIM untersucht. Diese Proteine 
sind für die Bildung des CRAC Kanals (Orai1-3), sowie seine Regulation verantwortlich 
(STIM1-2). Die Bestimmung des SGCE mittels fluoreszenz-basierter Messmethoden 
ermöglichte die Charakterisierung der intrazellulären Ca2+ Signale in den untersuchten 
Zelltypen. Die einzelnen Komponenten, die den CRAC Kanal bilden und steuern, wurden 
herunterreguliert um so ihre Beteiligung am SGCE zu ermitteln. Im Gegensatz zu anderen 
Phagozyten, zeigte sich in primären Monozyten nicht nur eine Beteiligung von Orai1 und 
STIM1 sondern auch Orai2 und STIM2 am SGCE. In Melanoma-Zelllinien hingegen, zeigte 
sich, dass der SGCE maßgeblich durch zwei der Isoformen vermittelt wird: Orai1 und STIM2.  
RSS tragen nicht nur zur Abtötung von Pathogene bei, sondern wirken auch als Signalmoleküle 
indem sie Oxidationsreaktionen ermöglichen. Monozyten tragen in ihrer Funktion als 
Phagozyten zu einem oxidativen Milieu in entzündetem Gewebe bei, indem bei Pathogen-
Kontakt eine Enzym-vermittelte RSS Produktion aktiviert wird. Die hauptverantwortlichen 
Enzyme sind die NADPH Oxidasen (NOX). NOX2 konnte in dieser Arbeit als das 
verantwortliche Enzym der RSS Produktion von Monozyten ermittelt werden. In einer 
vorhergehenden Studie konnte gezeigt werden, dass ein stark oxidatives Milieu, wie es durch 
Phagozyten im Rahmen einer Entzündung generiert wird, den SGCE in humanen CD4+ T-
Zellen inhibiert. Es zeigten sich zudem Unterschiede in der redox Sensitivität der einzelnen 
Kanal-bildenden Orai Proteine. Orai1 und Orai2 werden durch RSS inhibiert, wobei Orai3 sich 
als redox- insensitiv erwies. Es konnte zudem gezeigt werden, dass die Orai3 Expression im 
Laufe der T-Zell Differenzierung erhöht wird, um so Ca2+ Signale in T-Zellen auch in einem 
stark oxidativem Milieu aufrechterhalten zu können. Daher war es ein Hauptaspekt dieser 
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Arbeit, die Regulation der RSS Produktion durch ORAI und STIM vermittelten SGCE und 
wiederum die Wirkung der RSS auf die beteiligten CRAC Kanäle in einer Zellart zu 
untersuchen, die im Vergleich zu T-Zellen noch höheren Konzentrationen an RSS ausgesetzt 
ist. Monozyten eigneten sich aufgrund ihrer Funktion als RSS-Produzenten, daher besonders 
als Versuchsobjekt. Dazu wurde die extra- und intrazelluläre Produktion von •O2- und H2O2 
anhand spektroskopischer und fluoreszenz-basierter Methoden bestimmt. Hierbei zeigte sich 
eine Abhängigkeit der NOX2-basierten RSS Produktion vom SGCE. Durch Herunterregulation 
der Orai und STIM Proteine konnte gezeigt werden, dass Orai1 und STIM1 und in besonderem 
Maß auch STIM2 für eine hinreichende RSS Produktion benötigt werden.  
Der SGCE von Monozyten wies in Anwesenheit von H2O2 eine Dosis-abhängige Inhibierung 
auf. Eine Herunterregulation von Orai3 führte zu einer Verstärkung der Inhibition. Während 
Orai3 keine direkte Rolle an der Steuerung der Ca2+-abhängigen RSS Produktion zukommt, 
moduliert das Protein die inhibierende Wirkung von H2O2 auf die RSS-Produktion. Unter 
Kontrollbedingungen führe eine H2O2 Behandlung nicht zu einer Inhibierung der RSS-
Produktion, während eine verminderte Expression von Orai3 eine H2O2-bedingte Inhibierung 
zur Folge hatte. Zusammenfassend belegen diese Ergebnisse die Existenz eines regulativen 
Feedback-Loops zwischen der Orai- und STIM-abhängigen RSS Produktion und der RSS-
bedingten Inhibierung der CRAC Kanäle. Die festgestellte regulierende Wirkung des oxidativen 
Milieus unterstreicht die wichtige Rolle von RSS als Signalmoleküle im Immunsystem. Ein 
therapeutischer Eingriff in diesen regulatorischen Loop könnte eine Korrektur pathologischer 
RSS Level, wie sie z.B. bei rheumatoider Arthritis und Arteriosklerose vorliegen, ermöglichen. 
Obwohl dem SGCE eine große Bedeutung zukommt, zeigten Überlebensstudien, dass 
Monozyten eine hohe Resistenz selbst dramatischen Änderungen des Ca2+ Milieus gegenüber 
aufweisen.  
In Melanomen kann ein spontaner Wechsel zwischen einem proliferativen und 
metastasierenden Phänotyp auftreten, der durch verschiedenste, teilweise unbekannte, 
Faktoren reguliert wird und über die Progression des Melanoms und das Ansprechen des 
Tumors auf konventionelle Therapien entscheidet. Um die Rolle des durch Orai und STIM 
vermittelten SGCE und die Rolle des extrazellulären Ca2+ Milieus für die Phänotyp Ausprägung 
zu bestimmen, wurde die Migration und die Proliferation von Melanom-Zelllinien untersucht. 
Verringerte extrazelluläre Ca2+-Konzentrationen und durch Herunterregulation von Orai und 
STIM bedingte geringere Ca2+-Signale führten zu einer verstärkten Proliferation der Zellen. 
Zudem zeigte sich eine erhöhte Expression des Microphtalmie-assozierten 
Transkriptionsfaktors, ein bekannter Marker des proliferativen Phänotyps. Im Gegensatz dazu 
wurde das invasive Potenzial durch eine Herunterregulation von Orai1 und STIM2 vermindert. 
Dementsprechend zeigten Marker wie JARID1B und Brn2, die einen nicht-proliferierenden 
Phänotyp charakterisieren, eine verminderte Expression. Zusammenfassend unterstützen die 
Ergebnisse ein Model, in dem ein dynamischer Phänotypwechsel in Melanomen durch Orai1 
und STIM2 kontrolliert wird. Eine pharmakologische Regulierung von Orai1 und STIM2 könnte 
die Metastasierung eines Melanoms verhindern und den Tumor empfänglicher für 
konventionelle Therapien machen, die vornehmlich stark proliferierende Zellen zum Ziel haben.  
Weiter gedacht, können die in dieser Studie gewonnenen Erkentnisse über die Regulation 
zellulärer Funktionen in monozyten und malnom Zellen durch CRAC Kanäle ein Zugewinn für 
die klinische Forschung sein. Die Ergebnisse zeigen, dass Orai and STIM potenzielle 
Angriffspunkte in der Behandlung entzündlicher Erkrankungen und in der Krebstherapie sein 
können. Den Isoformen Orai3 und STIM2 kommt dabei eine besonderer Rolle zu.   
Summary 
 
 
 
11 
 
3.2 Summary 
Cellular function is defined by the interplay between the extra- and intracellular milieu. In this 
regard, Ca2+ and redox signaling play a decisive role. The skin and the immune system are two 
examples where Ca2+ and redox signaling are known to control several physiological and 
pathological conditions. The presence and relevance of a major calcium signaling pathway was 
analyzed in human melanoma cell lines and primary human monocytes as they cope with a 
characteristic Ca2+ and redox milieu in their respective tumor and inflammatory environment. In 
the skin, UV exposure leads to the release of a plethora of hormones by keratinocytes and 
melanocytes and the subsequent activation of the production of reactive oxygen species 
(ROS), as well as calcium signaling cascades. Under physiological skin conditions calcium 
signaling was shown to regulate essential melanocyte functions as pigment synthesis, while 
there was little information available on its role in pathological conditions as melanoma. 
Calcium signals were likewise shown to play an essential role in adaptive immunity, such as 
regulating the proliferation and differentiation of T cells. Furthermore, ROS production and 
redox signaling, as well as calcium signaling play an important role in innate immune responses 
to invading pathogens. However, the role of calcium and redox signaling in a very central cell 
type of innate immunity, the monocytes, was so far only poorly investigated.  
The signaling pathway investigated was the store-operated calcium entry (SOCE), mediated by 
the calcium release activated Ca2+ (CRAC) channels, as well as the specific roles of its 
molecular components Orai and STIM, responsible for channel formation and gating. Ca2+ 
signals of the investigated cell types were determined by fluorescence-based imaging methods. 
Specific siRNAs targeting the single channel components (Orai proteins) and their regulators 
(STIM proteins) were used to analyze their contribution to SOCE. In contrast to other 
phagocytes, not only Orai1 and STIM1, but also Orai2 and STIM2 contribute to SOCE in 
monocytes, whereas in melanoma cell lines, Orai1 and STIM2 are the dominant isoforms 
regulating SOCE.  
Monocytes, as part of the first line of host defense, contribute to an oxidative milieu by enzyme-
triggered ROS upon pathogen encounter. ROS are not only involved in pathogen clearance, 
but also act as signaling molecules by mediating oxidative regulation of proteins and enzymes. 
The NADPH oxidases (NOX) are responsible for enzymatic ROS production. The isoform 
NOX2 was identified as the major ROS-producing enzyme in human monocytes. A highly 
oxidizing environment, generated by ROS-producing phagocytes in an inflamed tissue, was 
shown to inhibit the essential SOCE in human CD4+ T cells in a prior study. The channel 
forming Orai proteins display differences in their redox responses. Orai1 and 2 were shown to 
be inhibited by ROS, while Orai3 was shown to be redox-insensitive. Upon T cell differentiation, 
Orai3 is up regulated by CD4+ T cells as mechanism to fine tune Ca2+ responses in an oxidizing 
milieu. Therefore, one of the major aspects of the here predented study was to investigate ROS 
production and SOCE, as well as the effect of produced ROS on CRAC channel activity, in a 
highly redox challenged cell type as monocytes. Using spectroscopic- and fluorescence-based 
techniques, the extra- and intracellular production of ROS was measured, revealing a 
dependency of NOX2 activity on SOCE. Orai1, STIM1 and STIM2 were revealed to equally 
contribute to SOCE-dependent ROS production. SOCE of monocytes was dose-dependent 
inhibited in the presence of H2O2. This inhibitory effect was enhanced with the down-regulation 
of the redox-insensitive isoform Orai3. While there is no contribution to SOCE-dependent ROS 
production by Orai3, the isoform is responsible for the modulation of the inhibitory effect of 
H2O2 on SOCE: an H2O2 treatment does not alter SOCE-dependent ROS production under 
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control conditions, but in the absence of Orai3, ROS production is inhibited under H2O2 
treatment. In summary, there are hints for a regulatory feedback loop between Orai and STIM-
dependent ROS production and the ROS-dependent inhibition of the CRAC channels. The 
regulatory function of H2O2 emphasizes the role of ROS as signaling molecules. The feedback 
loop might serve as a therapeutical target to modulate pathological ROS levels as they are 
known to be part of the clinical pattern of different inflammatory diseases as rheumatoid arthritis 
or atherosclerosis.  
Melanoma is one of the rarest, but most deadly form of skin cancer, progressing from 
melanocytes in the basal layer of the epidermis. The disease outcome, as well as the 
responsiveness to combination therapy is determined by spontaneous switching from 
proliferative to invasive phenotype. This phenotype switch and its underlying cellular features, 
proliferation and migration, are controlled by mainly unknown environmental factors. Therefore, 
the role of Orai and STIM-dependent Ca2+ signaling and the overall Ca2+ environment on 
melanoma phenotype was analyzed under lower extracellular Ca2+ conditions or following 
silencing of Orai1 and/or STIM2. In both cases, the experimental approaches resulted in a 
decrease in intracellular Ca2+. This decrease correlated with enhanced proliferation and 
increased expression of microphtalmia-associated transcription factor, a marker for proliferative 
melanoma phenotype. As counterpart, the invasive and migratory potential of melanoma cells 
was tested upon silencing of Orai1 and/or STIM2. Invasion and migration of melanoma cells, as 
well as the according markers for a non-proliferative, tumor-maintaining phenotype such as 
JARID1B and Brn2 were decreased. In summary, the results support a dynamic phenotype 
switching model in melanoma controlled by Orai1 and STIM2. Pharmacological tuning of Orai1 
and particularly STIM2 might thus prevent metastatic spread and render melanoma more 
susceptible to conventional combination therapy. 
Regarding the role of extracellular environment for cellular functions, the impact of an altered 
calcium environment on cellular behavior was also tested. While SOCE shows a meaning in 
both investigated cell types, the extracellular Ca2+ milieu only bears a meaning in regulating 
melanoma proliferation. In contrast, monocytes display a strong resistance to changes in the 
Ca2+ milieu, even under challenging conditions.  
In a broder scope, the findings on the role of the single Orai and STIM proteins in regulating 
cellular features of monocytes and melanoma, might provide new therapeutical applications for 
the treatment of skin cancer and innate immunity-associated diseases. In this regard, a 
distinctive role might come in for the STIM2 and Orai3 isoforms. Targeting this isoforms in a 
therapeutical approach could prevent harmful side effects on the respective signaling 
pathways, leaving Orai1 and STIM1 function unaltered, as the Orai1/STIM1 couple was shown 
to be essential in other cellular systems.  
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6 Introduction  
6.1 Cellular Signaling 
Cell life is regulated by complex signaling and metabolic pathways. Cells therefore have to 
receive, recognize, coordinate and integrate a huge variety of signals. Besides their role as 
acceptors, cells take an active part in the signaling process. By production and release of 
signaling molecules (hormones, cytokines) that can bind to receptors on either the producing or 
neighboring cells, they trigger further cellular responses (referred to as autocrine or paracrine 
signaling). Cellular signaling also includes physical interaction of neighboring cells or with 
components of the extracellular matrix, for example during adhesion and migration. Besides 
hormone, cytokine and enzyme release also the coordination and orchestration of extracellular 
and intracellular ion concentrations shapes signaling events. Signaling via changes in ion 
concentrations encloses a seemingly unmanageable network that requires tight regulation of 
the involved components. A plethora of channels, pumps and transporters are active to 
coordinate mainly Ca2+, Na+, K+ and Cl- concentrations for signaling purposes. The 
characteristics of two signaling molecules, namely Ca2+ and reactive oxygen species, that were 
investigated in the here presented study and their orchestration and relevance in a specific 
environment will be introduced in the following sections (6.1.1 - 6.1.3). This overview is followed 
by the presentation of the investigated cell types (6.2 and 6.3) and the molecular aspects 
underlying the analyzed signaling pathways with regard to the cellular context (6.4 and 6.5). 
Finally the detailed scientific questions addressed in this study are outlined with respect to the 
current knowledge regarding the investigated subject (6.6).  
6.1.1 Calcium Signaling  
Calcium ions (Ca2+) fulfill multiple and highly differential functions on cellular levels by acting as 
second messenger in cell signaling. Ca2+ passes the plasma membrane (PM) of cells exploiting 
transporting systems, such as channels, pumps and exchangers. In contrast to other ions, the 
great ability of Ca2+, to act as second messenger is based on its ubiquitous occurrence and the 
huge concentration gradients between the extracellular and intracellular space and subcellular 
compartments. The Ca2+ concentration ([Ca2+]) of the extracellular space with 1-2 mM exceeds 
the concentration in the cytosol, with about 100 nM, to a 10.000 fold. Meanwhile, internal stores 
as the ER/SR hold 0.5 mM, again exceeding cytosolic concentration (Figure 1, A).  
Ca2+ signal modulation 
By changing cytosolic Ca2+ concentration ([Ca2+]i(ntracellular)), different cellular processes are 
regulated, among these cell differentiation and proliferation, gene expression, cytokine 
production, exocytosis, ion channel activation and inhibition (Berridge et al., 2003; Clapham, 
2007). Ca2+ signaling is even more elaborated as not only the rise in [Ca2+]I, but also time, 
shape, location and magnitude of the signal defines the process to be regulated. In immune 
cells such as T cells, Ca2+ signals were shown to define cell fate, by leading to proliferation, 
apoptosis or tolerance. The different outcome of a Ca2+ signal depends on the modulation of 
shape (transient or oscillatory) and magnitude (high or low) (Qu et al., 2011). Within a Ca2+ 
signaling cascade, Ca2+ is bound by specialized Ca2+-binding proteins, as calmodulin or the 
members of the S100 protein family (Clapham, 2007; Donato et al., 2013). Ca2+ binding serves 
for either Ca2+-buffering or the transduction of the Ca2+ signal, by activating downstream 
cascade components. A common way of signal transduction by elevating [Ca2+]i, is the 
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activation and translocation of transcription factors (TF), whereas different TFs require different 
signals. For example the abundantly present TFs NFAT and NFκB, that are involved in 
regulating gene expression, promoting cell differentiation, proliferation, cytokine production and 
induction of immune responses (Pahl, 1999; Rao, 2009). NFκB is activated by high, short-term 
signaling events, while NFAT activation requires a lower, but long-lasting rise in cytosolic Ca2+ 
(Rao et al., 1997; Dolmetsch et al., 1997; Berridge et al., 1998; Crabtree, 1999).  
Ca2+ homeostasis: the basis for Ca2+ signaling  
A tightly regulated intermezzo of activation, inhibition and (co-) regulation of different kinds of 
Ca2+ permeating and transporting channels, pumps and exchangers is responsible for the 
maintenance of Ca2+ homeostasis and membrane potential. These two parameters are an 
essential prerequisite for proper signaling events across the plasma membrane. The plasma-
membrane Ca2+ ATPase (PMCA) is an ATP-consuming ion pump transporting Ca2+ ions from 
the cytosol to the extracellular space providing a backhaul mechanism. This backhaul 
maintains the driving force, required for further signaling events, and prevents a harmful rise in 
[Ca2+]I associated with apoptosis (Strehler & Treiman, 2004; Dong et al., 2006; Pászty et al., 
2007). Another Ca2+ ATPase is located in the membrane of the ER, called sarcoplasmic 
/endoplasmic Ca2+ ATPase (SERCA). This enzyme is responsible for the (re-) filling of internal 
Ca2+ stores, after they were emptied upon signaling events and leakage, an important aspect in 
calium homeostasis, but also specific calcium signaling pathways (Alonso et al., 2012). A 
scheme describing the components involved in regulating Ca2+ homeostasis is given in Figure 1 
(A).  
Ca2+ channels  
The variety of channels involved in regulating Ca2+ influx across the plasma membrane are 
sub-divided depending on their gating and activation mode into: receptor-operated channels, 
voltage-operated channels, second-messenger-operated channels and store-operated 
channels (SOC) (Parekh & Jr, 2005). SOC themselves are a highly versatile group of channels, 
but share a common activating pathway (see Figure 1, B and (Parekh & Jr, 2005)). The initial 
and central step in the activation cascade of SOC is the activation of phsopholipase C (PLC) 
that results in cleavage of the membrane residing phosphatidylinositol (PIP2) to diacylglycerol 
(DAG) and the release of inositol-(1,4,5)-trisphosphate (IP3) to the cytosol. IP3 binds to its 
cognate receptor (IP3R) located in the ER membrane. IP3R is a ligand-activated Ca2+ channel 
that releases Ca2+ from the internal stores to the cytosol upon activation. This rise is only 
transient due to the activity of PMCA, transporting Ca2+ to the extracellular space and SERCA, 
refilling the ER stores. Depletion of internal stores with transitional rise in [Ca2+]I is the 
activating trigger for SOC in the plasma membrane (Figure 1, B). The Ca2+ influx by SOC is 
therefore referred to as store-operated Ca2+ entry (SOCE). 
A member of the SOC family that is responsible for essential Ca2+ signaling events in many cell 
types is the calcium-release activated Ca2+ (CRAC) channel that mediates SOCE with a Ca2+ 
current (ICRAC) displaying distinct biophysical features. ICRAC was initially described in mast cells 
(Hoth & Penner, 1992; Zweifach & Lewis, 1993) and the molecular players of the CRAC 
channel remained unidentified for over 20 years. The CRAC channels and especially the role of 
their molecular components were the central point of this study and are described in detail 
below (6.4.1, 6.5 and 6.6.1).  
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Figure 1  Calcium homeostasis and signaling  
Adapted from (Clapham, 2007). (A) Involved channel and transporter activity in maintaining low cytosolic [Ca2+] at 
approx. 100 nM as requisite for Ca2+ signaling. Low cytosolic Ca2+ is maintained by extrusions of Ca2+ to the extracellular 
space by PMCAs and to internal Ca2+ stores as the sacro-/endoplasmatic reticulum by SERCA. Ca2+ can be released from 
internal stores via Ca2+-release receptors (IP3R and RyR). Secondary regulators of Ca
2+ concentrations as the NC(K)Xs are 
electrogenic and exchange cytosolic Ca2+ (and K+) with sodium ions from the extracellular space. The activation of K+ 
channels by Ca2+ and the subsequent efflux of K+ enhance the driving force for Ca2+ as further prerequisite for Ca2+ 
signaling. (B) The signaling cascades activating store-operated Ca2+ entry. Activation of cell surface receptors as RTKs or 
GPCRs, lead to the activation of PLC and the generation of IP3 and DAG from PIP2. IP3 binds to its cognate receptor, 
releasing Ca2+ from internal stores. This store release leads to the activation of different plasma membrane residing Ca2+ 
channels. The Ca2+ influx via these activated channels to the cytosol is an important factor in regulating cellular 
functions. Abbreviations used: NC(K)X – Sodium (Na+), calcium (Ca2+), (potassium (K+)) exchanger; PLC – Phospholipase 
C; PMCA – Plasmamembrane Ca2+ ATPase; IP3R – Inositol-trisphosphate- receptor; RyR – Ryanodine receptor; SERCA – 
Sarco-/endoplasmic reticulum Ca2+ ATPase; PtdIns – Phosphatidylinositols; PIP – Phosphatidylinositol phosphate; PIP2 – 
Phosphatidylinositol bisphosphate ; IP3 – Inositol-(1,4,5)-trisphosphate; DAG – Diacylglycerol; RTK – Receptor tyrosine 
kinase; GPCR – G-Protein coupled receptor.  
6.1.2 Redox Signaling  
6.1.2.1 Reactive Oxygen Species: Types and features 
Aside from Ca2+ as an important signaling molecule, more and more attention is paid to other 
small, organic molecules that act in signaling events. A prominent example are reactive oxygen 
species (ROS) that encompass a huge variety of approx. 20 small reactive molecules that 
initially derive from molecular oxygen (O2). Among these are superoxide- (O2• -), hydroxyl- 
(OH•), and peroxyl- (R-O2•) radicals, as well as hydrogen peroxide (H2O2) und hypochlorus acid 
(HOCl) (Dröge, 2002; Lambeth, 2004). The term ROS, although often misinterpreted only 
describing free radicals, comprises radical and non-radical species. These species differ in 
terms of their reactivity with organic molecules, their stability and life time and their spatial 
mobility. These features can be estimated by modelling approaches and based on chemical 
properties as the reduction potential or the determination of rate constants between different 
reaction partners. The occurrence of a redox reaction, dependents on the abundance of the 
oxidants, the presence of antioxidants or decomposing enzymes and the presence of 
competing interaction partners (Winterbourn et al., 2006; Winterbourn, 2008).  
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ROS production and formation includes conversion from different species into others, either 
spontaneously or by enzyme supported reactions, including dismutation, Fenton reactions (in 
presence of metal ions), peroxidase reactions (myeloperoxidase) and decomposition. An 
overview of major biological relevant ROS and the ways of (inter-) conversion is given in  
Figure 2 (Lambeth, 2004). 
The presence of these reactive molecules was considered as the companion of an aerobic life, 
because ROS can derive from electrons escaping the respiratory chain in mitochondria. These 
escaping electrons can react with molecular oxygen to generate the superoxide radical. In 
general, ROS can origin from either exogenous or endogenous sources. Exogenous triggers 
that give rise to ROS are irradiation, the uptake of environmental pollutants and different 
chemicals. Within cells, ROS can originate from specialized organelles as microsomes and 
peroxisomes and are generated by different enzymes, as NADP oxidases, cytochrome C 
oxidase and xanthine oxidase (Trachootham et al., 2008). An uncontrolled increase in ROS is 
referred to as oxidative stress and usually related to unspecific oxidation of biomolecules with 
harmful consequences as tissue damage and DNA strand breaks. The term oxidative stress 
therefore has to be distinguished from redox signaling, describing a controlled, enzymatic 
regulated production of certain ROS with defined concentrations and targets (Valko et al., 2007; 
Trachootham et al., 2008). The enzymes responsible for regulated ROS production are called 
NADPH oxidase and are described in detail in a following section (6.1.2.3).  
The importance of ROS was initially described in the immune system when upon pathogen 
encounter, a rapid increase in oxygen consumption and the release of huge amounts of ROS 
was observed in phagocytic cells (Babior, 1984a). This phenomenon is referred to as oxidative 
burst and was shown to be involved in pathogen clearance and initiation of further immune 
responses (Babior, 1984b; Reth, 2002). The involvement of ROS in regulating cellular function 
has expanded from the immune system to the brain, the skin and other organs. In a broader, 
more general scope, emerging evidence links ROS production and redox signaling to cancer 
(Waris & Ahsan, 2006; Liou & Storz, 2010). 
6.1.2.2 ROS as signaling molecules 
General aspects 
To serve as signaling molecules and to avoid excessive ROS production reaching harmful 
levels, ROS concentrations, as well as Ca2+ concentrations, have to be tightly regulated. This is 
why ROS clearing enzymes and mechanisms are equally important as ROS production itself. 
Major ROS clearing enzymes and mechanisms comprise enzymatic and non-enzymatic 
components and systems, while several systems and components work together, overlap or 
depend on each other. Major enzymatic ROS clearing enzymes are the family of superoxide 
dismuatase (SOD) or catalase, a heme-containing enzyme located in peroxisomes. SODs are 
involved in the dismutation of superoxide to H2O2, while catalase degrades peroxides as H2O2. 
The glutathione system together with glutathione peroxidase (GPx) and reductase (GR) is one 
example for a team up of enzymatic and non-enzymatic systems. GPx decomposes H2O2 to 
H2O in a coupled reaction with the oxidation of reduced glutathione (G-SH) to form GS-SG. GR 
is involved in the recycling of oxidized GS-SG under NADPH consumption. Reduced G-SH is in 
addition involved in thiol-disulfide exchange reactions and is therefore dependent on GR 
recycling (Dröge, 2002; Bedard & Krause, 2007; Trachootham et al., 2008).  
Production of certain ROS is restricted to specialized compartments and the different 
specialized enzymes involved in ROS production and inter-conversion are likewise constrained 
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in expression or localization to certain tissues, cells or sub-cellular compartments. These strong 
restrictions emphasize the necessity of spatial and temporal control of ROS production. For 
example myeloperoxidases (MPO) that generate the highly reactive HOCl, important for 
pathogen clearance, are restricted to membrane enclosed endosomes, with also the product 
trapped in the compartment (van der Veen et al., 2009; Winterbourn & Kettle, 2013). The key 
requirement for functional redox signaling is the maintenance of redox homeostasis, the 
balance between ROS production and scavenger activity. Imbalances are implicated in various 
diseases where either over- or underproduction of ROS without an adjustment of the 
scavenging machinery results in disease promotion (see 6.2.3 and 6.6.1 for details).  
Modes of redox regulation 
As signaling molecules ROS are involved in regulating cellular redox-mediated mechanisms 
that comprise transcriptional regulation or direct oxidative modification of proteins and 
enzymes. ROS can also be involved in regulating redox-sensitive interacting proteins, 
modifying enzymes and regulation of protein turnover (Trachootham et al., 2008). A very 
common way of redox-regulation is the oxidative regulation of protein tyrosine kinases and 
phosphatases (PTKs and PTPs). In summary, oxidative events favor phosphorylation of 
PTK/PTP targets as oxidation activates PTKs and inactivates PTPs (Chiarugi, 2005). There are 
multiple ways how proteins can be modified by oxidation with consequential activation or 
inactivation of the target. In proteins, the major target for oxidative modifications are thiol 
groups or cysteine residues (Bourdon & Blache, 2001; Poole et al., 2004; Groitl & Jakob, 2014). 
The different modes of oxidative modification comprise: resversible post-translational 
modifications such as S-gluthationylation, -prenylation and -farnesylations; the formation of 
disulfide bridges that are often involved in conformational changes of the target. The formation 
of reversible and irreversible sulphur acid derivatives such as sulfenic, sulfinic and sulfonic 
acid, are further ways to regulate protein function (Winterbourn & Hampton, 2008; Roos & 
Messens, 2011). 
H2O2 as biologically relevant ROS 
H2O2 is one of the biological most important ROS involved in regulation of cellular processes, 
because its properties fit key requirements of redox regulation. H2O2 has a limited target range 
and is mainly involved in the oxidation of cysteine residues, a key target in redox-regulated 
processes. In addition, oxidation of targets by H2O2 often requires activation energy although 
the reaction might by thermodynamically favored (Winterbourn, 2013). These strong restrictions 
prevent unspecific oxidation events. The damaging effects of H2O2 are limited and often caused 
by H2O2-derived species, rather than the oxidant itself, or only at very high concentrations. 
Compared to superoxide, H2O2 is very stable and is only decomposed in the presence of 
specialized enzymes as MPO generating HOCl, or catalase. The huge spatial motility of H2O2 
that can be up to 1.5 mm and the fact that H2O2 can pass biological membranes is a key factor 
for the regulation of even distant intracellular or extracellular targets (Winterbourn, 2008). Still, it 
has to be considered that H2O2 gradient build up over membranes. H2O2, as well as other non-
membrane-passing ROS, can be restricted to subcellular compartments due to the presence of 
reaction partners or antioxidative systems (Go & Jones, 2008; Jones & Go, 2010). Regarding 
the actual mode of H2O2-mediated redox regulation, there is still controversy whether direct or 
indirect oxidation of a target underlies the process. Direct oxidation of cysteine targets were 
described, but also different indirect models were suggested (Winterbourn, 2013). An indirect 
way for example would be the oxidative inactivation of a scavenging protein, interacting with the 
actual target, making the target accessible for oxidation.  
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6.1.2.3 ROS generating Enzymes: NADPH Oxidases 
The main enzymatic sources for ROS are the seven members of the NADPH oxidase (NOX) 
and dual oxidase (Duox) family: NOX1-5 and Duox1 and Duox2. The first enzyme identified 
with the major function of generating ROS instead of producing it as a byproduct was the 
NADPH oxidase of phagocytes (neutrophils and macrophages), with its catalytic main subunit 
termed phox (phagocyte oxidase), also referred to as gp91phox. In the family nomenclature the 
NOX of phagocyte that also serves as prototypic isoform, is termed NOX2.  
NOX enzymes reside in the plasma membrane or the membrane of different endosomes and 
produce superoxide by transmitting electrons from NADPH to molecular oxygen. The different 
isoforms show distinct features and similarities in their core structure, the necessity and number 
of additional subunits and their activation mode. NOX1-4 share a basic core structure with a 
six-transmembrane-domain topology and cytosolic N- and C-termini. Two bound heme 
molecules in the core structure provide the electron transfer chain required for the electron 
transport. The electrons are carried by cyclic reduction and oxidation of iron-centers within the 
bound heme molecules. NOX5 differs from NOX1-4 in carrying an additional Ca2+ binding 
domain facing the cytosol. The core unit of the dual oxidases comprises an additional 
transmembrane-domain, a Ca2+ binding domain, as well as a peroxidase domain facing the 
extracellular or intra-endosomal space, which enables the oxidation of target proteins under 
H2O2 consumption in addition to superoxide production (Lambeth, 2004; Bedard & Krause, 
2007).  
NOX and Duox enzymes can be found in many cells and tissues, but still the expression of 
several isoforms is restricted to certain tissues, or cells preferentially express one isoform. As 
for example Duox 1 and 2 are mainly found in thyroid and phagocytes preferentially express 
NOX2 (Krause, 2004). Regarding the organ systems addressed in the here presented study, 
the differential expression of NOX isoforms in the immune system and melanoma is briefly 
summarized. So far, NOX1 and NOX4 were described to regulate tumor progression and also 
NOX2 was shown to be expressed and to promote growth of melanoma skin-grafts in rodents 
(Kelkka et al., 2013). NOX1 activity was further related to enhanced invasion of melanoma cells 
(Liu et al., 2012). NOX4 activity was also linked to regulate melanoma progression, by 
enhancement of melanoma growth (Brar et al., 2002; Yamaura et al., 2009) and by rendering 
melanoma growth from a radial to a vertical, hence more aggressive, phenotype (Govindarajan 
et al., 2007). Although seeming to be mainly involved in enhancement of melanoma 
progression, NOX4-derived ROS was recently shown to induce an apoptotic pathway in 
melanoma cells (Liu et al., 2014). In the immune system, NOX2 is the predominant expressed 
isoform, as it is responsible for ROS production of phagocytes and was shown to be expressed 
in neutrophils, macrophages and monocytes, and several immune-cell derived cell-lines 
(Bedard & Krause, 2007). Recently NOX4, in addition to NOX2, was also suggested to 
contribute to ROS production and cellular signaling in monocytes (Lee et al., 2010a; Ullevig et 
al., 2012).  
6.1.3 Inflammatory and tumor environments  
With Ca2+ and redox signaling as the major aspects of this study, two different cellular systems 
were the object of investigation: the skin and the immune system. The two seemingly very 
different systems share a high importance for Ca2+ and reactive oxygen species in regulating 
cellular (signaling) processes both, on a molecular level as second messenger and as a 
component of the cellular environment (see also 6.1.2.3 and 6.6.1). 
Introduction 
 
 
 
21 
 
 
Figure 2 The basics of redox-signaling – Sources and inter-conversion of ROS 
Generation of reactive oxygen species (ROS) in human immune cells (phagocytes), their inter-conversion (blue arrows), 
involved enzymes or cofactors (blue ellipses), the reactivity (red) of the specific ROS and events and molecules that 
trigger the production (grey arrows). Reactivity and harmfulness of ROS is indicated by the color shift from green (not 
harmful, little reactivity) to red (harmful, high and unspecific reactivity). Localization of involved enzymes is indicated in 
blue. Information about sources from (Bogeski et al., 2011). Abbreviations used: Duox – Dual oxidase; NOX – NADPH 
oxidase; Phox – phagocyte NADPH oxidase (or NOX2); SOD – Superoxide dismutase, MPO - Myeloperoxidase. The 
figure is adapted and extended from (Lambeth, 2004).  
Regarding the challenging conditions cells are facing under pathological skin and immune 
conditions, not only Ca2+ and redox-signaling processes, but also changes in the Ca2+ and 
redox-environment impact cellular functions. In this context, the two cell types regarded in this 
study are briefly introduced here in terms of the role of the environment for cellular function, 
while the signaling processes investigated in this study are already outlined above (see 6.1.1 
and 6.1.2.). The two cell systems will further be described in the following sections (see 6.2 and 
6.3).  
6.1.3.1 Melanoma – an example for the role of a tumor environment  
The skin is a solid example of how an environment impacts cellular fate and the overall function 
of an organ. The Ca2+ environment in the epidermis, the most outer region of this multilayer 
organ, was shown to define the function and development of the residing cells. The epidermis 
displays a Ca2+ gradient, with low concentrations in the basal area and increasing 
concentrations towards the outer rim (Elias et al., 2002). This gradient was shown to determine 
the differentiation of keratinocytes, the major cell type in the epidermis, thereby ensuring barrier 
formation and sealing against the outer world (Hennings & Holbrook, 1983; Eckert et al., 1997; 
Beck et al., 2008). Under pathological skin conditions as malignant melanoma, the micro-
environment was shown to hold a huge potential in regulating tumor progression. It was 
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reported, that malignant melanoma were reprogrammed to a benign phenotype when 
transferred to an embryonic cellular environment in vitro (Topczewska et al., 2006; Díez-Torre 
et al., 2009). Hypoxia, is a characteristic environmental condition involved in the induction of 
redox stress responses and is often observed in tumors as for example melanoma (Bedogni & 
Powell, 2009). Hypoxic conditions were shown to accelerate the malignant transformation of 
melanoma, demonstrating the important role of the micro-environment for cellular development 
(Bedogni et al., 2005; Monsel et al., 2010). Although the skin is indeed an individual organ, it is 
also considered as part of the innate immune system. While it serves as a physical barrier 
towards the outside world and harmful intruders it also homes cells of the immune system and 
is a site of inflammatory events. Within this context, inflammatory processes were shown to 
contribute to melanoma initiation. Cytokines and metabolites, such as ROS, released by 
inflamed endothelia or activated immune cells, can contribute to the inhibition of apoptosis, 
enhancement of proliferation, or cause DNA damage of benign cells, thereby promoting 
tumorigenic transformation.  
6.1.3.2 Shaping monocyte and macrophage function – an example for the role of the 
inflammatory environment  
Monocytes and macrophages are two cell types of the innate immune system that are allocated 
to inflammatory processes. These cells are responsible for the clearance of intruding 
pathogens and tissue repair, as well as the recruitment of other immune cells and their 
regulation by releasing specific pro-inflammatory cytokines and chemokines. Monocytes and 
macrophages are highly versatile cells that reside in different tissues and are exposed to 
specific. local environments. The cells fulfill a plethora of functions, such as pathogen clearance 
during inflammation or tissue repair and maintenance under steady-state and post-
inflammatory conditions. Hence, different macrophage and monocyte subtypes develop and 
display specific characteristics depending on the local micro-environment (Nicholson et al., 
2009; Weidenbusch & Anders, 2012; Brüne et al., 2013). In inflammation, monocytes and 
macrophages release ROS within the oxidative burst, thereby defining the local oxidative milieu 
themselves in addition to ROS release from other cells, as for example endothelia cells (Carta 
et al., 2009). Due to the high potential of ROS to act as signaling molecules and the redox-
sensitivity of various signaling pathways (see 6.1.2.2), the redox milieu not only contributes to 
shape cellular function of monocytes and macrophages themselves (Weidenbusch & Anders, 
2012; Brüne et al., 2013), but also other immune cells, as for example T cells (Trujillo et al., 
2014).  
6.2 Monocytes  
6.2.1 Monocytes in the scope of the immune system  
Monocytes (MCs) are leukocytes that develop within the myeloid linage of the hematopoietic 
system and are allocated to the innate immunity. The involved organs and cells of the innate 
immune system are the first line of host defense against intrusion of harmful pathogens and are 
mediators to adaptive immunity. Together with macrophages (MØ) and dendritic cells (DC), 
monocytes are further allocated as mononuclear phagocyte cells (MPCs). MPCs can be 
distinguished from other leukocytes as neutrophil granulocytes and natural killer cells, which 
are also part of cellular innate immunity. As mentioned above (6.1.3), monocytes are highly 
versatile cells that fulfill three major functions on a cellular and humoral level: 1) clearance of 
pathogens by phagocytosis and production of inflammatory cytokines, 2) immune modulation 
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by linking inflammatory processes to adaptive immunity and 3) presentation of antigens (Dale 
et al., 2008; Auffray et al., 2009; Geissmann et al., 2010).  
Monocyte features 
Monocytes are non-proliferative cells that comprise 10% of human blood leukocytes and are 
found in the blood as well as in bone marrow and the spleen. They display characteristic 
morphological features as an irregular cell shape, an oval-shaped nucleus, cytoplasmic 
vesicles, a high cytoplasm-to-nucleus ratio and are very heterogeneous in size and shape. The 
life cycle of monocytes involves the development from bone marrow progenitors, circulation in 
the blood and invasion of peripheral tissues in response to chemoattractants and inflammation- 
or tumor-derived mediators (Partida-Sánchez et al., 2004; Ingersoll et al., 2011; Lee et al., 
2013).  
Monocyte function  
As effector cells, monocytes are professional phagocytes and are involved in pathogen 
clearance and tissue homeostasis as described in detail below (6.2.2). Monocytes fulfill 
immune-modulatory functions, as they give rise to macrophages and inflammatory dendritic 
cells. Macrophages, highly versatile cells themselves, are involved in tissue homeostasis and 
remodeling, clearance of invading pathogens and immune response enhancement by 
interaction with T cells and cytokine production (Suttles & Stout, 2009; Rees, 2010; Biswas & 
Mantovani, 2010). They can further differentiate into specialized cells to fulfill tissue specific 
functions. For example in the liver they are involved in lipid metabolism and toxin removal as 
kupffer cells or they contribute to neuronal pattering and fluid balance as microglia cells in the 
brain (Murray & Wynn, 2011; Wynn et al., 2013). Dendritic cells are professional antigen 
presenting cells and serve in the transition from innate to adaptive immunity by linking 
inflammatory processes to T cell responses. Monocytes and macrophages hold the molecular 
machinery to process and present antigens, but compared to dendritic cells, their presenting 
capacity is much lower. Upon the uptake of an antigen (pathogen-derived material), DCs evade 
the tissue to enter the lymphatic system in order to present the processed antigen to naïve T 
cells in peripheral or central lymph nodes. Despite, or due to their versatile roles, monocytes 
and macrophages contribute, or are associated to pathological processes especially in 
inflammatory related diseases (as described below in 6.2.3).  
Monocyte heterogeneity  
In line with their high versatility, monocytes display at least three different phenotypes and are 
subdivided to: classical (or inflammatory), resident (or pro-inflammatory) and intermediate 
monocytes. An overview of the different phenotypes and their major features is given in Table 
1. As effector cells monocytes are equipped with a huge variety of chemokine and adhesion 
receptors. These do not only mediate migration from blood to tissues during infection, submit 
responses to cytokines and are involved in cell activation, but are also used for classification of 
the subtypes (Gordon & Taylor, 2005; Robbins & Swirski, 2010; Tallone et al., 2011). Examples 
of a choice of different surface molecules used for classification in general and two selected 
additional ones are presented in Table 2. The major characteristic of monocytes, that 
distinguishes this cell type from other leukocytes, is the expression of the CD molecule CD14. 
Meanwhile, the characteristic expression of the Fcγ receptors I (CD64) and III (CD16) is used 
to discriminate between the different monocyte subtypes. Others receptors used for this 
purpose are receptors of the chemokine family. Chemokines are important players in 
modulating and orchestrating innate and adaptive immune responses, as for example 
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monocyte recruitment to inflammatory sites and the migration from the blood vessel into the 
tissue. (Campbell et al., 2003; Moser et al., 2004; Ingersoll et al., 2011; Shi & Pamer, 2011). 
The expression of the chemokine receptor CCR2 on inflammatory monocytes and the binding 
of its specific ligands, is important for the recruitment of this monocyte subtype (Weber et al., 
2000). CCR2 is consequentially only weakly expressed by the other subtypes. In contrast, the 
chemokine receptor CX3CR1, promoting monocyte survival (Landsman et al., 2009), is 
preferentially expressed by resident and intermediate monocytes.  
It so to mention, that there are strong limitations to the classification and description of the 
different monocyte subtypes. The majority of studies investigating monocyte (and macrophage) 
subtypes are conducted in rodents and several molecules used for classification could not be 
identified in humans, as for example the surface molecule Lyc6, to which no human counterpart 
could be identified so far (Gordon & Taylor, 2005; Ziegler-Heitbrock et al., 2010). Classifications 
and nomenclatures are subject to constant changes and developments. A recent publication by 
Guilliams and colleagues, addressed the MCP system and suggested a new way of 
classification (Guilliams et al., 2014). The authors proposed to subdivide the MPC system in 
two steps. The primary subdivision would be based on ontogenic parameters and in a second 
step, the cells would be classified based on their function and location. So far, the classification, 
as currently accepted and outlined above, is primarily based on function and location of the 
cells.  
6.2.2 Monocytes as professional phagocytes  
Phagocytosis 
Together with neutrophils and macrophages, monocytes act as professional phagocytes. The 
major role of these cells is the clearance of pathogenic intruders and clearance of cell debris 
from necrotic and apoptotic cells. Phagocytosis leads to the degradation of the pathogen, 
meanwhile triggering further signaling events emphasizing the immune response. The 
clearance of pathogens involves the recognition of pathogenic patterns (pathogen associated 
molecular patterns, PAMPS) by surface molecules and receptors, the uptake (phagocytosis) of 
the pathogen and its degradation. Activation of the phagocyte is required for the initiation of 
phagocytosis and comprises a range of molecular stimulants. Among these, the binding of 
complement system components, that are involved in opsonization of the pathogen and 
facilitation of the uptake, or the binding of PAMPS to specialized receptors. Upon encounter 
with an intruder, binding of PAMPs or complement factors lead to the engulfment of the 
pathogen by the phagocyte. Thereby, the pathogen is trapped in a membrane enclosed 
endosome – the phagosome. This specialized endosome further fuses in the cytosol with 
lysosomes to form the phagolysosome, where pathogen killing takes place. 
A classic example for PAMP recognition is the family of formylated peptide receptors (FPR). 
These Gi-protein-coupled receptors are specialized to bind formylated peptides, that derive 
from prokaryotic pathogens and mitochondria of host cells. Receptor binding triggers signaling 
cascades involved in chemotaxis and ROS production of phagocytes, as well as clearance of 
host cell debris (Reviewed for example by (Panaro et al., 2006; Migeotte et al., 2006)). Binding 
of FPR agonists results in GDP to GTP exchange on the α-subunit and the consequential 
dissociation of the βγ-subunit. The βγ-subunit activates PLC which is responsible for hydrolysis 
of PIP2 to DAG and IP3. 
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Table 1 Monocytes subsets in humans 
Information on monocyte subset characteristics was selected and assorted from (Gordon & Taylor, 2005; Dale et al., 
2008; Shi & Pamer, 2011). 
Monocyte Subset Major characteristics Features  
Classical or 
Inflammatory 
CD14
high 
CD16
- 
CD64
+ 
CCR2
high 
CX3CR1
low
 
High phagocytic activity and cytokine 
production. CCL2 induced recruitment of MCs to 
inflammatory sites (lesions) is a critical step in 
monocyte recruitment 
Resident or 
Pro-inflammatory 
CD14
+ 
CD16
+ 
CD64
- 
CCR2
low 
CX3CR1
high
 
CCR5 
Resemble mature tissue macrophages and show 
preferential development to DCs (rather than 
classical monocytes). 
Intermediate CD14
+
 CD16
+ 
CD64
+
 
CCR2
low 
CX3CR1
high
 
Share high phagocytotic activity and cytokine 
expression with classical monocytes. Immune 
regulatory functions. Involved in anti-viral 
responses and patrolling. Intermediate 
phenotype in differentiation to DCs.  
 
IP3 binding to its cognate receptor in the ER-membrane leads to a release of Ca2+ from the ER-
stores, an initial rise in cytosolic Ca2+ and the activation of SOC, followed by a sustained Ca2+ 
influx (see also 6.1, Figure 1 and Figure 6). This increase in cytosolic Ca2+ is one of the earliest 
responses of the cell to FPR activation and is associated to proper phagocyte function 
(Selvatici et al., 2006). Ca2+ and DAG are important for the activation of PKC that is involved in 
several signaling pathways depending on phosphorylation events. The βγ-subunit also 
activates PI3kγ that is responsible for the phosphorylation of PIP2 to PIP3 (Le et al., 2002; 
Selvatici et al., 2006). These membrane lipids serve as anchors in the plasma membrane and 
are involved in interactions with cytoskeleton components (actin filaments), thereby contributing 
to cytoskeleton rearrangements, which are important for phagocytosis and cell migration 
(Johnson & Rodgers, 2008; Chen & Iijima, 2012). 
ROS production and pathogen degradation in phagocytosis 
The phagolysosome comprises lytic substances and holds a pH of 7 in neutrophils and an 
estimated 5 - 5.5 in macrophages and monocytes (Lukacs et al., 1990; Hackam et al., 1997; 
Jankowski et al., 2002; Nordenfelt & Tapper, 2011). In macrophages it was shown that the 
more acid pH contributes to the perfect milieu for pathogen degradation (Sturgill-Koszycki et al., 
1994). Phagocytosis is accompanied by the oxidative burst that provides a huge amount of 
ROS, essential to trigger further signaling events and degradation of the pathogen (see 6.1.2). 
As described above, the responsible enzymes involved in this ROS production are NOX 
producing ·O2-. Further redox processes lead to the generation of H2O2 (triggered by SOD 
activity) and the production of HOCl by myeloperoxidases (see Figure 3 and 6.1.2).To the 
current view, pathogen clearance might be the results of parallel occurring events based on 
oxidation events and proteolytic degradation. Despite the intensive work invested in 
understanding and revealing the processes occurring in the phagosome, the hierarchy and 
meaning of the different aspects already identified is still under debate. 
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Table 2 Surface markers used for classification of monocytes subsets 
Surface molecule Other expression Description and features  
CD14  A component of the LPS-LBP-complex that binds LPS, a 
pathogen derived molecule, and is the co-receptor of 
TLR-4. The CD14-TRL4 couple is involved in the 
recognition and clearance of gram-negative bacteria. 
CD16 FcγRIII FcγRIII is the low affinity receptor for recognition and 
binding of IgG antibodies and is responsible for the 
facilitation of phagocytosis of IgG-bound antigens. 
CD64 FcγRI FcγRI is a high-affinity receptor for recognition and 
binding of IgG antibodies 
HLA-DR  Part of the MHCII complex and involved in antigen-
presentation. Peripheral blood monocytes are 
characterized by no or marginal expression of HLA-DR.  
CCR2  Member of the CC-family of chemokine receptors. Binds 
CCL2 ( = monocyte chemotactic protein-1, MCP-1) and 
is therefore involved in attracting and homing of 
leukocytes to sites of inflammation.  
CX3CR1  Only member of the CX3C-family of chemokine 
receptors. Binds the ligand fractaline and is associated to 
survival of monocytes.  
CD62L Leukocyte L Selectin A surface molecule involved in leukocyte rolling in the 
blood vessels. Rolling of the cells at the vessel wall is a 
prerequisite for transmigration into the tissue.  
 
The complexity of ROS processes in the phagosome has been under continuing investigation 
for at least 30 years. Several groups, as for example Winterbourn and colleagues, provide 
precise insights into biochemical properties of ROS acting in the neutrophil phagosome 
(Winterbourn & Hampton, 2008; Winterbourn & Kettle, 2013). Another important factor in 
phagocytosis is the type of pathogen to be cleared. Ongoing research aims on identifying 
differences and similarities in innate immune responses to different types and subtypes of 
fungal, bacterial or viral infections (Serbina et al., 2008; Shi & Pamer, 2011).  
6.2.3 Monocytes in chronic inflammatory diseases 
Although being of high importance in the immune response to bacterial, viral and fungal 
infections, monocytes also contribute to the pathogenesis of sterile inflammation or 
inflammatory diseases such as atherosclerosis and rheumatoid arthritis by production of 
inflammatory cytokines and ROS. Prolonged inflammatory processes with their corresponding 
side effects and the damage to host tissue promote the development of inflammatory diseases. 
However, familiar predisposition and genetic susceptibility towards the onset and manifestation 
of chronic inflammatory diseases has to be taken into consideration (Blandizzi et al., n.d.; 
Incalcaterra et al., 2013; Korczowska, 2014). The necessity to identify molecular players 
underlying monocyte (mal-) function gains importance, due to the high incident number of 
patients displaying chronic inflammatory diseases, and the consequential high social-economic 
burden (Jacobs et al., 2011). 
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Figure 3  Generation of reactive oxidants by cellular NADPH oxide systems  
Oxidant generation in the phagosome following ingestion of a bacterium. NADPH oxidase (NOX2) is activated on the 
phagosomal membrane, and electrons are transported from NADPH across the membrane to oxygen to generate 
superoxide radicals, which dismutate to hydrogen peroxide. Degranulation releases myeloperoxidase (MPO), which 
generates hypochlorous acid (HOCl) involved in pathogen degradation and other decomposing acid enzymes and 
antimicrobial peptides. The figure and the text of the legend was adapted from (Winterbourn, 2008).  
Atherosclerosis is a sterile inflammatory disease that is characterized by a chronic inflammation 
of the artery wall with the formation of atherosclerotic plaques. The recruitment of monocytes to 
atherosclerotic lesions is a hallmark in disease onset. Monocyte function and differentiation into 
macrophages and dendritic cells further contribute to the disease pattern (Galkina & Ley, 2009; 
Shi & Pamer, 2011; Fenyo & Gafencu, 2013). Especially the formation of foam cells that 
originate and mature upon the uptake of oxidized low-density lipoproteins by macrophages, as 
wells as ROS production by monocytes and macrophages, were shown to accelerate the 
inflammatory process. These processes regulate monocyte and macrophage recruitment, 
differentiation, activation and autophagy, related to atherosclerotic symptoms and disease 
promotion (Cathcart, 2004; Galkina & Ley, 2009; Tavakoli & Asmis, 2012).  
Another inflammatory disease displaying an involvement of innate immunity is rheumatoid 
arthritis (RA) (Gierut et al., 2010; Ozbalkan et al., 2010). RA is an autoimmune disorder with the 
key feature of imbalanced tissue homeostasis resulting in joint destruction, accompanied by 
pain, stiffness and swelling. Monocytes and monocyte-derived cells play a central role in 
disease progression. On the one hand, accumulation of macrophages and increased 
production of ROS is associated to tissue (cartilage) damage (Dröge, 2002; Hadjigogos, 2003). 
On the other hand, studies in rodents revealed, that arthritis severity is dependent on NOX 
activity, as activation of NOX2 and the subsequent ROS production were shown to reduce or 
protect from arthritis symptoms (Hultqvist et al., 2006). In detail, the ncf-1 gene, coding for a 
cytosolic NOX2 subunit (p47phox), and mutations within the gene, were shown to regulate NOX2 
activity and severity of arthritis (Olofsson et al., 2003, 2007; Hultqvist et al., 2011). NOX-derived 
and ncf-1 regulated ROS were associated to regulate T cell activity and their impact on tissue 
damage and disease promotion (Gelderman et al., 2006; Hultqvist et al., 2006), emphasizing 
the protective role of ROS in autoimmune diseases (Hultqvist et al., 2009; Pizzolla et al., 2012).  
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6.3 Melanoma 
6.3.1 Skin – Melanocytes – Melanoma 
Structure of the skin and skin cancer origin 
The skin is a highly complex organ, composed of different compartments and cell types. The 
major function of this organ is barrier formation against the outer world and the invasion of 
pathogens, prevention of water loss and protection against UV radiation (UVR). While the 
epidermis is composed of mostly two cell types, keratinocytes and melanocytes, the dermis 
hold different cell types and structures as fibroblasts, hair follicles, sweat glands, nerves and 
blood- and lymph-vessels. The dermis is bordered by the subcutaneous tissue that holds the 
major blood vessels for oxygen and nutrient supply of the skin. Figure 4 shows a schematic 
overview of the human skin.   
Regarding pathological skin cancers, the outer layer, the epidermis, is of highest interest. The 
epidermis is build up from a basal layer of keratinocytes and melanocytes at the basement 
membrane that confines the epidermis from the dermis. The basal keratinocytes are covered by 
multiple layers of squamous keratinocytes that build up the different layers of the epidermis: 
stratum spinosum, stratum granulosum and stratum corneum. Basal keratinocytes are 
epidermal stem cells that continuously provide new cells and the layers display different stages 
of keratinocyte differentiation and barrier formation. Keratinocytes in the stratum corneum are 
completely differentiated (corneous cells) and are continuously shed off and replaced from the 
bottom layers. Melanoma is the most aggressive type of skin cancer that develops from the 
malignant transformation of melanocytes. During the malignant progression, melanoma cells 
spread into distant organs and thereby reduce the average survival of patients below 7 months 
(Balch et al., 2009; Garbe et al., 2011). Although, melanoma is the most aggressive malignant 
skin cancer it is the rarest one.  
Melanocytes as origin for melanoma: their physiological function in skin pigmentation 
Keratinocytes hold the pigment melanin that protects against UV radiation by absorbing 
radiation energy. Melanocytes are highly specialized cells that reside in the basal layer of the 
human epidermis. There they synthesize melanin, which is transported to the surrounding 
keratinocytes. Hence, these cells are responsible for skin pigmentation. Melanocytes display a 
long life span and are quite resistant to apoptosis (Quevedo et al., 1969; Bowen et al., 
2003).This resistance is achieved by constitutive activity of anti-apoptotic mechanisms, such as 
the expression of the anti-apoptotic cell death regulator Bcl2. However, due to their long-life 
span, melanocytes are prone to the accumulation of mutations. In particular, defects in genes 
coding for cell cycle regulators are frequently found in early stages of melanoma (Greene, 
1999; Marzuka-Alcalá et al., 2014). Melanin synthesis is the major function of melanocytes and 
is restricted to specialized organelles: the melanosomes. Melanosomes hold the enzymes 
important for melanin synthesis as there are tyrosinase and tyrosinase related protein 1 and 2 
(TYRP1,2) and are transferred to keratinocytes and thereby placed in the outer layers of the 
epidermis (Hearing, 2005). Pigmentation is highly differential between individuals, between and 
within different races. While the number of melanocytes is stable between individuals, the rate 
of melanin synthesis and the type of melanin produced defines the pigmentation status. The 
rate of melanin synthesis is further defined by the transcriptional regulation of the involved 
molecular components, such as TYRPs, transcription factors and growth factor receptors. In 
addition, there are two types of melanin synthesized, eumelanin and pheomelanin, with the 
Introduction 
 
 
 
29 
 
eumelanin amount as defining parameter of cutaneous pigmentation. Eumelanin displays a 
black or brown color and is therefore involved in UV radiation absorption in the skin, while 
pheomelanin displays a red color and is for example found in red haired individuals, lips, labia 
and the foreskin.  
 
Figure 4 Schematic overview of the human skin and the comprising cell types 
The human skin is comprised of three major layers with distinct functions: the subcutaneous tissue, the dermis and the 
epidermis. The subcutaneous tissue provides the major blood vessels for oxygen and nutrient supply. The dermis is the 
most complex layer, as it homes lymph- and blood vessels, hair follicles and sweat glands. The epidermis is mainly 
comprised of two cell types, melanocytes and keratinocytes. Melanocytes synthesize melanin for pigmentation and 
protection against UV radiation effects. Keratinocytes are responsible for the barrier formation to prevent water loss 
and the invasion of pathogenic intruders.3  
6.3.2 Melanoma progression  
The phases of melanoma progression  
The progression of melanoma is described by the Clark model that subdivides tumorigenes and 
the accompanying and determining phenotypic and genotypic changes into five stages, as 
illustrated in Figure 5 (Clark et al., 1984). Key factors in melanoma progression are altered 
migration and invasion, as well as aberrant proliferation and growth. Melanocytes undergo the 
malignant transformation to melanoma cells upon accumulation of mutation events and upon 
mutations in characteristic signaling pathways (see 6.3.3). In stage one benign nevi display an 
increased, though normal mode of proliferation and are the core nuclei for tumor development. 
The proliferation can be accompanied by an irregular growth of the residing melanocytes, and 
these aberrant, dysplastic nevi are further accounted to stage two. In this stage an increased 
number of characteristic mutations can be identified. Genetic defect are observed in genes 
coding for tumor suppressor genes and cell cycle regulators. Within progression, the tumor 
undergoes two differential growth phases. In stage three, the radial growth phase, melanoma 
cells gain the potential to outgrow the nevi and the basement membrane and invade the 
epidermis. The following vertical growth phase, stage four, describes the ability of the tumor 
cells to escape the epidermis and to trans pass the basement layer to invade the dermis. This 
change in growth phenotype is the result of an altered expression of cadherins and integrins 
that are important players in cell-cell, and cell-matrix interactions. 
                                                     
3
 http://www.cancer.gov/cancertopics/pdq/genetics/skin/HealthProfessional/ 
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Figure 5  Melanoma Progression  
The Clark model subdivides melanoma progression into five stages. These stages are characterized by specific 
morphological changes and the occurrence of molecular changes, as changed expression profiles of signaling cascades 
components involved in growth, survival, proliferation and invasion and metastasis. The figure was adapted from (Miller 
& Mihm, 2006).  
Severe alterations in these cell adhesion mechanisms that usually regulate tissue homeostasis 
and remodeling can lead to the detachment of cells from the original tumor (Johnson, 1999). In 
this fifth stage, metastatic melanoma, cells successfully evade the dermis and enter blood and 
lymphatic vessels in the subcutaneous tissue and spread to distant sites of the body. 
Melanoma metastasis mainly establish in the liver, lungs and the brain, and survival rates 
significantly decline in this stage of tumor progression (reviewed and illustrated by (Miller & 
Mihm, 2006)). Several hypotheses have emerged to explain the escape of cells from the tumor 
as it occurs in stage four and five. Pani et al. for example, suggested that metastasis results 
from an escape mechanism of tumor cells, to avoid hypoxic conditions and an increased redox 
stress in the tumor (Pani et al., 2010).  
Phenotype switch: Proliferation vs. Migration  
Regarding the issue of metastasis, it was observed that melanoma cells hold the ability and the 
potential to switch between different phenotypes to a rather more proliferative or more 
migratory type (Hoek et al., 2008). This switch is essential to tumor cells to establish a 
metastasis, when proliferation and growth are required to form a solid tumor, following the 
migration from the original tumor site. Apparently, subpopulations of melanoma cells possess a 
considerable migratory capacity while still retaining the potential to switch into a highly 
proliferative phenotype after arriving at the metastatic niche (Pinner et al., 2009). The 
mechanisms that control this phenotypic switch are largely unknown, but most likely involve 
extracellular signals from the tumor environment and complex intracellular signal transduction 
(Hoek et al., 2006, 2008; Hoek & Goding, 2010). Factors that were shown to stimulate 
proliferation of cancer cells including melanoma by engagement of membrane bound receptors 
and subsequent activation of transcription factors, are for examples hormones and peptides in 
vivo, or fetal calf serum (FCS) in vitro. Ca2+ signaling was shown to regulate important down-
stream effects to these stimuli (Roderick & Cook, 2008). This supports the potential of 
differences in composition of a local environment to alter melanoma phenotype in terms of its 
proliferative features. 
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6.3.3 Major signaling pathways and molecular players in melanoma progression  
Mitogen-activated protein kinase (MAPK) cascades 
The family of mitogen-activated protein kinases (MAPK) build a network of signaling cascades 
that are involved in regulating gene expression, mitosis, metabolism, motility, survival, 
apoptosis, and differentiation (Pearson et al., 2001; Cargnello & Roux, 2011). The signaling 
cascades are triggered by multiple activators binding to growth factor or G-protein-coupled 
receptors. Activation of MAPK cascades dependent on stepwise phosphorylation events of 
different MAPKs, resulting in phosphorylation and activation/inactivation of the final target 
substrate. In melanoma, the MAPK signaling cascade is a central pathway in regulating overall 
cellular functions. All MAPK signaling pathways consist of the following components: A MAPK 
kinase kinase (eg. B-Raf) that phosphorylates and activates the subsequent MAPK kinase (eg. 
MEK1) which is further responsible for the activation by phosphorylation of the final MAP kinase 
(eg. ERK1/2). Two important targets of the final MAP kinase ERK1/2 are the TFs CREB and 
MITF. The kinase activity of ERK1/2 leads to the phosphorylation of its target and its 
subsequent translocation to the nucleus. Ca2+ elevations upon cell stimulation are required for 
MAPKK kinase activation, as the initial activation of its family members, as for example B-Raf, 
is calcium/calmodulin-dependent (Salzano et al., 2012). There are different MAPK pathways 
that share similar basic components, but differ in terms of their activation. One example is the 
activation by ligand binding to the MC1 receptor that is involved in adaptive tanning of the skin. 
In this case, the initial MAPKKK is B-Raf that is activated by the small GTPase N-Ras. The 
MAPK cascade has further interesting implications in melanoma treatment, because the genes 
coding for B-Raf and N-Ras are prominent oncogenes in cutaneous melanoma (Wang & Qi, 
2013). BRAF shows point mutations in 40-65% of all cases and NRAS shows mutations in 10-
20%. The most common BRAF mutation is the point mutation V600E, located in the kinase 
domain of the enzyme (Hocker & Tsao, 2007). The mutation leads to an over activation of the 
MAPK signaling cascades and it targets (as for example MITF). BRAF, as other melanoma 
oncogenes and signaling cascade components, have been considered as therapeutical target, 
because BRAF mutation often occur at the very beginning of melanoma onset (Pollock et al., 
2003; Dong et al., 2003). B-Raf inhibitors have therefore evolved as important component of 
melanoma combination therapy (Wang & Qi, 2013). 
Micropthalamin-associated transcription factor (MITF) 
The TF MITF is often referred to as master regulator of melanoma and melanocyte function 
(Levy et al., 2006). This association is based on the plethora of target genes, regulated by 
MITF, that are involved in tumor-associated, but also basic cellular functions. In melanocytes, 
MITF is involved in the modulation of melanin synthesis, one of the major cellular functions, by 
regulating the expression of tyrosinase and TYRP1. An important aspect for melanoma 
progression is the survival and escape from cell cycle regulation of aberrant cells. Bcl-2, a 
central anti-apoptotic factor, as well as CDK2, p16 and p21, responsible for cell cycle 
regulation, are prominent targets of MITF. Furthermore, MITF is in charge of cellular stress 
responses by hypoxia-induced activation of HIF1-alpha. HIF1-alpha is a TF itself and activates 
the expression of genes, involved in responses to hypoxic stress, as for example growth factors 
essential for angiogenesis (MITF targets reviewed for example by (Cheli et al., 2010)). MITF 
activity is not only regulated by upstream signaling cascades, but also on the DNA level. Brn2 
is an important suppressor of MITF activity and is ubiquitously expressed in many cell lineages. 
Brn2 binds to the MITF gene, leading to suppression of MITF expression. In melanoma, activity 
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of Brn2 is therefore associated to the suppression of proliferation and differentiation and the 
enhancement of invasion and metastatic behavior (Goodall et al., 2008). 
Autocrine and paracrine signaling in the skin  
Signaling in the skin and likewise in skin cancers such as melanoma is comprised of a complex 
network that is based on autocrine and paracrine signaling events. These events are 
responsible for the intercommunication between fibroblasts, keratinocytes and melanocytes 
and are mainly involved in the regulation of melanocyte function in UVR responses. A 
prominent example for simultaneous autocrine and paracrine signaling under physiological and 
likewise pathological conditions is the chemokine CXCL-8 (or IL-8) and its two cognate 
receptors CXCR1 and CXCR2. IL-8 was shown to play an important role in different cancers 
such as prostate-, breast- and skin cancer (Waugh & Wilson, 2008). The chemokine was 
credited to serve as important component of the tumor environment. IL-8 receptors are 
expressed not only on tumor cells, but also on endothelia cells, recruited neutrophils and tumor-
associated macrophages. Therefore, IL-8 is involved in autocrine, as well as paracrine 
signaling in the tumor environment. Ligand-receptor interaction results in the activation of the 
coupled G-proteins and the subsequent activation of signaling cascades that result in the 
promotion of angiogenesis, enhanced proliferation and survival, as well as the promotion of 
migration and metastasis (Waugh & Wilson, 2008; Singh et al., 2010). IL-8 secretion and 
binding to its receptors is involved in the regulation of a plethora of targets, as for example TFs 
involved in proliferation-associated genes (Wu et al., 2012). The central MAPK-signaling 
cascade and its target were shown to be activated and regulated by IL-8. The cascade plays an 
important role in the enhancement of proliferation and survival of several tumors other than 
melanoma, such as ovarian and lung cancer (Venkatakrishnan et al., 2000; Luppi et al., 2007). 
Furthermore, IL-8 signaling holds an important role in melanoma progression and skin in 
general, due to its activation by UVR (Gebhardt et al., 2007). 
6.3.4 Ca2+ signaling in melanoma  
Ca2+ is known to play an important role in skin function, displayed by the Ca2+ gradient in the 
epidermis. Lowest Ca2+ concentrations are found in the basal layer that increase towards the 
outer layer, the stratum corneum (Menon 1985). The gradient is involved in barrier formation 
and is in return regulated and maintained within the barrier. Disruption and reformation of the 
barrier after injury was shown to be accompanied by the loss and rebuild of the Ca2+ gradient 
(Elias et al., 2002). Barrier formation is mainly provided by keratinocytes, and their proliferation 
and differentiation was shown to be defined by the epidermal Ca2+ gradient (see 6.1.3.1 and 
(Hennings & Holbrook, 1983; Eckert et al., 1997; Beck et al., 2008)). 
In addition to the importance of extracellular Ca2+ levels, intracellular Ca2+ signaling regulates 
many processes in skin such as barrier formation, cell differentiation, melanogenesis and tumor 
progression. These signaling events are mediated by TRP and store-operated channels, as it is 
discussed below (6.6.1). Aberrant Ca2+ signaling was early credited to play an important role in 
cancer onset and progression. This association is based on the link of Ca2+ signaling to 
functions related to tumor development such as invasion, migration and proliferation of cancer 
cells (Capiod et al., 2007; Monteith et al., 2012; Schwarz et al., 2013). 
The strong relation of Ca2+ signaling to melanoma progression is based on the fact, that Ca2+ 
mobilization is one aspect in the activation of major signaling pathways, as for example MAPK. 
This central signaling cascade is regulated by Ca2+ itself, as well as it triggers the elevation of 
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Ca2+ signals (see above 6.3.3). Several transcription factors, down-stream targets of MAPK, 
such as MITF and NfKB are Ca2+-dependent in terms of their activation (see also 6.1.1). As it 
was pointed out above, NfkB is regulated by cytosolic Ca2+ mobilization and is involved in the 
transcriptional regulation of IL-8. Thereby Ca2+ signals are involved in regulation of a 
chemokine involved in several aspects of melanoma progression (6.3.3). Hence, Ca2+-
mediating channels, that are responsible for cytosolic Ca2+ mobilization are important players in 
the regulation of melanoma progression and therefor an ongoing topic of research. 
6.4 Molecular aspects of calcium and redox signaling  
6.4.1 Store-operated calcium entry via calcium-release activated channels 
The components …  
Although the current mediated by the CRAC channel was already identified in mast cells in the 
early nineties (Hoth & Penner, 1992; Zweifach & Lewis, 1993) it took a long and winding road 
till the STIM (Roos et al., 2005; Liou et al., 2005; Zhang et al., 2005) and the Orai proteins (or 
CRAC modulators, CRACM) were identified as the molecular components of the CRAC 
channel (Feske et al., 2006; Vig et al., 2006b, 2006a; Zhang et al., 2006; Prakriya et al., 2006). 
STIM1 and 2 (or stromal-interacting molecule (STIM) 1 and 2) are monomeric proteins with a 
single trans-membrane domain. They were identified and proposed as tumor suppressor 
proteins (Manji et al., 2000; Williams et al., 2001), before they were later uncovered to gate the 
CRAC channels. As Ca2+-binding proteins, STIMs were identified as the missing link between 
the early observed presence of a Ca2+ entry mechanism and the release of Ca2+ from the ER 
(reviewed by (Johnstone et al., 2010; López et al., 2012; Soboloff et al., 2012)). Orai1, Orai2 
and Orai3 were identified as the pore-forming subunits of the CRAC channel (Prakriya et al., 
2006; Lis et al., 2007; Gwack et al., 2007), with four trans-membrane domains and cytosolic N-
and C-Termini. From the five molecular players identified, the gating of Orai1 by STIM1 was the 
focus of early investigations, as it was shown to provide essential SOCE in T lymphocytes 
(reviewed by (Hogan et al., 2010; Shaw & Feske, 2012a; Shaw et al., 2013)).  
… and the signaling cascade 
A schematic overview of the signaling cascade is provided in Figure 6. The receptor triggered 
depletion of the ER Ca2+ stores (see 6.1 and Figure 6) is sensed by the ER-membrane residing 
STIM1 and STIM2 molecules. STIM1 and STIM2 are trans-membrane proteins, carrying EF-
hands in the ER-luminal side. Under resting conditions and filled Ca2+ stores, Ca2+ is bound by 
the EF-hands. Upon depletion of the stores, Ca2+ dissociates from the molecule resulting in a 
conformational change leading to dimerization, translocation and cluster formation in areas 
close to the plasma-membrane; so-called puncta formation (Liou et al., 2005; Barr et al., 2009). 
Orai proteins are four-transmembrane proteins, forming homo- and heteromeric channels in the 
plasma-membrane. The so-called channel interacting domain (CAD) of STIM proteins was 
shown to be responsible for activation of the Orai proteins mediated by protein-protein-
interaction with coiled-coiled domains in the C-term of Orai subunits (Frischauf et al., 2009). 
STIM-Orai interaction is followed by change in channel conformation mediating an influx of Ca2+ 
from the extracellular space. The channel activity is regulated by two aspects: fast and slow 
Ca2+ -dependent inactivation of the channel itself and the refilling of the ER-stores by SERCA. 
The Ca2+ -dependent inactivation is overcome by Ca2+ uptake by mitochondria in close or 
further proximity to the channel, enabling a sustained Ca2+ influx that is for example responsible 
for activation of certain transcription factors (see 6.1).  
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Channel conformation …  
The biochemical properties of the Orai proteins to form homo- and heteromeric channels was 
investigated in detail, but the actual conformation of the CRAC channel is still under debate (Lis 
et al., 2007; Gwack et al., 2007; Peinelt et al., 2008). Although the CRAC channel was 
described as tetrameric channel (Mignen et al., 2008a; Penna et al., 2008), a publication by 
Hou and colleagues in 2012 suggested a hexameric conformation, based on a crystallization 
model from Drosophila Orai protein (Hou et al., 2012). Thompson and Shuttleworth described 
the hexameric channel to be a non-selective cation channel, conducting Ca2+ as well as Cs+ 
and Na+, in contrast to the highly Ca2+-selective tetrameric Orai channel, or the native CRAC 
channel itself (Thompson & Shuttleworth, 2013). Hence, further investigation is needed to solve 
the question of CRAC channel conformation.  
Based on finding from heterologous expression studies, all Orai isoforms might form bonafide 
CRAC channels, since they all displayed CRAC channel characteristics (Mercer et al., 2006; 
Lis et al., 2007; DeHaven et al., 2007). These characteristics encase activation by store 
depletion, Ca2+ over Na+ selectivity and an inwardly rectifying current/voltage relationship of 
ICRAC (Hoth & Penner, 1992; Zweifach & Lewis, 1993). In addition, all Orai proteins were shown 
to form homo- and heteromeric channels (Lis et al., 2007; Gwack et al., 2007; DeHaven et al., 
2007), but the stoichiometry of the single Orai-subunits in endogenous CRAC channel is 
controversial and under current investigation.  
Orai2 was initially stated to either not function as a bonafide channel, as there was no effect on 
SOCE following down-regulation, or only in the presence of Orai1 (Feske et al., 2006; Hoth & 
Niemeyer, 2013). The protein was also suggested to mediate remaining CRAC-like currents in 
immune cells from Orai1 knockout mice rather than Orai3 or another SOC (Vig et al., 2008; 
Gwack et al., 2008). The recent identification of a role for Orai2 (and STIM2) in mediating 
SOCE in neurons and dendritic cells implies that Orai2 forms an endogenous bonafide CRAC 
channel (Berna-Erro et al., 2009; Bandyopadhyay et al., 2011). Although Orai3 was described 
as bonafide CRAC channel in vitro, it might not be very likely that an Orai3 homo-multimer 
would form an endogenous channel. Orai3 is the lowest expressed isoform in most tissues with 
little exceptions. Thus and regarding that the CRAC channel might be a hexamer, an insertion 
of Orai3 in a hetero-multimer is more likely (Hoth & Niemeyer, 2013). As first example, the 
arachidonate-regulated Ca2+ channel (ARC channel), that displays a similar current/voltage 
relationship as ICRAC, but is not store-operated, was shown to be formed by Orai1 and Orai3 
(Mignen et al., 2008b, 2009). The ARC channel was further described as pentameric 
Orai3/Orai1-multimer, although based on the results from Hou et al. (Hou et al., 2012), a 
hexameric conformation of the ICRAC-like ARC channel is also possible.  
…and channel gating.  
Concerning the gating mechanism, the current accepted model suggests an optimal Orai to 
STIM ratio of 1:2. Thus, within a tetrameric channel, an optimal or maximum Ca2+ influx results 
from binding of eight STIM molecules (Li et al., 2011; Kilch et al., 2013). The amount of 
publications regarding STIM1-gated Orai1 function exceeds the one regarding the other 
subunits. This imbalance is most likely based on the essential role of Orai1/STIM1 in T 
lymphocyte function (Feske et al., 2006; Feske, 2010) and the strong immune phenotypes 
displayed by knockout mice (Oh-Hora et al., 2008; Gwack et al., 2008). STIM1 and STIM2 were 
both shown to activate Ca2+ currents mediated by Orai1, Orai2 and Orai3 (Parvez et al., 2008; 
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Wang et al., 2009; Schindl et al., 2009). An emerging number of publications reveal equal 
importance in CRAC channel gating for both STIM isoforms (reviewed by (Johnstone et al., 
2010; López et al., 2012; Soboloff et al., 2012). Thus, the mode of STIM activation and the Orai 
isoform to which it binds might depend on expression profiles, cell functional needs and might 
even be related to the evolutionary ancestry and development of a cell type (Collins & Meyer, 
2011).  
Studies in cell types preferential expressing STIM2 rather than STIM1, actually revealed STIM2 
as the dominant isoform regulating SOCE in cooperation with Orai2 (neurons and dendritic 
cells) and Orai1 (melanocytes) (Berna-Erro et al., 2009; Bandyopadhyay et al., 2011; Stanisz et 
al., 2012). Regarding cell functional needs, a study by Kar et al. revealed that activation of 
different types of receptors requires a differential contribution of STIM1 and STIM2 to trigger 
Ca2+ oscillations and transcription factor translocation (Kar et al., 2012). STIM2 was early 
allocated to play a role in basal cytosolic Ca2+ homeostasis rather than Ca2+ signaling events 
(Brandman et al., 2007), due to the lower Ca2+-binding affinity of the STIM2 EF-hand compared 
to STIM1 (Zheng et al., 2008). STIM2 was therefore related to trigger characteristic Ca2+ 
signals in response to the degree of store depletion, providing a mechanism to elevate different 
Ca2+ signals and cellular responses depending on the activation mode (Thiel et al., 2013). 
Melanocytes and neurons both derive from pluripotent neuronal crest progenitor cells. The 
similarities in preferentially STIM2 over STIM1 expression might indicate a correlation of 
evolutionary development and dominance of a certain STIM isoform mediating SOCE.  
6.4.2 Underlying mechanisms of enzymatic ROS production  
The assembly process 
Enzymatic production of ROS is strictly regulated as a requisite for ROS to serve as signaling 
molecules and to prevent harmful or pathological effects of imbalanced ROS levels (see also 
6.1.2). The importance of a strict regulation is reflected by the activation mode that requires 
multiple coinciding processes, leading to the assembly of spatially separated subunits to form a 
functional holoenzyme. Due to its proven function in phagocytes as macrophages and 
neutrophils and its consequential importance for this work, the molecular aspects of the 
activation of enzymatic ROS production are illustrated for NOX2 (Figure 7).  
The multi-component enzyme NOX2 is dissembled under resting conditions. Activation of a 
phagocyte upon pathogen encounter triggers coinciding activation pathways that result in the 
generation of the superoxide radical (•O2-). The activated enzyme consists of a core unit, the 
flavocytochrome b588, a hetero-multimer of the catalytic subunit gp91phox and the membrane 
protein p22phox, three cytosolic subunits (p47phox, p67phox and p40phox), the small GTPase RAC 
and two members of the S100 Protein family (Vignais, 2002; Kerkhoff et al., 2005; Bedard & 
Krause, 2007; Bréchard et al., 2013). The superscript (phox) states the affiliation of the subunits 
to NOX2, the phagocyte oxidase (phox), while the given numbers of the proteins (p) reflect their 
molecular weight. In contrast to the components involved in SOCE, the proteins contributing to 
ROS production are not glycosylated, with exception of the glycoprotein gp91phox. Under resting 
conditions, the subunits (with exception of the flavocytochrome) are disassembled and 
restricted to the cytosol. Gp91phox holds the electron-transport chain responsible for the transfer 
of electrons from the electron donor NADPH to molecular oxygen, while p22phox serves as a 
stabilizer for the enzyme and anchor for the cytosolic subunits. Upon stimulation four major 
cellular processes coincide to the assembly of the enzyme: 1) lipid metabolism, providing 
anchors for the recruitment of cytosolic subunits; 2) rise in cytosolic Ca2+ levels, leading to 
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translocation of Ca2+ sensing, complex stabilizing proteins and the activation of PKC; 3) 
phosphorylation of a cytosolic subunit initiating its translocation to the core unit and 4) 
nucleotide exchange on RAC, enabling the GTPase to bind to the complex and contribute to 
the activation. The three cytosolic protein subunits serve as organizer (p47phox), activator 
(p67phox) and modulator (p40phox) within the assembly process and hold complex interactions 
among each other, with the core unit and membrane anchors (see Figure 31 for details).  
 
Figure 6 Store-operated Calcium Entry (SOCE) 
Signaling cascade: Activation of cell-surface receptors triggers the activation of PLC and subsequent generation of IP3 
and DAG from PIP2. Soluble IP3 binds to its cognate receptor in the ER-membrane (IP3R). Upon binding, Ca
2+ is released 
by IP3R from internal Ca
2+ stores. The drop in Ca2+ store content is accompanied by dissociation of Ca2+ from the EF-
hands of so called STIM proteins residing in the ER- membrane (STIM1 and 2). Ca2+ unbound STIM proteins form 
dimers and relocate to ER junctions close to the plasma membrane to form puncta. STIM-clusters activate PM-residing 
CRAC channels that are buildup of hetero-tetramers of Orai family proteins (Orai1-3). Optimal activation of the channels 
occurs under the STIM-Orai stoichiometry of 2:1. Activated CRAC channels mediate the store-operated Ca+ entry to the 
cytosol. Mitochondria in close vicinity to the channels buffer entering Ca2+, thereby delaying fast and slow Ca2+ -
dependent inactivation of the CRAC channels. SOCE mediated by CRAC channels fulfills a diverse set of functions in 
immune cells ranging from essential regulating to modest modulation of Ca2+ -dependent processes. Inactivation of the 
CRAC channels and refill of the Ca2+ stores by SERCA pumps in combination with extrusion of Ca2+ from the cytosol by 
PMCAs terminates SOCE meanwhile building up status quo for further signaling events. Abbreviations used: PLC – 
Phospholipase C ; PIP2 - Phosphatidylinositol bisphosphate; IP3 – Inositol-(1,4,5)-trisphosphate; DAG – Diacylglycerol; 
IP3R – Inositol-trisphosphate- receptor; STIM – Stromal interaction molecule; CRAC – Ca
2+ -release activated Ca2+ 
channel; SOCE – Store-operated Ca2+ entry; SERCA – Sarco-/endoplasmic reticulum Ca2+ ATPase; PMCA – Plasma-
membrane Ca2+ ATPase. 
Focus on the role of Calcium in the assembly of NOX2: 
A crucial step for the activation of NOX2 is the rise in cytosolic Ca2+ levels. Firstly, the activation 
of PKC is dependent on Ca2+ and the interaction with DAG to phosphorylate the cytosolic 
subunit p47phox and gp91phox (Faust et al., 1995; El Benna et al., 1996; Raad et al., 2009). This 
step is thereby not only dependent on Ca2+ signaling itself, but also the generation of DAG from 
PIP2 as it takes place in the receptor mediated SOCE activation cascade (e.g. by activation of 
FPR receptors by bacterial products, see 6.2.2 and Figure 6). Besides phosphorylation of 
cytosolic subunits, phosphorylation of the core unit by PKC is involved in the activation 
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cascade. Secondly, the Ca2+-binding proteins S100 A8/A9 that are expressed by phagocytes 
as neutrophils and monocytes, are recruited to the NOX2 complex upon Ca2+-binding to their 
EF-hands, thereby contributing to NOX2 activation and stabilization (Kerkhoff et al., 2005). 
These proteins are members of the Ca2+-binding protein family S100 that fulfill multiple 
functions in inflammation, Ca2+ homeostasis, proliferation and migration (Donato et al., 2013). 
S100 A8/A9 binds aracidonic acid (AA), which is also involved in stabilization of the NOX2 
complex. The complex is recruited to the membrane by interaction with the subunit p67phox and 
RAC (Kerkhoff et al., 2005). It was shown that stimulation of different receptors triggers 
different signaling pathways that lead to the activation of PLC or PLD. In both cases, activation 
of kinases and the generation of specific second messengers lead to Ca2+ mobilization from 
internal stores and a Ca2+ influx via SOC (Nunes & Demaurex, 2010). Ca2+ signals are further 
involved in other factors that are important for phagocyte ROS production, as rearrangement of 
the cytoskeleton and fusion events of the phagosome with lysosomes or lytic granules (Nunes 
& Demaurex, 2010).  
6.5 The interplay of Ca2+ and redox signaling  
6.5.1 CRAC Channels and Redox Signaling  
SOCE mediated by CRAC channels is accepted to play an important role in phagocytic ROS 
production, as it is involved in the assembly of NOX (Bréchard & Tschirhart, 2008; Nunes & 
Demaurex, 2010) (see also 6.4.2). The role of the single Orai and STIM isoforms in this context 
was so far only investigated in neutrophils and neutrophil-like cell lines, mainly focusing on the 
Orai1/STIM1 couple.  
In neutrophil-like HL-60 cells, Orai1, in cooperation with TRPC channels 1 and 6, was 
suggested to mediate SOCE necessary for NOX activation and H2O2 production. Although the 
authors could not detect TRPC expression on protein level, the contribution was concluded 
from functional effects following siRNA treatment. Different stimuli were used and the 
physiological stimulus fMLF resulted in Ca2+ elevation and H2O2 production, while the SOCE 
activator Tg triggered Ca2+ signals but no production of H2O2 In another study using the HL-60 
cell line, phagosomal ROS production was shown to be dependent on Orai1 and STIM1 
mediated SOCE. Although Orai2 and Orai3 mRNA expression levels were even higher than 
those of Orai1, RNAi mediated knockdown did not reveal a contribution to SOCE. Interestingly, 
STIM2 expression was neither investigated (mRNA expression level), nor targeted by RNAi. In 
addition to Orai1 and STIM1, the Ca2+ binding proteins S100A8/A9 were shown to serve as a 
Ca2+ sensor, linking Ca2+ influx to phagosomal ROS production (Steinckwich et al., 2011). 
Regarding the role of STIM, Bréchard et al. identified and confirmed STIM1 as regulator of 
SOCE and to be involved in mediating the Ca2+ influx necessary for NOX-dependent ROS 
production in the HL-60 cell line. STIM2 expression was confirmed, but an siRNA-mediated 
knockdown did not reveal a contribution of this isoform to either SOCE, or Ca2+ -dependent 
ROS production (Bréchard et al., 2009). Besides regulating SOCE and NOX activity, STIM1 
was also shown to be involved in the recruitment of ER junctions to the phagosome. ER 
remodeling is often observed during phagocytosis and is involved in cytoskeleton 
rearrangement, an important mechanism for phagosomal maturation. STIM1 was revealed as 
key molecule in recruiting ER junctions and promoting phagosomal Ca2+ signals in mouse 
embryonic fibroblasts and the HL-60 cell line (Nunes et al., 2012). So far, the participation of 
Orai1 and STIM1 in regulating SOCE-dependent activity of NOX enzymes was proven, leaving 
the role of Orai2, Orai3 and STIM2 within this process to be further elucidated.  
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Figure 7 Components and assembly of NADPH oxidase 2  
Assembly and activation of NOX2 upon inflammatory signals (adapted from (Lambeth, 2004)). The membrane-residing 
core unit flavocytochrome b588 is a hetero-multimer of the catalytic subunit gp91
phox and the membrane protein p22phox. 
Metabolism of PTPs in the membrane and interaction sites on p22phox provide lipid anchors for the recruitment of 
cytosolic components. Cell activation triggers a rise in cytosolic Ca2+ levels leading to the activation of PKC and the 
translocation of Ca2+ sensing S100 proteins to the PM (Steinckwich et al., 2011; Bréchard et al., 2013). The cytosolic 
subunits p40phox and p67phox are bound by the organizer subunit p47phox. Phosphorylation of p47phox by PKC leads to 
exposure of interaction domains mediating the binding to p22phox and recruiting the bound subunits to the core unit. 
Translocation to the PM is facilitated by binding of p47phox to PIP2 lipid anchors. Superoxide production is triggered by 
interaction of the activator domain of the activator subunit p67phox (green star) with gp91phox. The small GTPase RAC is 
bound to the inhibitor RhoGDI under resting conditions. Upon cell activation, nucleotide exchange on GDP results in 
dissociation of the small GTPase RAC from its inhibitor and binding to the activator subunit p67phox. The modulator 
subunit p40phox binds to membrane lipids and is involved in stabilization of the complex and enhancement of ROS 
production. The activated catalytic subunit generates the superoxide radical (•O2
-) by transferring two electrons from the 
electron-donor NADPH to molecular oxygen. Rapid dismutation of •O2
- by SOD leads to the formation of H2O2. 
Abbreviations used: p – protein, gp – glycoprotein, PIP – phosphatidylinositol phosphate; PIP2 – phosphatidylinositol 
bisphosphate, PIP3 – phosphatidylinositol trisphosphate, RhoGDI – Rho GDP-dissociation inhibitor, SOD – superoxide 
dismutase. Information taken from (Lambeth, 2004; Kerkhoff et al., 2005; Bedard & Krause, 2007; El-Benna et al., 2009).  
6.5.2 Redox Regulation of CRAC Channels  
Comparing the so far published reports of how ROS affects SOCE and CRAC channel activity 
revealed severe discrepancies. While on the one hand there seems to be an agreement on an 
inhibitory effect of ROS or oxidizing substances, others reported an elevation or enhancement 
of SOCE (reviewed by (Bogeski et al., 2012; Nunes & Demaurex, 2013)). While for example 
Bogeski et al. showed an H2O2-induced inhibition of SOCE in T cells (Bogeski et al., 2010), 
Grupe et al. reported a STIM1 mediated CRAC channel activation upon H2O2 treatment in HEK 
cells (Grupe et al., 2010). The observed discrepancies can be allocated to either cell-type 
specific differences in the SOCE machinery and its regulation or to the differential functional 
outcome of the diverse types of thiol modifications (see 6.1.2 and (Nunes & Demaurex, 2013)). 
It is therefore important to consider the species involved, the potential redox targets and the 
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biochemical type of modification to fully understand the underlying mechanism of redox 
regulation of SOCE in a certain cell type.  
Nunes and colleagues recently summarized and evaluated to date work on redox regulation of 
SOCE (Nunes & Demaurex, 2013). They concluded two general mechanisms in the redox 
regulation of SOCE and CRAC channels with 1) the Ca2+ status of the ER regulated by ROS as 
modulator of CRAC channel activity and 2) STIM and Orai proteins as direct targets for redox 
modification. Early reports already demonstrated the elevation of cytosolic Ca2+ signals upon 
oxidative triggers. This Ca2+ elevations were mediated via activation of IP3 and ryanodine 
receptors (Missiaen et al., 1991; Hilly et al., 1993; Poitras et al., 1993), or the inhibition of 
SERCA (Xu et al., 1997; Grover et al., 1997; Barnes et al., 2000), resulting in either an active or 
passive depletion of the ER Ca2+ stores. Thus, a redox-dependent regulatory mechanism of 
SOCE and the corresponding channels were revealed, prior to the identification of the 
molecular players of the CRAC channels (Parekh & Penner, 1995). In general ROS were 
suggested to be involved in regulating SOCE, by defining the amount of Orai and STIM 
proteins via transcriptional regulation (reviewed by (Trachootham et al., 2008; Nunes & 
Demaurex, 2013)). A prominent example is the TF NfκB, involved in the transcription of Orai1 
and STIM1 (Eylenstein et al., 2012). NfκB activity is modulated by various signaling pathways 
upon receptor stimulation, among these also cellular redox homeostasis (Morgan & Liu, 2011). 
A shift to high oxidizing levels was shown to favor an inhibition of NfκB and subsequent down-
regulation of Orai1 and STIM1 levels, while lower levels are related to an increased activity of 
the TF (Jing et al., 2006; Wang et al., 2012).  
The STIM molecules appeared as interesting targets in the redox regulation of SOCE because 
they contain cysteine residues. Information from databases and primary structure analysis lists 
5 cysteine residues for STIM1 and 15 for STIM2. 4  They reside in an organelle strongly 
regulated by the local redox milieu: the ER. Among the two STIM isoforms most attention was 
so far paid to STIM1 and, though being an even more promising target, little information on 
STIM2 is so far available (reviewed by (Bogeski et al., 2012)). Protein folding in the ER is 
redox-sensitive, as the protein Ero1p, involved in protein folding, is regulated by the oxidative 
state of the organelle. Ero1p catalyzes the reactivity of Pdi1P, a thioredoxin-like protein 
responsible for disufulfide-bond formation. An increased oxidized ER status results in an 
inhibition of Ero1p and the subsequent reduced Pdi1p activity. STIM1 however was shown to 
bind to an oxidoreductase of the thioredoxin family (ERp57). This reductase acts together with 
the members of the isomerase PDI family, like Pdi1p. The binding of STIM1 by ERp57 depends 
on the redox state of the ER and regulates disulfide bond formation in STIM1, thereby 
influencing SOCE activity (Prins et al., 2011).  
Regarding the Orai proteins as potential redox targets, Bogeski and colleagues provided a 
detailed study on the redox sensitivity of the single Orai isoforms (Bogeski et al., 2010). Orai1 
and Orai2 were shown to carry three redox-sensitive cysteines; C126 and C143 in TM2 and 
C195 at the extracellular site of TM3. Orai3 instead lacks the cysteine 195 but holds two 
additional residues in an extracellular loop. Orai1 and Orai2 mediated SOCE was shown to be 
inhibited by pre-incubation with H2O2, while Orai3 was redox-insensitive. Within the 
differentiation of naïve T cells to effector cells, Orai3 expression was up regulated with an 
increase in the relative Orai3 to Orai1 expression. This process was accompanied by an 
                                                     
4
 See for example: http://www.ncbi.nlm.nih.gov/nuccore/NM_001169118.1 
and http://www.ncbi.nlm.nih.gov/nuccore/JX014264.1  
Introduction 
 
 
 
40 
 
increase in redox resistance of SOCE. Mutagenesis studies revealed C195 as the residue 
defining redox sensitivity of Orai1 and Orai2. The up-regulation of Orai3 within differentiation 
was suggested as adaptive mechanism to tune redox sensitivity of SOCE to maintain sufficient 
Ca2+ signals in an oxidizing environment.  
The results from Bogeski and colleagues raised the question whether the observed mechanism 
might be restricted and unique to T cells, or whether it is present in other cell types and organs 
coping with an oxidizing environment. Cells of the innate immunity as monocytes, encounter an 
oxidizing environment under physiological and pathological conditions, meanwhile contributing 
to a high redox state by production of ROS (see 6.2.2 and 6.2.3). In the scope of this study not 
only monocytes, but also the skin provides an excellent experimental background to study 
redox regulation of SOCE. Cells of the skin are redox challenged under UV radiation under 
physiological but also under cancerous conditions, such as melanoma (see 6.3.1).  
6.6 Scientific Question  
6.6.1 State of the art - The role of the individual Orai and STIM isoforms in the skin and 
innate immunity  
With the essential role in T lymphocytes, the importance of Orai and STIM in adaptive immunity 
is indisputable, while there is only little known about the role of SOCE and the contribution of 
the single Orai and STIM subunits in innate immunity (Shaw & Feske, 2012b). As pointed out 
above (6.5.1), neutrophil granulocytes are the only intensively investigated cells of the innate 
immunity, displaying an essential role of Orai1 and STIM1 regulated SOCE during 
phagocytosis and ROS production (described in detail below) (Bréchard et al., 2008, 2009; 
Steinckwich et al., 2011). Monocytes take a central role in innate immunity as professional 
phagocytes and progenitors to dendritic cells and macrophages. Still, only few publications 
focused on the role of CRAC channels in mononuclear phagocyte cells and no information is 
available on the role of CRAC channels in monocytes themselves to the present day.  
In rodent dendritic cells, Orai2 and STIM2 were shown to be the predominant CRAC channel 
components. In contrast to T lymphocytes, STIM2-gated and Orai2-mediated SOCE was 
identified as the major Ca2+ signaling process (Bandyopadhyay et al., 2011). Further on, Félix 
and colleagues demonstrated an important role for STIM1 and Orai1 mediated SOCE in the 
maturation of human dendritic cells, while no expression, and hence no contribution, of STIM2 
could be detected (Félix et al., 2013). In murine macrophages, the Ca2+ response triggered by 
cell stimulation was found to be mediated by CRAC channels. This Ca2+ signals were linked to 
stimulation-induced ROS production, prior to the identification of the molecular components of 
the CRAC channels (Jin et al., 2006). Gao et al. further suggested store-depletion and 
sustained Ca2+ signaling in human macrophages to be dependent on a close functional 
coupling of CRAC channels and potassium channels (K(Ca)3.1) (Gao et al., 2010). In a broader 
scope, the role of CRAC channels was investigated in osteoclasts, a cell type important in bone 
remodeling and bone tissue homeostasis that derive from macrophages. Ca2+ signaling, 
important for osteoclast function, is mediated by CRAC channels and ryanodine 
receptors/channels (Robinson et al., 2010). A down-regulation of the CRAC channel 
components was observed within osteoclast differentiation, however channel activity was 
shown to be important in late differentiation steps and overall cell function (Zhou et al., 2011). 
In  a recent report, a specific role of Orai1-mediated Ca2+ signaling was determined in 
osteoclast differentiation, by regulating the activity of the TF NFAT (Hwang & Putney, 2012).  
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As described above, Ca2+ is known to play an important role in skin function and intracellular 
Ca2+ signaling regulates many processes in the skin such as barrier formation, cell 
differentiation, melanogenesis and tumor progression (see also 6.3). These processes appear 
to be linked to the activity of several TRP channels rather than CRAC channels and only few 
publications pay attention to Orai and STIM mediated Ca2+ signals in the skin (Saul et al., 
2013). In keratinocytes, the presence of Orai and STIM is connected to basic Ca2+ signaling 
(Ross et al., 2008), Ca2+-switch mediated differentiation (Numaga-Tomita & Putney, 2013) and 
Ca2+-dependent migration (Jans et al., 2013). In melanocytes, Orai1 and STIM2 were finally 
proven to serve as the major Ca2+ influx pathway having an essential function for 
melanogenesis and adaptive tanning (Stanisz et al., 2012). Thus, further investigation of Orai-, 
and STIM-regulated skin cell function, also under pathological conditions as melanoma, might 
reveal deeper insight into the role of CRAC channels in skin and tumor biology. 
6.6.2 Research focus 
The main aim of the here presented study was to identify the role of CRAC channels in general 
and the role of the single Orai and STIM isoforms in detail in primary human monocytes and 
melanoma cells. In both cases SOCE mediated by the CRAC channels was characterized and 
the major contributing Orai and STIM isoforms were further investigated in terms of their 
contribution to Ca2+-dependent processes. The regulation of SOCE and the impact of the 
cellular environment on Ca2+-signaling and overall cell function was an additional focus of the 
study. The specific and shared scientific questions of the two investigated cell systems are 
outlined below.  
Monocytes. ROS production is an important function of monocytes during phagocytosis and 
was known to be dependent on Ca2+ signaling. Also, a role for Orai1 and STIM1 in this process 
was already identified in neutrophils. Monocytes, instead of neutrophils, were chosen as object 
of research because of two major aspects. On the one hand, the central position of monocytes 
in the MPC-system provides the potential to transfer experimental findings to the other 
members as dendritic cells and macrophages. On the other hand, the little information about 
the role of CRAC channels in this cell type provided the chance of entirely new insights. These 
aspects and the progressive emerging evidence for an important role of CRAC channel function 
and redox regulation of the channels were reason to develop and address the following 
questions:  
What role do the SOCE and the mediating CRAC channels play in monocytes, and 
which Orai and STIM isoforms contribute to Ca2+ signaling?  
Is ROS production in monocytes dependent on Orai and STIM-mediated Ca2+ signals? 
How might ROS, produced by monocytes, impact Orai and STIM-dependent Ca2+ 
signaling?  
Melanoma. Studies in human melanocytes revealed Orai-, and STIM-mediated SOCE as 
important Ca2+ signaling pathway. Orai and STIM mediated Ca2+ signaling was further already 
related to different malignant cancers. Based on the findings in human melanocytes and the 
prominent role of Ca2+ in regulating skin cell function, the following questions were addressed: 
What role does the SOCE play in melanoma cells, and what Orai and STIM isoforms 
contribute to Ca2+ signaling?  
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Are the molecular players determining melanoma progression dependent on Orai and 
STIM presence and function? 
ROS production in the skin upon environmental factors and characteristic ROS patterns in 
tumors pointed to the further question: 
How might ROS influence Ca2+ signaling in cancer (melanoma) cells?  
Monocytes and Melanoma. During the investigation of the general role of CRAC channels in 
the different cell systems, shared features and questions became obvious. Although the skin is 
indeed an individual organ, it is also considered as part of the innate immune system. The skin 
serves as a physical barrier towards the outside world and harmful intruders and therefore 
homes specialized immune cells. Regarding the challenging conditions cells are facing under 
pathological skin and immune conditions not only Ca2+ and redox signaling, but also changes in 
the Ca2+ and redox environment impact cellular functions. The analysis of the interdependency 
of ROS and Ca2+ signaling, as well as the impact of altered redox and Ca2+ conditions on cell 
function were therefore also addressed in the here presented study.  
The ongoing association of CRAC channel function to not only physiological processes, but 
also pathological disease patterns, emphasizes the importance of gathering more information 
on the implication of the involved molecular players and to reveal and interpret their potential to 
serve as therapeutical targets.  
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7 Materials and Methods 
7.1 Materials 
7.1.1 Chemicals 
Chemicals, dyes and reagents used for the presented study are listed in Table 3. General 
laboratory chemicals were purchased from Sigma-Aldrich and are not presented here.  
Table 3 Chemicals  
Chemical Supplier Product-/Order-number 
2-Aminoethyl-diphenylborinate (2-APB) Sigma D9754 
3-[1-[3-(Dimethylamino)propyl]-5-methoxy-
1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-
2,5-dione  
(BisGö, Gö 6983)  
Sigma G1918 
5-(and-6)-carboxy-
2’,7’difluorodihydrofluorescein-diacetate 
(H2-DCFDA) 
Invitrogen C 13293 
Accutase PAA L11-007 
Agarose Broad Range Cark Roth GmbH T846.3 
Albumin (human) Sigma A9418 
Ammonium chloride (NH4Cl) Sigma A0171 
Ammonium persulfate (APS) Sigma A3678 
Amplex® UltraRed Reagent 
Invitrogen
TM
/Molecular 
Probes® 
A36006 
Albumin from bovine serum (BSA)  Sigma A2153  
Calcium chloride solution (CaCl2) Fluka Analytical/ Sigma 21115 
CellTiter-Blue® Promega G8081 
Chloroform (99 %) 500 ml Sigma C-2432 
Complete (Proteinase Inhibitor) Roche 04 693 132 001 
Diethylpyrocarbonat (DEPC) Sigma D5758 
Dimethylsulfoxid (DMSO) Sigma D8418 
Diphenyleneiodonium chloride (DPI) Sigma D2926 
Ethanol 100 % absolute Sigma 32205 
Ethylenediaminetetraacetic acid (EDTA) Sigma E9884 
Fetal bovine serum  
(Fetal calf serum (FCS)) 
Invitrogen/Gibco 10270-106 
N-Formyl-Met-Leu-Phe (fMLF) Sigma F3506 
Fura-2 AM Invitrogen F1221 
Glucose Merck 104933 
Glycin Applichem A3707,1000 
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Chemical Supplier Product-/Order-number 
Glycogen Invitrogen 10814-010 
H2O2 (10M) Sigma 31642  
HEPES Sigma Ultra (50g) Sigma H7523 
Insuline solution (human)  Sigma I9278 
Ionomycin (1mg) Calbiochem 407950 
Isopropanol Fluka/Sigma 59304 
Magnesium chloride solution (MgCl2) JT Barker 0504 
Methanol Sigma 32213 
N,N,N',N'-Tetramethylethylendiamin 
(TEMED) 
Sigma T7024 
NP-40 Sigma 74385 
Penicillin 10.000 U/ ml 
Streptomycin 10.000 µg/ ml 
Invitrogen/Gibco 15140-122 
Peroxidase from horseradish Serva 31943 
Phorbol 12-myristate 13-acetat (PMA), also 
known as 12-O-Tetradecanoylphorbol-13-
acetate (TPA) 
Sigma P1585 
Poly-L-ornithine hydrobromide  Sigma P3655 
Potassium bicarbonate (KHCO3) Sigma 12602 
Potassium chloride solution (KCl) Merck 105833 
Prestained Protein Ladder Fermentas 26616 
Rotiphoresegel 40 Roth T802 
Sodium chloride solution (NaCl) Sigma S9888 
Sodium dodecyl sulphate (SDS) Sigma L3771 
Superoxide Dismutase (SOD) Sigma S7511  
4-Hydroxy-TEMPO (Tempol) Sigma 176141 
Thapsigargin (Tg)  Invitrogen T7458 
Tris HCL Roth 9090.3 
Trisbase Sigma T1503 
Triton Eurobio 018774 
TRIzol® Reagent  Invitrogen 15596-026 
TWEEN
®
 20 Sigma P1379 
 
7.1.2 Kits and special laboratory equipment 
General laboratory equipment that was used to conduct the described experiments, as cell 
culture supply, tubes, flasks, beaker, pipettes and other items, that are not listed in Table 4, 
were provided by Eppendorf, BDFalcon and Greiner Bio-One. Table 4 lists ready-to use kits 
and assay components used in transfections, qRT-PCR or Immunoblotting.  
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Table 4 Kits and special laboratory equipment 
Item Supplier Product # 
Amaxa NHEM-Neo Nucleofector Kit Lonza AG C-002-5C 
Amaxa™ P3 Primary Cell 4D-Nucleofector™ 
X Kit L 
Lonza AG V4XP-3024 
Amaxa™ Human Monocyte Nucleofector™ 
Kit 
Lonza AG VPA-1007 
Amersham Hyperfilm ECL (High 
performance chemiluminescense film) 
GE Healthcare 28906837 
BCA Protein Assay Reagent (bicinchoninic 
acid) 
Thermo Scientific 23225 
Cell Culture Inserts 
(8 µm) pore size 
Millipore PIEP12R48 
Costar Ultra Low Cluster Plate (24 well) Corning Incorporated 3473 
dNTPs (100 mM each) 
dGTP Solution  
dTTP Solution 
dATP Solution 
dCTP Solution 
Invitrogen  
10218-014 
10219-012 
10216-018 
10217-016 
Dynabeads® Untouched™ Human 
Monocytes System 
Invitrogen 113.50D 
Oligo dT12-18 Primer Invitrogen 18418-012 
Pierce ECL Western Blotting Substrate Thermo Scientific 32209 
Protein LoBind Tubes Eppendorf 022431081 
QuantiGlo
® 
Human IL-8 Chemiluminescent 
Immunoassay 
R&D Systems Q8000B 
QuantiTect SYBR Green PCR Kit  Invitrogen 204145 
RNase OUT
TM
 Invitrogen 10777-019 
Roti-PVDF (nitrocellulose membrane) Roth T8301 
Superscript
TM
 II Reverse Transcriptase Kit Invitrogen 18064-014 
96-Well Microplate (black/transparent) BD FalconTM  353219 
7.1.3 Devices 
Major divces used for the performance of experiments are listed in Table 5 including their 
intended purpose. Specifications of application are presented in the according method sections.  
Table 5 Devices and intended purpose 
Item Supplier Purpose  
4D-Nucleofector
TM
 System: 
4D-Nucleofector™ Core Unit 
4D-Nucleofector™ X unit 
Lonza Transfection of primary cells 
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Item Supplier Purpose  
Nucleofector
TM
 II Lonza Transfection of Melanoma cell lines  
Centrifuge 5415C Eppendorf  Centrifugation of 1.5 ml reaction tubes 
Centrifuge Universal 32R Hettich Centrifugation of 15/50 ml reaction tubes 
MX3000 PCR Cycler 
MXPro Software 
Stratagene qRT-PCR 
CFX96
TM
 Real-Time System 
C1000
TM
 Thermal Cycler 
BioRad qRT-PCR 
 
Plate Reader 
Tecan Genios Pro 
Tecan  Proliferation and survival of melanoma and 
monocytes 
Plate Reader  
Tecan infinite M200 Pro 
Tecan Ca
2+
 -dependent proliferation and survival of 
melanoma and monocytes 
Electrophoresis System 
Mini-PROTEAN® System  
BioRad SDS-PAGE and Blotting  
Electrophoresis System BioRad General purposes (Agarose gels)  
7.1.4 Solutions and Media composition  
Different solutions and media were used for cell isolation, cell culture, calcium imaging and 
ROS-measurements. Ready-to-use media and solutions are listed in Table 6. The composition 
of protein gels used for western blots, as well as the compositions of solutions and media with 
multiple components are presented in Table 7.  
Table 6 Media and solutions for cell culture and experiments  
Solution/Medium Composition Supplier Product# 
Dulbecco’s Phopsphate 
Buffered Saline (1x) (DPBS) 
-  Invitrogen/Gibco 14190-094 
Hank’s BSS (1x) (HBSS) -  PAA Laboratories  H15-009 
L15 Leibovitz liquid-
medium 
-  Biochrom F 21315 
LSM 1077 Lymphocyte 
Seperation Media  
(= Ficoll) 
-  PAA Laboratories  J15-004 
MCDB153 Keratinocyte 
medium 
-  Biochrom F8105 
RPMI 1640 (1x)  
+ L-Glutamin 
Medium 
RPMI (500 ml) 
+10% FCS 
+1% Pen/Strep  
Invitrogen/Gibco 21875-034 
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Table 7 Multi-component buffers, solutions and media  
Solution/Medium Composition 
5x RIPA lysis buffer 50 mM Tris, ph 7,5 
150 mM NaCl 
2 mM EDTA 
2 mM EGTA 
0,2 % Triton 
10% NP-40 
Blotting buffer 10x SDS-Puffer (1 part) 
H2Odest. (7 parts) 
Methanol (2 parts) 
Erythrocyte Lysis-buffer 
 
100 ml (H2O dest.) 
0,829 g NH4Cl 
0,1 g KHCO3 
3,8 mg EDTA 
Gel solution A (Rotiphoresegel 40) 40 % Acrylamid 
1.04 % Bisacrylamid 
Gel solution B 1.5 M Tris HCl (pH 8.8) 
0.4 % SDS 
in H2Odest. 
Gel solution C 0.5 % Tris HCl (pH 6.8) 
0.4 % SDS 
in H2Odest. 
PBS-T 0,1 % Tween in PBS 
Protein separation gel (10 %) 2.5 ml gel solution A 
2.5 ml gel solution B 
5 ml H2Odest. 
100 µl APS 
8.3 µl TEMED 
Protein separation gel (15 %) 3.75 ml gel solution A 
2.5 ml gel solution B 
3.75 ml H2Odest. 
100 µl APS 
8.3 µl TEMED 
Protein stacking gel (5 %) 375 µl gel solution A 
800 µl gel solution C 
2.125 ml H2Odest. 
33.3 µl APS 
2.7 µl TEMED 
Ringer-solution 
Physiological solution for Ca
2+ 
imaging and ROS 
measurements. 
155 mM NaCl  
4.5 mM KCl  
10 mM Glucose 
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Solution/Medium Composition 
(0 mM Ca
2+
) 5 mM HEPES 
3 mM MgCl2  
1 mM EGTA 
In H2Odest. 
Ringer-solution 
(0.25 mM Ca
2+
) 
155 mM NaCl 
4.5 mM KCl 
10 mM Glucose  
5 mM HEPES 
2.75 mM MgCl2  
0.25 mM CaCl2  
In H2Odest. 
Ringer-solution 
(0.5 mM Ca
2+
) 
155 mM NaCl 
4.5 mM KCl 
10 mM Glucose  
5 mM HEPES 
2.5 mM MgCl2  
0.5 mM CaCl2  
In H2Odest. 
Ringer-solution 
(1 mM Ca
2+
) 
155 mM NaCl 
4.5 mM KCl 
10 mM Glucose  
5 mM HEPES 
2 mM MgCl2  
1 mM CaCl2  
In H2Odest. 
Ringer-solution 
(20 mM Ca
2+
) 
155 mM NaCl  
4.5 mM KCl  
10 mM Glucose 
5 mM HEPES 
2 mM MgCl2  
20 mM CaCl2  
In H2Odest. 
SDS 
(1x from 10x in H2Odest.) 
10 x SDS-buffer: 
250 mM Tris Base  
1,92M Glycin  
1 % SDS  
Stripping buffer 100 mM Glycin in H2Odest. (pH 2,8) 
Tumor-medium 
(2 % TU-medium) 
MCDB153 (4 parts) 
L15- Medium (1 part) 
2 % FCS 
1,68 mM CaCl2  
2.5 ng/ml Insulin 
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7.1.5 Activators and Inhibitors  
Several activators or inhibitors of cellular components or pathways were used in the presented 
study to investigate the role of Orai and STIM mediated Ca2+-signaling in monocyte and 
melanoma function.  
Table 8 lists the chemicals and describes their function within the experiments whereas 
information on chemical supply is presented in Table 3.  
Table 8  Activators and inhibitors of
 
Ca
2+ 
and redox signaling pathways 
Chemical Specifications and features Application  
Gö6983 
(BisGö) 
Inhibitors of protein kinase C (PKC) 
Isoforms PKCα, PKCβ, PKCσ and PKCζ.
5
 
Used as inhibitor of ROS production, by 
blocking all of the different PKC isoforms, 
which are responsible for phosphorylation of 
cytosolic NOX2 subunits. Inhibition of the 
assembly of the holo-enzyme (indirect 
inhibition). 
DPI Unspecific inhibitor of nitric oxide 
synthase (NOS) and NADPH oxidases 
(NOX).
6
 Upon interaction with an 
electron-transporter, DPI forms a radical 
that further inhibits the transporter 
through covalent binding. DPI inhibits 
members of the NOX family by 
interaction with the heme- or flavin 
group of the catalytic subunit. DPI also 
inhibits xanthine oxidase, mitochondrial 
complex I and cytochrome P450 
reductase (Bedard & Krause, 2007).  
Used as inhibitor of ROS production, by 
targeting the responsible enzyme NOX2 
(direct inhibition).  
fMLF Fromylated tri-peptide (methionine, 
leucine and phenylalanine), bacterial 
product that is bound by specialized 
receptors (formylated peptide receptors 
= FPR) that are G-protein coupled and 
trigger an immune response in 
monocytes (and other phagocytes) (Le et 
al., 2002; Lee et al., 2010b). 
Trigger of SOCE for calcium imaging and ROS 
measurements. Used as a rather physiological 
activator of SOCE (compared to Tg), via 
receptor activated depletion of internal Ca
2+
 
stores, resulting in the activation of CRAC 
channels. 
Ionomycin Ion carrier, specific to bind and transport 
Ca
2+ 
through biological membranes.
7
 
Used for calibrations for calcium imaging to 
gain a sufficient Ca
2+
 depletion from all 
internal Ca
2+
 stores (ER, mitochondria, 
vesicles). Used in combination with 
Thapsigargin. 
PMA Artificial, but potent activator of PKCs 
that mimics the molecular structure of 
physiological PKC activator DAG 
(Castagna et al., 1982). 
Used as potent activator of NOX2 (ROS 
production) by interacting with PKC, an 
essential step to activate the assembly of the 
NOX enzyme. Serves as positive control, due 
to its reliable and strong response.  
                                                     
5
 http://www.sigmaaldrich.com/catalog/product/sigma/g1918?lang = de&region = DE 
6
 http://www.sigmaaldrich.com/catalog/product/sigma/d2926?lang = de&region = DE 
7 http://www.merckmillipore.com/germany/life-science-research/ionomycin-free-acid-
streptomyces-conglobatus 
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Chemical Specifications and features Application  
 
Thapsigargin Artificial SERCA blocker, indirect activator 
of SOCE (Lytton et al., 1991). Tg blocks 
SERCA, thereby preventing backhaul of 
Ca
2+
 to the ER stores. ER stores are 
thereby emptied due to lack of 
compensation of constant Ca
2+
 leakage 
to the cytosol. This leads to 
multimerization of STIM and further 
activation of CRAC channels. 
Passive activation of CRAC channels and 
SOCE in calcium imaging and ROS 
measurements.  
7.1.6 Objects of research (cell systems)  
Research on primary human cells and cell lines has been approved by the local ethics 
committee. Figure 8 shows representative images of the melanoma cell lines and primary 
human monocytes, used for experiments.  
 
Figure 8  Primary human monocytes and SK-MEL-5 and WM3734 melanoma cell lines 
Representative images of human melanoma cell lines WM3734 (A), SK-MEL-5 (B), and primary human monocytes (C). 
Images were recorded using an inverted Zeiss microscope with a 40x magnification.  
7.1.6.1 SK-Mel-5 and SK-MEL-28 
SK-Mel-5 and SK-MEL-28 are commercially available melanoma cell lines and were provided 
by the Institute of Dermatology (Dr. Hedwig Stanisz, Prof. Dr. Thomas Vogt), originally 
purchased from the CLS Cell Lines Service GmbH, Germany 8. SK-Mel-5 cell line originates 
from an axillary lymph node metastasis of a caucasian female, aged 24 years. SK-MEL-28 
derived from a primary skin melanoma of a 51 year old male patient of unknown ethnic. The 
two cell lines were (together with others) first isolated by Carey et al. (Carey et al., 1976). 
These cell lines carry a characteristic mutation of the BRAF gene, that codes for the B-raf 
protein, a serine-tyrosine kinase and a member of the MAPK/ERK signaling pathway. Due to 
the regulatory nature of this pathway and its components in cell differentiation and growth, 
mutations often lead to cancer progression. 9  BRAF is therefore also referred to as proto-
                                                     
8
 http://www.cell-lines-service.de/content/index_ger.html 
9
 Summarized information on BRAF mutation was found on: 
http://www.neuropathologie.med.uni-muenchen.de/genetik/braf-
v600_mutationsstatus/index.html 
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oncogene and the BRAF V600E mutation is very often found in tumor cells (Davies et al., 
2002). SK-Mel-5 and SK-MEL-28 were cultured in standard RPMI medium, supplemented with 
10% FCS and were splitted biweekly with a ratio of 1:3.  
7.1.6.2 WM3734 
The WM3734 cell line was kindly provided by the Wistar Institute, Philadelphia, PA USA (Dr. 
Thomas Roesch, Prof. Dr. M. Herlyn) and is not commercially available. The WM (Wistar 
Melanoma) 3734 cell line originates from a human melanoma brain metastasis. The cells were 
cultured in 2% TU medium (see Table 6 and (Satyamoorthy et al., 1997; Roesch et al., 2010)) 
and splitted with a ratio of 1:2 to 1:3 twice a week.  
7.1.6.3 Primary human monocytes 
Primary monocytes were isolated from human blood samples (see 7.2.1), provided by the 
Institute of Haemostaseology, Universitätsklinikum Saarland (Prof. Dr. Eichler). Monocytes 
originate from the myeloid lineage in the differentiation of leukocytes and can be characterized 
by their CD expression pattern. Three monocyte subtypes are present in humans and can be 
identified by their distinct CD expression (see above in 6.2.1). The inflammatory phenotype 
(that covers 95% of circulating blood monocytes) shows a characteristic CD pattern with 
CD14high, CD64high, CCR2, CD62L and the absences of CD16 (Gordon & Taylor, 2005). 
Monocytes were cultured in RPMI medium supplemented with 10% FCS and, if required, 0.1% 
penicillin/streptomycin. Cells were kept in a cell culture incubator at all times at 37 °C with 5% 
CO2 in the atmosphere. These culture conditions are further referred to as standard culture 
conditions and standard culture medium (with or without antibiotics) or RPMI (+10% FCS). 
7.2 Methods 
7.2.1 Cell isolation and cultivation 
Primary human monocytes were isolated from peripheral blood mononuclear cells (PBMCs). 
PBMCs were obtained from leukocyte-reducing-system (LRS) chambers, provided by the local 
blood bank (Department of Haemostaseology, Universitätsklinikum Saarland). The cells were 
separated from the rest of blood content by Ficoll density gradient centrifugation. The Ficoll was 
placed in a 50 ml Falcon tube and centrifuged shortly (RT, 1000 x g, 30 s). The tubes contain 
filters at the bottom of the tube to facilitate the formation of the density gradient. Further on, the 
blood from LRS-chambers was rinsed onto the Ficoll and the density gradient was established 
by centrifugation (RT, 450 x g, 30 min, no brake). The separated leukocyte phase was 
transferred to a new reaction tube and washed once by centrifugation with HBSS (RT, 250 x g, 
15 min). Remaining erythrocytes and thrombocytes in the leukocyte pellet were abolished by 
erythrocytes lysis (2 ml Erythrocyte-lysis-buffer, Table 6), followed by gentle centrifugation (RT, 
130 x g, 10 min).  
Monocytes were isolated from PBMCs (in PBS + 0.5% BSA) either by negative isolation or by 
adhesion. Negative isolation was performed using the Dynabeads® Untouched™ Human 
Monocytes System following the manufacturer’s instructions. In a first step, PBLS were mixed 
with a blocking reagent against Fc-receptors to prevent a cross-reaction or activation of the 
monocytes via CD64 within the procedure. Next an antibody mixture was added, that targets for 
specific markers of T cells, NK-cells and other PBMC (despite monocytes). These cells were 
further bound by secondary antibodies that target for the Fc-region of the first set of antibodies. 
The secondary antibodies were conjugated to magnetic beads, which allowed separation of the 
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monocyte fraction from the rest of the PBMCs (antibody- and bead-bound) using a magnet. The 
monocytes in suspension were further cultured in standard culture medium at standard 
conditions (see 7.1.6.3). 1.5 x108 PBLs were used per isolation with a yield of 14% on average.  
For isolation by adhesion, 1.5-2.5 x108 PBMCs were transferred into culture flasks (175 cm2) 
containing 30 ml standard culture medium (plus antibiotics) and kept under standard culture 
conditions for 2 h to allow adherence of the monocytes to the flask surface. Next, growth 
medium was exchange and cells were harvested after additional 24h of incubation in fresh 
medium (plus antibiotics). Cells were washed with PBS (supplemented with 0.5% BSA), 
scratched from the surface to detach using cell scrapers and suspended in standard culture 
medium (no antibiotics). After isolation, cells were cultured in RPMI (10% FCS) in 24-well 
plates (ultra-low attachment surface, see Table 4), with a density of 1-4 x106
 
cells/ ml and well. 
Purification and cell quality was determined by flow cytometry (see 7.2.3).  
7.2.2 Expression analysis on mRNA level 
In general, the status of protein biosynthesis, and hence the expression levels of genes, can be 
tested by determination of either mRNA or protein level. The protein biosynthesis includes two 
major steps: transcription and translation. In transcription, a complementary RNA sequence 
(= template) of a gene is synthesized. The template, generated in the nucleus and further 
transported and processed to the cytosol, serves as outline for translation. Due to its 
transmitting character from DNA to protein sequence the template is referred to as messenger 
RNA (mRNA). Total (m)RNA can be isolated from cells and transcribed to cDNA (reverse 
transcription). Based on cDNA a PCR can be performed providing quantitative and temporal 
representation of the expression status of the cells. Here, the method was used to test the 
general expression status and to confirm the success of knockdown experiments.  
7.2.2.1 RNA-Isolation and cDNA synthesis 
Isolation of total RNA from the cells is based on the so-called “single-step” method, initially 
introduced by Chomczynski and Sacchi (Chomczynski, 1987). Monocytes (1-3 x106) and 
melanoma cells (0.5-1 x 106) were collected per sample and suspended in 800 µl of Trizol 
reagent (contains Guanidiniumthiocyanate und Phenol). Samples were stored at -80 °C prior to 
further handling. Cells were thawed at RT and centrifuged to separate solved components from 
cell debris (12000 x g, 10 min, at 4 °C). Guanidiniumthiocyanate in solution is responsible for 
lysis of the cells and digestion of endogenous RNAses that would otherwise disintegrate the 
sample. The supernatant was further incubated at RT for 5 min and 160 µl chloroform were 
added. By thoroughly shaking three liquid phases build up due to the chemicals in suspension: 
RNA is solved in the upper water phase, while the intermediate phase contained DNA and the 
lower phenol phase solved proteins. The water phase was transferred to a new reaction tube. 
RNA was pulled down by addition of 1 µl glycogen and 400 µl isopropanol and incubation at RT 
for 10 min. After centrifugation (12000 x g, 10 min, at 4 °C) and removal of the supernatant, 
RNA was washed in ethanol (800 µl 75% in DEPC-treated H2Odest. from 100% ethanol) by 
further centrifugation (12000 x g, 10 min, at 4 °C). RNA pellet was dried, suspended in 10 µl 
DEPC-treated H2Odest. (RNAse free) and controlled by running a 2% agarose gel. Photometric 
determination of concentration was performed using a 1:50 dilution of the RNA in a standard 
photometer calculated with Equation 1.  
Equation 1 RNA (ug/ml) = OD260 x 40 (Absorption coefficient) x Dilution factor   
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Synthesis of cDNA was performed using a standard PCR-cycler with 0.8 µg (0.5 µg in cases 
with low yield) with a total volume of 10 µl and 1 µl oligo-dT-primers (0.5 µg/µl) and 1 µl dNTPs 
(mixture of dNTPS for strand synthesis). After 5 min heating to 65 °C, 4 µl 5x first strand buffer, 
1 µl DTT (0.1 M) and 1 µl RNAse OUT (components from the RNAse out Kit) were added and 
heated to 42 °C for another 2 min. As final step 1 µl SupercriptII Reverse Transcriptase was 
added and further incubated at 42 °C for 50 min. In this step the strand synthesis was finally 
performed by the enzyme, whereas the recent steps were responsible for annealing of the 
necessary components to the template. The procedure ended with a final temperature rise to 
72 °C for 15 min and a cool down to 4 °C.  
7.2.2.2 Quantitative (real-time) polymerase chain reaction (qRT-PCR) 
The cDNA obtained from reverse transcription served as template for quantitative PCR. In this 
variation of the PCR technique DNA fragments (cDNA) are amplified by the use of specific 
primer pairs for the genes of interest. In this study specific primers for the detection of Orai1-3, 
STIM1-2 and NOX family members were used. The PCR conditions used are presented in 
Table 9 and were chosen to fit the primer and sample needs. Primer Sequences and 
specifications are listed in Table 10 and Table 11.  
The double-stranded cDNA template is denaturized and separated into single strands by an 
initial rise in temperature to 94 °C. This is followed by repeated temperature cycles for 
annealing of the primers to the single strands, elongation of the complementary strand by the 
enzyme DNA-polymerase and again denaturation to generate new single strands for the next 
step. The temperatures in the elongation steps were chosen depending on the primer 
sequence to ensure optimal annealing to the single DNA strands. 
Table 9 PCR conditions for quantitative real-time PCRs  
Melanoma cell lines Monocytes 
15 min 94 °C  15 min 94 °C  
30 s 
45 s 
30 s 
94 °C 
58 °C 
72 °C 
45 cycles 
30 s 
45 s 
30 s 
94 °C 
55 °C 
72 °C 
45 cycles 
60 s 
30 s 
30 s 
95 °C 
55 °C 
95 °C 
 60 s 
30 s 
30 s 
95 °C 
55 °C 
95 °C 
 
   30 s 25 °C  
 
This temperatures can be defined in a simplified way by calculating the amount of GC (4 °C for 
each nucleotide) and of AT (2 °C for every nucleotide). To quantify the level of gene expression 
a fluorescent dye – SYBRGreen – was used, that intercalates within the double strand helix of 
the DNA. Upon excitation, the resulting emission can be measured when the dye is 
intercalated. The intensity of the fluorescent signal reflects the amount of cDNA of the gene of 
interest and thereby reflects the expression level of the mRNA in the analyzed sample. The 
expression was normalized to the reference gene TATA-box binding protein (TBP), always in 
the presence of a second reference gene RNAPolymerase (RNAPol) to verify the reliability of 
the first one. These reference genes are used, since the expression of the gene of interest has 
to be evaluated in the context of total gene expression of the sample cells. All templates were 
tested in duplicates. The QuantiTect SYBR Green PCR Kit provided all necessary components 
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for the amplification (salts, nucleotides, dye). Each template was tested with 0.5µg cDNA and 
1 µl of the according primer pair. For each primer pair a negative control (water instead of 
cDNA template) was used. Two different PCR-cycler, as listed in Table 5 and the 
corresponding software were used. to perform the experiments. The analysis of the PCR 
results is based on the 2-ΔΔCT method (Livak & Schmittgen, 2001; Huggett et al., 2005; Bustin et 
al., 2009). The software determines the so-called quantification cycle (Cq value, former CT 
value with T for threshold), that reflects the cycle number in the PCR when the intensity 
threshold of the system for the SYBRGreen signal is first exceeded. The signal intensity is 
measured at the end of each elongation step when DNA is in a double-stranded form and the 
dye can intercalate into the helix. The lower the Cq value, the higher the expression of the gene 
of interest in the sample. All PCR conditions were tested in duplicates. Resulting Cq values 
were therfore averaged (referred to as ∆Cq). ∆Cq values were further normalized to the 
expression of the reference genes by the calculation of the ΔΔCq value (∆Cq value target gene 
– ∆Cq value reference gene) and are presented as 2-(∆∆Cq). This parameter was used to 
evaluate and discuss the expression levels of the genes of interest.  
7.2.2.3 Expression analysis of Orai and STIM isoforms 
The expression levels of the CRAC channel components Orai1-3 and STIM1 and 2 in primary 
cells, cell lines and cells transfected with siRNA against the respective targets were determined 
using the Primer sets presented in Table 10 to evaluate general expression levels and to 
confirm the success of RNAi. Templates for the expression analysis were obtained as 
described above (0) and PCR conditions are presented in Table 9.  
Table 10 Primer sequences for quantitative RT-PCR of Orai and STIM 
Primer Sequence 
Annealing 
Temperature [°C] 
Expected product size 
[bp] 
Orai1_forward 
Orai1_reverse 
5’ ATGAGCCTCAACGAGCACT 3‘ 
5’ GTGGGTAGTCGTGGTCAG 3’ 
58 
58 
190 
 
Orai2_forward 
Orai2_reverse 
5’ TGGAACTGGTCACCTCTAAC 3’ 
5’ GGGTACTGGTACTGCGTCT 3’ 
60 
60 
165 
 
Orai3_forward 
Orai3_reverse 
5’GTACCGGGAGTTCGTGCA 3’ 
5’GGTACTCGTGGTCACTCT 3’ 
58 
56 
192 
TBP_forward 
TBP_reverse 
5’ CGGAGAGTTCTGGGATTGT 3’ 
5’ GGTTCGTGGCTCTCTTATC 3’ 
58 
58 
160 
RNAPol_forward 
RNAPol_reverse 
5’ GGAGATTGAGTCCAAGTTCA 3’ 
5’GCAGACACACCAGCATAGT 3’ 
58 
58 
133 
STIM1_forward 
STIM1_reverse 
5’ CAGAGTCTGCATGACCTTCA 3’ 
5’ GCTTCCTGCTTAGCAAGGTT 3’ 
60 
60 
124 
STIM2_forward 
STIM2_reverse 
5’ GTCTCCATTCCACCCTATCC 3’ 
5’ GGCTAATGATCCAGGAGGTT 3’ 
62 
60 
113 
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7.2.2.4 Expression analysis of NOX family isoforms 
The presence of the NOX family isoforms (Nox1, Nox2, Nox3, Nox4, Nox5, Duox1 and Duox2) 
was analyzed by quantitative real-time PCR based on cDNA from primary human monocytes 
as described above (0). Primers were designed using the free-available software Primer310. 
The specificity of the used primers was verified on positive controls prior to the experiments. 
Positive controls were generated by 1) performing standard PCR using the choosen primers 
and 2) cloning the obtained products into the pJet vector. The cDNA templates for positive 
control generation were: HCT116 for Nox1; primary human monocytes for TBP, RNA 
polymerase, Nox2 and Duox2; HEK wild type cells for Nox3 and 4; HL-60 cells for Nox5 and 
DU145 for Duox2. Sequence analysis of the constructs carrying the positive controls, confirmed 
the specific gene detection using the primers shown in Table 11. For qRT-PCR the same 
temperature and time settings were used as for analysis of Orai and STIM expression (see 
Table 9).  
Table 11 Primer sequences for quantitative RT-PCR of NOX family members 
Primer Sequence 
Annealing 
Temperature [°C] 
Expected product 
size [bp] 
Nox1_forward 
Nox1_reverse 
5’ AATCCTTGGGTCAACATTGG 3‘ 
5‘ CCTCAGGAAGGACAGCAGAT 3’ 
58 109 
Nox2_forward 
Nox2_reverse 
5’ TCACTTCCTCCACCAAAACC 3’ 
5’ GGGATTGGGCATTCCTTTAT 3’ 
58 211 
Nox3_forward 
Nox3_reverse 
5’ GCCCAACTGGAACAATGAGT 3’ 
5 ’ ATGAACACCTCTGGGGTCAG 3’ 
58 147 
Nox4_forward 
Nox4_reverse 
5’ CTGGTGAATGCCCTCAACTT 3’ 
5’ GGCCAGGAACAGTTGTGAAG 3’ 
58 115 
Nox5_forward 
Nox5_reverse 
5’ ATCTGCTCCAGTTCCTGCAT 3’ 
5’ ACAAGATTCCAGGCACCAG 3’ 
58 142 
Duox1_forward 
Duox1_reverse 
5’ CCACCAGGAGTGGCATAAGT 3’ 
5’ TGGTCATTCTCCTCCACCTC 3’ 
58 212 
Duox2_forward 
Duox2_reverse 
5’ GGCTCCCCAGAGGATAAGTC 3’ 
5’GTCAGCTCCTCCTTGTCCTG 3’ 
58 199 
7.2.3 Characterization of primary human monocytes by flow cytometry 
Flow cytometry (FC) was used to characterize the monocyte subtype at hand and the purity of 
the isolation steps. FC is a technique that is suitable to collect statistical data from a huge 
population of cells, by simultaneous analysis of multiple characteristics. The parameters that 
can be analyzed are cell size and number, cell complexity (internal and external granularity), 
surface marker expression (phenotype determination) or the health status of the cells. For the 
purpose of this study the flow cytometer Canto II from BD and the corresponding FACSDiva 
software were used. In order to characterize the monocyte subset, the expression of chosen 
surface proteins (= markers, CD-molecules) was analyzed using specific antibodies that were 
conjugated to fluorophores.  
                                                     
10
 http://www.ncbi.nlm.nih.gov/tools/primer-blast/ 
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Monocytes appear in three different subsets (Gordon & Taylor, 2005), with the inflammatory or 
classical subset showing the highest proportion (95 %) of circulating blood monocytes. Based 
on the publication from Tallone and colleagues (Tallone et al., 2011), five CD markers were 
chosen to characterize the present monocyte subset: CD14, CD16, HLA-DR, CD62L and 
CD64. Three stainings were performed with 1) CD14, CD16, HLA-DR and CD62L; 2) CD14, 
CD16, HLA-DR and CD64 and 3) the corresponding isotype controls to test for unspecific 
antibody binding. Table 12 shows the antibodies, their conjugated fluorophore and isotype 
controls including their properties, used for characterization. 1 x106 monocytes (day three after 
isolation) were washed once and re-suspended in 100 µl PBS (+0.5 % BSA). 5 µl of the desired 
antibody solution or isotype control was added and incubated for 15 min at RT or 30 min at 
4 °C. Labeled cells were washed twice in PBS (+0.5 % BSA) and re-suspended in a final 
volume of 200 µl PBS (+0.5 % BSA) and measured within 2-4 h. 
Table 12 Antibodies and isotype controls used for flow cytometry  
Indication (Target) Fluorophore Antibody subtype Supplier Catalogue #  
PE anti-human CD14 Antibody 
(CD14) 
PE IgG1 biolegend 325606 
Anti-Human CD16 FITC (CD16) FITC IgG1 eBioscience 11-0168-42 
Pacific Blue™ anti-human HLA-
DR Antibody (HLA-DR) 
Pacific Blue IgG2b biolegend 327016 
APC anti-human CD62L 
Antibody (CD62L) 
APC IgG1 biolegend 304810 
PE/Cy7 anti-human CD64 
Antibody (CD64) 
PE-Cy7 IgG1 biolegend 305021 
Pacific Blue™ Mouse IgG2b, κ 
Isotype Ctrl Antibody 
Pacific Blue  IgG2b biolegend 400331 
PE Mouse IgG1, κ Isotype 
Control Antibody 
PE IgG1 biolegend 400111 
Mouse IgG1 K Isotype Control 
Alexa Fluor® 488 
FITC  
(Alexa488) 
IgG1 ebioscience 53-4714-42 
APC Mouse IgG1, κ Isotype 
Control Antibody 
APC  
(Alexa647) 
IgG1 biolegend 400119 
PE/Cy7 Mouse IgG1, κ Isotype 
Control Antibody 
PE-Cy7 IgG1 biolegend 400125 
 
7.2.4 Protein determination  
Western blot (Immunoblotting) technique was used to determine Orai and STIM isoform protein 
expression and to verify the success of RNAi mediated knockdowns. In addition, the technique 
was used to determine the expression of the TF MITF, Jarid1B and the pro-apoptotic factor 
Brn2 in melanoma cell lines. In the following section the experimental outline is described, 
combining general aspects of the technique and the specifications used for this study. The 
determination of protein content of a sample is achieved by the combination of different steps. 
In a fisrt step, the protein is made available by lysis of the cells and further denaturized. In a 
second step, the proteins are separated according to their size using a SDS-polyacrylamid-gel 
electrophoresis (SDS-PAGE).  
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Following the separation, the proteins are transfer from the gel to a nitrocellulose membrane. In 
a final step, the membrane is probed with specific antibodies to detect the desired proteins. 
Antibodies used in the here presented study are listed in Table 13. 
Table 13 Antibodies used for western blot 
Antibody Dilution Supplier Order# Secondary AB 
Brn2 1:100 Sigma AV31218 rabbit 
GAPDH 1:8000 Santa Cruz sc-25778 rabbit 
Goat anti mouse 1:10000 Sigma A-3682  = secondary AB 
Goat anti rabbit 1:10000 Jackson 
ImmunoResearch 
111-035-046  = secondary AB 
JARID1B 1:100 Novus NB100-97821 rabbit 
MITF 1:250 Sigma HPA003259 rabbit 
Orai1 1:2000 Sigma O8264 mouse 
STIM2 1:2000 Sigma 
Anaspec 
S8572  
PRS4125 
rabbit 
 
Cells were harvested and shock frozen in liquid nitrogen as preparation for protein extraction. 
Samples were re-suspension in 1xRIPA lysis-buffer and incubation on ice for 30 min. The lysis-
buffer contained proteinase inhibitors as essential component to prevent digestion of the 
samples by endogenous proteinases. Shear forces were used to facilitate protein extraction by 
passing the cell suspension through hallow needles repeatedly. Protein concentration of the 
lysate was determined using the bicinchoninic acid (BCA) protein assay following the 
manufactures instructions.11 Protein content of the sample is calculated from a standard curve, 
based on defined protein concentrations, determined for each single experiment. 20 µg of 
protein, mixed with 5 µl page ruler, were separated by 15 % or 10 % SDS-PAGE (130 V, 
60 mA, 2 h) in 1xSDS-running buffer. The highly negatively charged chemical SDS binds 
protein, creating a negatively charged complex, thereby enabling an efficient separation during 
electrophoresis. The composition of buffers and gels used for this study are presented in Table 
6 with single components listed in Table 3. Separated protein was blotted from gels onto 
nitrocellulose membranes (70 V, 20 mA, 16 h) in blotting buffer. The transfer is a necessary 
step to detect the desired proteins, since the epitopes of the proteins are not available for 
antibody detection when bound in the gel, but become accessible after transfer onto a 
membrane. The membranes were blocked in 5 % milk in PBS-T for one hour to prevent 
unspecific antibody binding in the following steps. Primary antibodies were incubated with the 
membrane overnight at 4 °C. The membranes were washed three times with PBS-T and were 
subsequently incubated with the appropriate secondary antibody for one hour at RT. The 
membranes were washed again three times with PBS-T and detected with Pierce ECL western 
blotting Substrate on Amersham Hyperfilm ECL. Different exposure times (1-30 min) were used 
depending on the primary antibody. To evaluate protein amount and equal loading, blots were 
stripped and probed against GAPDH as loading control. Due to its abundantly high expression, 
GAPDH is commonly used as reference to normalize target protein expression.  
                                                     
11
 http://www.piercenet.com/browse.cfm?fldID = 02020101 
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7.2.5 Gene silencing using RNA interference (RNAi) 
7.2.5.1 Method  
There are in general two different approaches to regulate gene expression, either by altering or 
deleting the DNA-sequence or by interfering in protein biosynthesis at a post-transcriptional 
level. Gene silencing, by alteration of DNA sequence (mutation), or a gen knock-out, by 
deleting a DNA sequence, are different approaches to target a gene on DNA level. Another 
option is the RNA interference (RNAi) on mRNA level using so-called small-interfering RNAs 
(siRNA). That way, the gene sequence stays untouched and can be transcribed into mRNA, but 
further translation is prevented. Gene-silencing by siRNAs or other regulatory small RNA 
constructs like microRNAs are also endogenous processes to regulate gene expression.  
SiRNAs are short (21-23 bp), double-stranded RNA sequences. Such siRNAs can be 
processed in vitro and transfected into cells. Double-stranded siRNAs are recognized and 
separated into single strands by the RNA-induced silencing complex (RISC), a multi-
component enzyme. The sense strand of the construct is identical to the target mRNA, thus the 
antisense strand binds the target mRNA after being processed within the cell. The resulting 
double-strand RNA complex is again recognized by RISC, degraded and the target mRNA is no 
longer available as template for protein translation. This knockdown of gene function is only 
transient, because mRNA is constantly processed. In addition the siRNA itself is prone to 
degradation.  
7.2.5.2 Nucleofection of siRNA 
Nucleofection is a type of electroporation that is used to transfers siRNAs (or DNA constructs) 
into cells. Pooling the cells and the construct to be transferred in a salt free solution and 
subjecting it to an electric pulse, enables the construct to traverse the membrane. The 
manufacturer claims to guarantee a directed trafficking of the construct into the nucleus, 
thereby increasing the efficiency of transfection. This method was designed for transfection of 
primary cells and difficult-to-transfect cell lines. Moreover, it serves as a method to transfect 
non-proliferating cells and as an alternative method to the usage of lentiviral transfection. The 
devices used for electroporation of melanoma cell lines and monocytes are presented in Table 
5. 1 x106 melanoma cells and 7.5 x106 monocytes were used per transfection and gently 
centrifuged (200 x g, 6 min for melanoma and 1500 x g, 6 min for monocytes). The cell pellet 
was re-suspended in 100 µl of the respective nucleofector solutions (at RT) inculding 2-4 µl of 
the desired siRNAs or control non-silencing RNA (approx. 20-30 pmol). The suspension was 
placed in a cuvette and subjected to electroporation using the specific protocols (intensity and 
time of the pulse, cell specific pre-sets provided by the supplier).12  500 µl of pre-warmed 
medium was added immediately after pulsing and the whole mixture was transferred into the 
specific culture plates containing pre-warmed medium.  
In all cases despite STIM2 and Orai2, a mixture of 2 different siRNAs was used (see Table 14). 
The sequences of the siRNAs for knockdown of Orai1, Orai2, Orai3 and STIM1 genes were 
chemically modified to ensure stability over 48 h. The modifications were initially introduced in 
the lab to stabilize siRNA for transfection of primary T cells. The insertion of chemical 
modifications was shown to support stability of siRNA by several research groups and 
information about the used modifications was taken from (De Paula et al., 2007; Mantei et al., 
                                                     
12http://bio.lonza.com/fileadmin/groups/marketing/Downloads/Protocols/Generated/Optimized_
Protocol_302.pdf 
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2008). Besides lack of stability, the induction of an immune response by siRNAs, has to be 
taken into consideration (Judge et al., 2005; Whitehead et al., 2011). Based on findings that 
modifications at the C2’ ribose provoke a reduced immune response and increase the stability 
of the siRNA, these modifications were chosen for the here described experiments (De Paula et 
al., 2007; Mantei et al., 2008). The used siRNAs to target the different CRAC channels 
components are listed in Table 14. To rule out side effects of the transfection method or the 
presence of small RNAs in general, non-targeting RNAs were used in separated control 
transfections. Depending on the used siRNAs modified or unmodified RNAs were used as 
corresponding controls, as listed in Table 15.  
Table 14 Sequences of siRNAs used for specific gene knockdowns 
The modifications introduced to the siRNA sequence are indicated as follows: OMe, O-methylation at C2’ of the ribose; 
d, deoxygenation at C2’ of the ribose. The sense strands display a TT overhang at the 3’end of the sequence, a typical 
feature of siRNAs. 
Target mRNAs and sequences of used siRNAs 
Target mRNA 
Orai1.1 
 
 
 
 
Orai1.2 
Orai1 (NM_032790) 
O1.1 sense 
5’ OMeC-OMeG-GCCUGAUCUUUAUCG-d(UCU)-d(OMeT-OMeT) 3‘  
O1.1 antisense 
5’ dA-AGACGAUAAAGAUCAGGC-OMeC-OMeG 3’ 
 
O1.2 sense 
5’ OMeC-OMeA-ACAUCGAGGCGGUGA-d(GCA)-d(OMeA-OMeT-OMeT) 3‘ 
O1.2 antisense 
5’ d(U)-UGCUCACCGCCUCGAUGU-OMeT-OMeG - 3’ 
Target mRNA 
Orai2 
Orai2 (NM_032831) 
O2 sense 
5’ OMeC-OMeA-ACAUGAGUGCUGAGC-dU-dU-dA-dOMeA-dOMeT-dOMeT 3’ 
O2 antisense 
5’ dU-UAAGCUCAGCACUCAUGU-OMeT-OMeT 3’ 
Target mRNA 
Orai3.1 
 
 
 
 
Orai3.2 
Orai3 (NM_152288) 
O3.1 sense 
5’ OMeC-OMeA-CCAGUGGCUACCUCC-d(CUU)-d(OMeA-OMeT-OMeT)3’ 
O3.1 antisense 
5’ d(U)-AAGGGAGGUAGCCACUGG-OMeT-OMeG 3’ 
 
O3.2 sense 
5’ OMeT-OMeC-CUUAGCCCUUGAAAU-d(ACA)-d(OMeA-OMET-OMeT)3’ 
O3.2 antisense 
5’ d(U)-(UGUAUUUCAAGGGCUAAG)-OMeG-OMeA 3’ 
Target mRNA 
STIM1.1 
 
 
STIM1 (NM_003156) 
S1.1 sense 
5’ OMeU-OMeG-AGGUGGAGGUGCAAU-d(AUU)-OMeA-OMeT-OMeT 3’  
S1.1 antisense  
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Target mRNAs and sequences of used siRNAs 
 
 
STIM1.2 
5’ dU-AAUAUUGCACCUCCACCU-OMeC-OMeA 3’ 
 
S1.2 sense 
5’ OMeC-OMeU-GGUGGUGUCUAUCGU-d(UAU)-OMeU-OMeT-OMeT 3’ 
S1.2 antisense 
5’ dA-AUA 3’ACGAUAGACACCACC-OMeA-OMeG 3’     
Target mRNA 
STIM2 
 
STIM2 (NM_001169117.1) 
S2 sense 
5’ UAAGCAGCAUCCCACAUGA-d(TT) 3’ 
S2 antisense  
5’ d(TT)-UCAUGUGGGAUGCUGCUUA 3’ 
 
Table 15 Sequences of non-targeting RNAs used as controls for specific gene knock-downs 
The modifications introduced to the siRNA sequence are indicated as follows: OMe, O-methylation at C2’ of the ribose; 
d, deoxygenation at C2’ of the ribose. The sense strands display a TT overhang at the 3’end of the sequence, a typical 
features of siRNAs. 
Sequences of used non-targeting control RNAs  
Control (1) 
Unmodified 
by Microsynth 
Sense 
5’ AAAGGUAGUGUAAUCGCCUUGTT 3’ 
Antisense 
5’ CAAGGCGAUUACACUACCU 3’ 
Control (2)  
Modified 
by Microsynth 
Sense 
5’ OMeA-OMeA-AGGUAGUGUAAUCGC-d(CUU)-OMeG-OmeT-OMeT 3’ 
Antisense 
5’ dC-AAGGCGAUUACACUACCU 3’ 
Control (3)   
Modified 
by Qiagen 
Sense 
5’ OMeA-OMeA-UUCUCCGAACGUGUC-d(ACG)-OMeU-OMET-OMeT-OMeT 3’ 
Antisense 
5’ d(A)-CGUGACACGUUCGGAGAA-OMeT-OMeT 3’ 
7.2.6 Detection of reactive oxygen species  
7.2.6.1 Electron Paramagnetic Resonance Spectroscopy (EPRS) 
EPRS technique was applied to characterize the source and the role of SOCE for ROS 
production by primary human monocytes and was performed by Reinhard Kappl and David 
Conrad (Institute of Biophysics, Saarland University). The EPR experiments were performed 
with a Bruker spectrometer (ESP300e) equipped with a standard 4102ST cavity which holds 
the capillary support quartz glass finger. The finger is temperature controlled and set to 37 °C 
for experiments with cells (temperature controller BioIII-TGC, Noxygen). The modulation 
amplitude was generally 0.1 mT and the microwave power was set to 20 mW as standard 
condition for all experiments. Spectra were recorded with scan times of 60 s and stored 
consecutively to monitor the kinetic behavior of the signal. 2.5-5 x 105 monocytes were used 
per experiment and stimulated with the according additives. Tg was used to passively activate 
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CRAC channels and Bisgö and DPI to inhibit NOX2. 300 µM of the redox activated cyclic 
hydroxylamine spin trap CMH (1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetramethylpyrrolidine) 
was used for all experiments to monitor superoxide production. CMH was added last, the 
sample was filled in a 50 µl glass capillary and immediately transferred into the capillary holder. 
The experiments were performed in Ringer’s solution at 37 °C (Ca2+ free or containing 1mM 
[Ca2+]). The oxygen concentration in solution was about 200 µM. All control experiments with 
single components of the assays and CMH were tested for unwanted radical production. In 
addition, superoxide radical as the reacting species was identified by suppression of the CMH 
signal by SOD (100 U/ml) acting as scavenger. The EPR spectra of the CM radical were 
evaluated with the custom-made program Medeia which measures the peak-to-peak intensity 
and width of one (or several) lines of a radical visible in a time series. In absence of line width 
changes and saturation effects, the intensity information can be translated to radical 
concentration by calculating the integral of the monitored line and considering the multiplicity of 
the radical signal. This value is compared to a reference sample of known concentration 
(usually 100 µM Tempol) recorded under identical conditions for quantitative measures. 
7.2.6.2 Fluorescent Dyes 
H2O2 production by monocytes was measured extracellular using the H2O2 sensitive and 
specific fluorescent dye Amplex®UltraRed (AUR). AUR reacts with H2O2 to its fluorescent 
product Resorufin in a 1:1 relation, catalyzed by horseradish peroxidase (HRP). NOX2-
depended H2O2 production by monocytes was measured after activation of SOCE by Tg or 
fMLF and the PKC activator PMA as positive control (1 µM each). Experiments were performed 
in 96-well plates (black casket/ transparent bottom). All experiments were conducted in 
Ringer’s solution with 1 mM [Ca2+] or Ca2+ free (0 mM [Ca2+]). 25.000 cells/ well were used in 
duplicates or triplicates per condition. The total desired cell number for one experiment was 
centrifuged, re-suspended in Ringer’s solution with a concentration of 25.000 cells/ 10 µl and 
seeded into the 96-well plate. Assay components and concentrations were: AUR (50 µM), HRP 
(0.5 U/ml) and SOD (10 U/ml) in 180 µl/ well. SOD was added to the reaction to ensure a 
sufficient conversion of the initially produced superoxide to H2O2. PMA, Tg and fMLF 
concentration was set to 20 µM and used with a volume of 10 µl/well to achieve a final 
concentration of 1 µM. For negative controls Ringer’s solution containing 2 % DMSO was 
added with 10 µl/well to achieve a final concentration of 0.1 % . 2-APB and DPI were used 
yielding to a final concentration of 50 µM and 10 µM, therefore preset to 2 mM and 1 mM. H2O2 
production by measurement of the resulting Resorufin intensity (as RFU), with excitation at 
535 nm and emission at 590 nm, was performed using the Tecan GENios Pro Reader with a 
bottom reading setting. ROS production was recorded for 50-90 min with a cycle time of 2 min. 
Different concentrations of H2O2 were measured in three independent experiments with AUR to 
create a standard curve, with a regression value of 0.999. The standard curve was further used 
to calculate [H2O2] based on RFUs (see Equation 2 and result section).  
Equation 2 H2O2 (nM) = (RFU/2.56) – 47.32  
Internal ROS was determined on single cell level by the fluorescent dye H2-DCFDA displaying 
an excitation maximum at 485 nm and an emission maximum at 535 nm. H2-DCFDA is a rather 
non-specific sensor of internal ROS. The dye is a fluorescein-derivate (chemically reduced), 
that carries an ester bound diacetate-group, rendering it cell membrane permeable. The dye is 
trapped in cells due to cleavage of the diacetate-group by endogenous esterases. It was 
chosen, to test a H2O2 feedback on ROS production, instead of the more reliable AUR, 
because of the required pre-treatment of the cells with H2O2 for the intended purpose. Cells 
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were loaded with Thapsigargin and H2-DCFDA (1 µM each) for 30 min at RT for both, control 
and H2O2 conditions. Prior to loading a pre-treatment with 300 µM H2O2 for 15 min at dark (RT) 
was performed to determine the effect of oxidants on Tg-triggered ROS production.
 
Loading 
and pre-treatment, as well as the measurements were performed in 1 mM [Ca2+] Ringer’s 
solution. Cell handling and recordings were done using the same hard- and software 
components as for fluorescent-based calcium imaging (see 7.2.7). Recorded RFUs were 
calculated and presented as percent of un-stimulated, H2-DCFDA loaded control cells.  
7.2.7 Calcium imaging 
7.2.7.1 Method 
The here described method, referred to as calcium imaging, was used to measure intracellular 
Ca2+ concentrations [Ca2+]i of monocytes and melanoma cell lines (SK-MEL-5 and WM3734) on 
single cell level. Cells were loaded with the dye Fura-2AM which comprises a 
polyaminocarboxylate fluorophore, that binds divalent ions such as Ca2+ and is conjugated to a 
acetoxymethylester-group (AM). The AM-group enables the dye to permeate into cells and is 
further cleaved off by endogenous esterases in the cytosol, trapping the dye in the cell. Fura-
2AM is a ratiometric dye that exhibits two absorption maxima with excitation at 340 nm and 
380 nm and one emission maximum at 510 nm. The binding of Ca2+ results in an increased 
emission under excitation at 340 nm and a decreased emission under excitation at 380 nm. 
The emission ratio 340 nm/ 380 nm reflects changes in [Ca2+]i and is indicated as relative 
fluorescent unit (RFU). This relative indicator can be converted to a Ca2+ concentration ([Ca2+]) 
after calibration of the system to evaluate the minimal and maximal achievable values of the 
investigated cell types under defined measuring conditions. This method of estimating [Ca2+]i 
was initially proposed by Grynkiewicz and colleagues (Grynkiewicz et al., 1985) and the 
provided equation was used to convert fluorescent units to calcium concentration (Equation 3). 
Parameter definitions of the Grynkiewicz equation are as follows: Kd: dissociation constant, sf1 
(signal free dye): signal of unbound dye at 340 nM; sf2: signal of unbound dye at 380 nM; 
sb1(signal bound dye): signal of Ca2+ bound dye at 340 nm excitation; sb2: signal of Ca2+ 
bound dye at 380 nm excitation. The parameter Rmin is calculated from (sf1/sf2), and reflects 
the lowest possible Ca2+ concentration and Rmax, calculated from (sb1/sb2), defines the highest 
possible values. The advantages of a radiometric determination are the abolishment of usual 
occurring problems like imbalanced loading and bleaching events.  
Equation 3 Calcium (nM) = Kd (Fura) x ((RFU-Rmin)/(Rmax-RFU)) x (sf2/sb2)  
7.2.7.2 Experimental handling  
The data was recorded on a set-up comprising an inverted microscope (Olympus IX70) using a 
20x objective (UApo/340, N.A. 0.75), a xenon-lamp with control unit (Polychrome V 
monochromator), an infrared lamp and a CCD camera (all items provided by T.I.L.L. Photonics 
GmbH), using the tillvison software. For measurement of monocytes, experiments were 
performed with 1-5 x 105 cells per measurement. Cells were loaded with 1 µM Fura-2AM 
(25 min, RT) in standard culture medium containing 100 mM HEPES to stabilize pH. Loaded 
cells were placed on coverslips coated with poly-l-ornithine (0.1 mg/ml in H2Odest) to prevent 
movement of the cells during the measurements. Coverslips were placed into a measuring 
camber, connected to a perfusion system. For measurement of melanoma cell lines, cells were 
seeded on coverslips two days before the experiments and were loaded with 1 µM Fura-2AM in 
their specific culture medium (20 min, 37 °C, 5% CO2). 
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The standard measuring protocol involved perfusion steps of Ringer’s solutions with different 
calcium concentrations (see Table 6), supplemented with Thapsigargin (Tg, 1 µM) or fMLF 
(1 µM) to activate CRAC channel signaling. These steps were: 0.5 mM [Ca2+] to estimate basal 
concentrations, 0 mM [Ca2+] to abolish extracellular Ca2+, 0 mM [Ca2+] containing a stimulus to 
activate the signaling cascade by depleting the intracellular Ca2+ stores, re-addition of 0.5 mM 
[Ca2+] to estimate Ca2+ influx via activated channels, followed by 0 mM [Ca2+] to stop the influx. 
This protocol is further referred to as store-depletion protocol. As described above the 
calculation of [Ca2+] based on RFU values requires a calibration of the system. Calibrations 
were performed on non-transfected monocytes and SK-MEL-5 cells (as representative for 
melanoma cell lines). Calculation of [Ca2+] was based on the measured RFUs, with the 
parameters given in Equation 4 for monocytes and Equation 5 for melanoma. 
Equation 4 Calcium (nM) = Kd (224nM) x ((RFU-0.183)/(5.736)) x 5.149 
Equation 5 Calcium (nM) = Kd (224nM) x ((RFU-0.158)/(4.798)) x 6.421 
The calibration protocol involved perfusion steps of Ringer’s solution with different Ca2+ 
concentrations and chemicals to elevate Ca2+ from all subcellular compartments. These steps 
were: 0.5 mM [Ca2+] to estimate basal concentrations; 0 mM [Ca2+] plus ionomycin (4 µM) and 
Tg (1 µM) to remove Ca2+ from all cellular compartments and the cytosol; followed by re-
addition of 20 mM [Ca2+] to achieve the highest possible [Ca2+]i.  
7.2.8 CellTiter-Blue viability and proliferation assay  
The CellTiterBlue viability assay was used to analyze cell survival and proliferation of 
monocytes, SK-MEL-5 and WM3734. Survival and proliferation was tested according to specific 
culture environments or following RNAi to determine to involvement of CRAC channels in these 
processes. The assay is based on the conversion of the indicator dye Resazurin to its 
fluorescent form Resorufin by metabolic active cells. The dye displays an excitation maximum 
at 574 nm and an emission maximum at 590 nm. For measurements an excitation wavelength 
of 535 nm was applied to prevent interference with the used culture medium. For non-
proliferating monocytes this assay was used to determine the number of surviving cells in an 
oxidizing environment and/or when exposed to different extracellular Ca2+ concentrations. For 
melanoma cells the assay was used to determine proliferation when exposed to different Ca2+ 
concentrations in the medium or following a knockdown of Orai1 or STIM2. All experiment s 
were performed in 96-well plates (black casket/transparent bottom), with triplicates per 
condition, using 25.000 cells/well for monocytes and 4000 or 3000 cells/well for SK-MEL-5 and 
WM3734 respectively. Fluorescence was detected using the Tecan GENios Pro Readers with 
bottom reading setting. The specific measurement parameters are listed in Table 16.  
In order to determine monocyte survival in an oxidizing environment cells were seeded in 
200 µl standard culture medium per well, containing increasing concentrations of H2O2 ranging 
from 1 µM to 10 mM (concentration in medium). Cells were cultured under these conditions for 
24 h. 20 µl of CellTiterBlue was added per well and incubated for 3h before fluorescence was 
detected. IC50 of cell viability was calculated from RFUs of H2O2 treated cells, normalized to un-
treated control cells. The Origin software and an exponential decay fitting was applied to 
determine the IC50. 
To analyze the effect of ion changes in the extracellular compartment on cell survival and 
proliferation, different Ca2+ concentrations in medium were achieved by supplementation with 
the Ca2+-chelator EGTA. 
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Table 16  Experimental settings of CellTiterBlue Assays 
Measurement Purpose  Device used Parameters/Settings 
Survival of monocytes in an 
oxidizing environment (H2O2) 
Tecan GENios Pro Reader Number of flashes/Well: 5 
Manual gain: 42 
Integration time: 40 µs 
Multiple Reads/Well: 3X3  
Survival of monocytes in an 
oxidizing environment (H2O2) 
depending on the extracellular 
Ca
2+
 milieu 
Tecan infinite M200 Pro 
Reader 
Number of flashes/Well: 5 
Manual gain: 75 
Integration time: 40 µs 
Multiple Reads/Well: none 
Proliferation of SK-MEL-5 cells 
with knockdown of Orai1 and 
Stim2 
Tecan GENios Pro Reader Number of flashes/Well: 3 
Manual gain: 35 
Integration time: 40 µs 
Multiple Reads/Well: 3X1 (line) 
Proliferation of SK-MEL-5 cells 
depending on the extracellular 
Ca
2+
 milieu 
Tecan infinite M200 Pro 
Reader 
Number of flashes/Well: 5 
Manual gain: 75 
Integration time: 40 µs 
Multiple Reads/Well: 3X3 
 
The resulting free Ca2+ concentration ([Ca2+]free) was measured using two different techniques: 
The Calcium Gen.2 Assay (Roche Diagnostic)13 performed by the Central Clinical Laboratory, 
University of Saarland and the Combination Calcium Electrode perfectIonTM (Mettler Toledo)14. 
A stock-solution of 100 mM EGTA in H2Odest. was used to adjust [Ca2+]free in the medium. The 
Calcium Gen.2 Assay, in general, is used for quantification of [Ca2+]free in serum, plasma or 
medium samples. Within the assay performance, free Ca2+ binds to a chromofor NM-BABTA in 
a 1:1 relation which results in a color shift of the solution. In a second step EDTA is added. This 
calcium chelator has a higher binding affinity to Ca2+ than BABTA, resulting in the formation of 
an EDTA-Ca2+ complex and free BABTA in solution. The concurrent color back-shift of the 
solution is measured using excitation at 340 nm and is proportional to the free (bondable) Ca2+ 
concentration in the sample. Measurement of [Ca2+]free using the calcium electrode were 
performed following the manufacturer’s instructions.15 The electrode was calibrated using three 
defined Ca2+ concentrations (2.5 x10-5 mM, 2.5 x10-4 mM, 2.5 x10-3 mM) in H2Odest.. 10 ml of 
RPMI -/+ 10% FCS and -/+ EGTA (0.1-0.9 mM) were prepared and subjected to the different 
techniques. For each EGTA concentration in both medium types three independent 
measurements were performed.  
                                                     
13
 Description of test performance by Roche Diagnostic see: http://www.roche-
diagnostics.de/diagnostics/testsundparameter/immundiagnostik/calcium/Documents/FactSheet
_Calcium2.pdf 
14
 
http://de.mt.com/de/de/home/supportive_content/product_documentation/operating_instructions
/GB_Fluoride/jcr:content/download/file/file.res/perfectION_Guidebook_Fluoride_de.pdf 
15
 
http://de.mt.com/de/de/home/supportive_content/product_documentation/operating_instructions
/GB_Fluoride/jcr:content/download/file/file.res/perfectION_Guidebook_Fluoride_de.pdf 
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For Proliferation and survival experiments of monocytes and melanoma cells in different 
Ca2+milieus, EGTA supplemented medium was prepared 2-fold concentrated and equilibrated 
at 37 °C, 5% CO2 for minimum 2 h. The equilibration step was necessary, due to a high 
influence of EGTA supplementation on medium pH. Cells were seeded in 100 µl medium/ well 
(no EGTA-supplementation) and 100 µl/well of the prepared medium. Cells were incubated 
under these condition for 48 h/ 72 h (melanoma) or 48 h with or without 24 h of additional 
treatment with H2O2 (monocytes). 20 µl of CellTiterBlue was added per well after 48 h and 
incubated for another 3 h before fluorescence was detected. 
7.2.9 Transwell-migration assay 
Migration properties of melanoma cell line WM3734 was determined in a transwell-migration 
assay. Within this assay, cells were allowed to adhere to and migrate through a membrane with 
a specific pore size. The membrane is part of a cell culture insert that was placed in a well of a 
24-well plate, thereby creating two compartments: the upper compartment containing cells in 
their respective medium and a lower compartment (the culture plate well), also containing 
medium. For this study the role of CRAC channels for migration of melanoma cells was 
investigated by knockdown of Orai1 and STIM2 using RNAi (see 7.2.5).  
WM3734 transwell-migration was determined using cell culture inserts with 8 µm pore size, 
following the manufacturer’s instructions. 24 h after transfection, 1 x105 Orai1, STIM2 and 
control siRNA treated cells were loaded with the fluorescent dye Calcein-AM (1 µM) for 25 min 
at 37 °C. Calcein-AM is a cell permeable dye and is trapped in the cell after cleavage of the 
AM-group by endogenous esterases in the cytosol. Cell were washed after loading, re-
suspended in standard culture medium with 1 x105 cells/ 200 µl, seeded with 200 µl/ insert and 
placed in 24-well plates. Cells were allowed to adhere to the membrane of the insert and 
migrate for 24 h (37 °C, 5 % CO2). Inserts were then placed into wells containing 1 ml 
accutase, for detachment of the cells from the downside of the membrane for 20 min (37 °C, 
5 % CO2). Amount of migrated cells was detected by measuring Calcein fluorescence using the 
Tecan infinite M200 Pro Plate Reader with a 470/525 nm excitation/emission and a bottom 
reading setting. Accurate cell number was calculated from Equation 6, based on a calibration 
curve (R² = 0.985), determined from three independent measurements using Calcein-loaded 
cells with defined cell numbers ranging from 1 x102 – 1 x105. 
Equation 6 Cell number = RFU/0.037   
7.2.10 Detection of cytokines using ELISA 
IL-8 production by SK-MEL-5 cells was measured using the QuantiGlo® Human IL-8 
Chemiluminescent Immunoassay. QuantiGlo works as a sandwich enzyme linked 
immunosorbent assay (ELISA). To bind IL-8 from a sample a monoclonal IL-8 antibody is 
immobilized on a microplate. Within the assay, IL-8 from the sample binds to the antibody and 
non-bound sample components are removed in a wash step. Next, a polyclonal IL-8 antibody is 
added to bind the Fc region of IL-8. Since IL-8 from the sample is bound from two sides, this 
way of detection is referred to as “sandwich assay”. The polyclonal antibody is conjugated to a 
functional peroxidase. This enzyme reacts with the luminol substrate added in the last step, 
producing light.  
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This way of chemiluminescence detection (light generation by enzyme activity) eliminates 
background interferences and is more sensitive than other methods. The intensity of emitted 
light is proportional to the amount of bound IL-8.16  
In order to measure IL-8 production by SK-MEL-5 cells, samples were taken from supernatants 
of proliferation experiments with a total volume of 120 µl (pooled from according triplicates) and 
diluted with H2Odest. (1:2). Samples were treated following the manufacturer’s instructions. 50 µl 
of diluted sample were placed in the prepared antibody coated wells of the provided 96-well 
plate, mixed with the provided assay diluent and incubated for 2 h (RT, shaking) to enable IL-8 
in the sample to bind to the immobilized antibodies. Wells were washed three times and 200 µl 
of provided IL-8 conjugate (containing the polyclonal IL-8 antibodies) were added to each well. 
After an incubation period of 3 h (RT, shaking), the wells were carefully washed as described 
before. 100 µl of freshly prepared luminol substrate (mixture of enhanced stabilized luminol and 
stabilized hydrogen peroxide, 1:2) were added to each well, incubated for 20 min. Developed 
luminescence was measured using the Tecan GeniosPro reader with 1000 ms lag-time and 
500 ms read-time. All conditions were measured in duplicates. IL-8 concentration was 
calculated using a calibration curve (Equation 7, with R2 = 0.987), that was drawn from one of 
two independent collected standard curves based on a provided IL-8 standard. 
Equation 7 IL-8 (pg/ml) = ((Mean RLU – S0 (zero value of standard curve)) / 733.92   
7.2.11 Data Analysis and Statistics 
Figures and graphs. Data analysis was performed using the software Microsoft Office Excel 
and Origin Pro 6.1 if not otherwise indicated. All line and bar graphs were plotted with Microsoft 
Excel, with exception of the box-plot-whisker-diagrams and diagrams for IC50 determination that 
were plotted with Origin Pro. All figures and schemes presented in this dissertation were edited 
using CorelDraw X4.  
Statistics. Data is presented as mean or median with error bars indicating the standard error of 
the mean (SEM). For determination of statistical significance of the obtained results, the 
standard student T-Test (paired or un-paired) was applied. The T-Test was also applied under 
non-optimal conditions, when sample size was < 30 and when data sets did not follow a 
gaussian distribution. Significant changes are indicated with * for p < 0.05, ** for p < 0.01 and 
*** for p < 0.001. All data sets were tested for outliers using the free-available outlier calculator 
(graph pad) and outliers with a significance level of 0.01 were excluded from calculations.17 
  
                                                     
16
 http://www.rndsystems.com/pdf/q8000b.pdf 
17
 http://www.graphpad.com/quickcalcs/Grubbs1.cfm 
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8 Results 
8.1 Characterization of investigated cell types 
8.1.1 Orai and STIM expression profiles  
An essential part of the characterization of SOCE and the analysis of the individual CRAC 
channel components required investigation of their expression patterns. The expression levels 
of Orai and STIM family members in primary human monocytes (day 1-3 after isolation) and 
three different melanoma cell lines (SK-MEL-5, SK-MEL-28 and WM3734) were compared to 
reference genes, using qRT-PCR. The three melanoma cell lines were chosen due to their 
difference in origins. SK-Mel 28 derived from a primary melanoma, while SK-MEL-5 and 
WM3734 derived from metastatic melanoma (see 7.1.6 for details). The results of qRT-PCR, 
presented in Figure 9 (A and B), revealed a distinct expression of the single isoforms in the 
different cell types. In monocytes Orai1 and Orai2 as well as STIM1 and STIM2 showed 
comparable expression levels (Figure 9, A). On the other hand, melanoma cell lines show a 
significantly higher expression of Orai1 and STIM2 compared to Orai2 and Orai3 and STIM1, 
respectively (Figure 9, B). In all tested cell lines Orai1 expression exceeded Orai2 with 2-∆∆Cq 
values being 6-, 12- and 7- fold higher for SK-MEL-5 (2.21 to 0.18, Orai1/Orai2), SK-MEL-28 
(1.96 to 0.31, Orai1/Orai2) and WM3734 (1.57 to 0.22, Orai1/Orai2), respectively. Similarly, 
STIM2 expression level was higher than that of STIM1 in all tested cell types. The expression 
level was increased 5-fold for SK-MEL-28 and WM3734 (1.43 or 1.56 to 0.28 or 0.32, STIM1/ 
STIM2) and 4-fold in the case of SK-MEL-5 (1.12 to 0.29, STIM1/STIM2). In all cases 
(monocytes and melanoma) expression levels of target genes were normalized to the reference 
gene TBP. In monocytes, Orai3 was the least expressed isoform with an absolute expression 
value of 0.13 (2-∆∆Cq). Melanoma cell lines showed a higher Orai3 expression with 0.43 and 
0.34 for SK-MEL-28 and SK-MEL-5, respectively. WM3743 Orai3 expression with a 2-∆∆Cq value 
of 0.11 was lower than that of other melanoma cell lines, but comparable to expression levels in 
monocytes. Among the Orai isoforms, Orai2 was the least expressed in melanoma cell lines.  
In order to verify whether the differences observed in mRNA expression levels also exist on 
protein levels, western blot analysis was performed for melanoma cell lines. The expression of 
Orai1 and STIM2 was compared to GAPDH, which served as reference and loading control. 
Representative blots are shown in Figure 9 (C and D). In the investigated cell lines, Orai1 and 
STIM2 showed variable protein levels (reflected by differences in band size and run point), 
which can be explained by different post-translational modifications. Orai1 protein runs as two 
distinguishable bands due to differences in post-translational glycosylation. The non-
glycosylated protein runs at the expected 34 kDa, while the complex glycosylated protein runs 
at 55 kDa. (Figure 9, C). STIM2, that has an estimated molecular weight of 100 kDa, depicted a 
major band between 95 and 110 kDa and several smaller bands between 80 and 95 kDa 
(Figure 9, D). 
8.1.2 The relative expression of Orai proteins regarding their redox properties  
The relative expression of the different isoforms of Orai and STIM proteins, rather than the 
absolute expression, are more likely to shape SOCE in different cell types. Orai3 is the least 
expressed isoform in monocytes and relatively low expressed in melanoma cell lines (Figure 9). 
Its relative expression though showed interesting differences. Orai3 has distinguishable 
biophysical and pharmacological properties when compared to Orai1 and Orai2, which bear 
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relatively comparable properties (see 6.4.1). The current study focused on differences in redox-
properties and the relative expression of the isoforms. Thus, the relative expression of the 
redox-insensitive isoform Orai3 to the sensitive isoform Orai1 (Orai3/Orai1) was determined for 
primary human monocytes and melanoma cell lines using the corresponding 2-(∆∆Cq) values 
(Figure 10).  
 
Figure 9 Expression of Orai and STIM isoforms in primary human monocytes and melanoma cell lines.  
Expression pattern of Orai and STIM isoforms in investigated cell types was determined by qRT-PCR and western blot. 
(A) mRNA levels determined for primary human monocytes. (B) mRNA levels determined for human melanoma cell lines 
SK-MEL-28 (brown), SK-MEL-5 (orange) and WM3734 (yellow). (C-D) Representative western blots of Orai1 (C) and 
STIM2 (D) expression in human melanoma cell lines normalized to the reference gene GAPDH (loading control). 
Expression of mRNA indicated as 2-ΔΔCq values averaged from n = 8 (monocytes) and n = 3 (melanoma cell lines) 
experiments, normalized to the reference gene TBP. Error bars indicate SEM.  
In a recent study (Bogeski et al., 2010), relative Orai3 expression was determined for CD4+ 
T helper cells (naïve and effector). These values are presented in Figure 10 (grey shades) for 
comparison with permission of the authors. With a ratio value of 0.04 effector T cells showed 2-
fold higher relative Orai3 to Orai1 expression than naïve cells. Monocytes (blue) showed a ratio 
value of 0.15, reflecting a 3.5-fold higher relative Orai3 expression compared to effector T cells. 
The melanoma cell lines were variable, with SK-MEL-5 (orange) being comparable to 
monocytes while SK-MEL-28 displayed a significantly higher ratio of 0.21 (brown). WM3734 
displayed a significantly lower ratio of 0.07 (yellow). These ratio values and their functional 
influence were important for different aspects of this study and are further discussed below.  
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Figure 10 Relative Orai3 expression levels.  
Relative Orai3 to Orai1 expression ratio calculated from 
2-∆∆Cq values from qRT-PCR data with n = 5 (CD4+ 
Tcells), n = 7 (monocytes), n = 3 (melanoma cell lines) 
independent experiments. Data for CD4+ T cells (naïve 
and effector) was taken with permission from Bogeski et 
al. (Bogeski et al., 2010) and is depicted here for 
comparison with monocyte and melanoma data.  
 
 
 
8.1.3 Validation of RNAi  
Down-regulation on mRNA level of the single Orai and STIM isoforms was achieved by 
application of RNAi technology. Cells were transfected with specific siRNAs, followed by 
intracellular Ca2+ imaging experiments to decipher the importance of the missing protein on 
SOCE. For monocytes, the results are presented in Figure 11 (A) as averages of at least three 
independent experiments. Expression values were determined both for control non-targeting 
RNA (NT RNA) transfected cells (CTRL, black) and cells transfected with specific siRNA 
targeting the single Orai or STIM isoform (siRNA, red). The efficiency of RNAi was determined 
as the percentage of change in relative expression values (Figure 11, B), displaying high 
variation depending on the different siRNA. Percentages were calculated from 2-(∆∆Cq) values for 
the single isoforms to the respective controls. Knockdown of Orai1 and Orai3 mRNA was nearly 
complete with 93% and 88%, respectively (light grey and black). The knockdown of Orai2 and 
STIM1 was less effective with 74% and 71% (grey and dark green). In the case of STIM2 the 
used siRNA deleted 47% (light green) of the respective mRNA. 
Efficiency of knockdown of siRNAs targeting Orai1 and STIM2 was also monitored on protein 
level by Western blot analysis for SK-Mel5 melanoma cells. Lysates obtained from NT RNA 
(CTRL) or Orai1 or STIM2 siRNA transfected SK-MEL-5 cells were probed with the respective 
Orai1, STIM2 or control (GAPDH) antibodies. The representative blots in Figure 11 (C and D), 
show that Orai1 and STIM2 proteins were successfully down-regulated. Cross reactivity of 
STIM siRNA was excluded by probing for STIM2 in STIM1 down-regulated cells. The resulting 
blot (Figure 11, D) showed an unaltered STIM2 expression level compared to the control.  
The same siRNAs were used for RNAi in monocytes and melanoma cell lines. Orai1, Orai3 and 
STIM1 siRNAs were previously tested for specificity and efficiency and regularly used in the 
laboratory at the beginning of this study. Orai2 and STIM2 siRNAs were tested during this study 
and two sequences were selected to perform the presented experiments. In order to rule out 
possible cross reactivity of the individual siRNAs on other Orai or STIM isoforms, the 
expression of all 5 isoforms (Orai1-3 and Stim1-2) was monitored by qRT-PCR in each 
knockdown experiment. The tested siRNAs showed isoform specificity with the exception of 
Orai3 siRNA. The down-regulation of Orai3 was accompanied by down-regulation of Orai1 
mRNA levels by 20% on average (n = 6, data not shown). Other siRNAs did not show any 
interference with the expression of other isoforms.  
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Figure 11 Confirmation of RNAi induced down-regulation of Orai and STIM isoforms in human 
monocytes and melanoma cell lines.  
(A-D) Samples from primary human monocytes and SK-MEL-5 cells, transfected with siRNA targeting the single CRAC 
channel subunits, were collected 48h after transfection, transcribed to cDNA and subjected to qRT-PCR or used for 
western blot analysis. Results of qRT-PCR presented as 2-ΔΔCq values. (A) mRNA levels determined for NT RNA 
transfected (black) and Orai1-3 and STIM1 and STIM2 siRNA transfected cells (red). (B) Success of down-regulation 
presented as percent of control. Means were calculated from n = 6 (Orai1), n = 4 (Orai2), n = 8 (Orai3), n = 4 (STIM1) 
and n = 4 (STIM2) independent experiments. (C-D) Representative western blots of samples from NT RNA and Orai1 
and STIM2 siRNA transfected SK-MEL-5 cells. Error bars indicate SEM and significance of knockdown is indicated with *, 
p < 0.05,**, p < 0.01 and ***, p < 0.001, determined by the paired standard student’s t-test.  
8.1.4 Characterization of primary human monocyte phenotype  
The isolation of primary human monocytes from PBMCs was achieved either by bead-isolation 
or adhesion. While bead isolation provided a nearly 100% pure monocyte population, the 
adhesion method was more prone to contain a fraction of lymphocytes from the PBMCs. Not 
only purity, but also the phenotype of the monocyte subset was of interest for further 
experiments. The phenotype of isolated monocytes and the purity of the isolation protocol were 
therefore confirmed in three in-dependent flow cytometry experiments. 
Figure 12 (A) shows a representative dot plot of a monocyte fraction at day three after isolation 
by adhesion. In a first step, the lymphocyte-monocyte fraction was gated based on size and 
granularity (marked in blue, first plot in A). Smaller (and more granular) cells were identified as 
apoptotic cells or cell debris (lower left corner, A). In a second step, the monocyte fraction was 
gated (marked in blue, second plot in A). The overall percentage of lymphocytes in the 
monocyte fraction was 19.65 %, revealing a purity of 80.35% for monocytes using the 
adhesion-method for isolation (Figure 12, B). The identification of the monocyte subset was 
preliminary based on the determination of the expression of the surface markers CD14, CD16 
and HLA-DR (see 7.2.3 for argumentation for choice of markers). 
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Figure 12 Characterization of monocyte subset using flow cytometry 
The purity of isolation of primary human monocytes by adhesion and the definition of the monocytes subset was 
analyzed by flow cytometry. (A) Representative dot plots of flow cytometry measurements of a monocyte population. 
Side scatter (SSC) reflects the granularity of cells, while the forward scatter (FSC) indicates the size of the cells. 
Lymphocyte-monocyte-fraction gated based on size and granularity (blue, first plot) and the monocyte fraction was 
further gated within the first population (blue, second plot). (B) Purity of monocyte fraction was determined with 80.35 
% . (C) Expression of surface markers was determined on relative fluorescent intensities of fluorophore-conjugated 
antibodies targeting CD14, CD16 and HLA-DR. Presented as box-plot-whisker-diagrams, indicating the median (blue), 
minimal and maximal values and boxes enclosing 25% -75% of the data points. Purity and expression levels of CD14, 
CD16 and HLA-DR were based on N = 3, number of isolations and n = 22, number of performed measurements. (D) 
Expression of additional surface markers CD62L, CD64 and CCR2 determined from, N = 3 independent isolations and n 
= 3 independently performed measurements per isolation. Data is presented as single data points (one geometrical 
figure presents one data set) and median fluorescent intensity is indicated in blue.  
The expression was determined within the gated monocyte fraction (A) as relative fluorescent 
intensities measured from fluorophore-conjugated antibodies targeting the different surface 
markers. Results are presented as box-plot-whisker-diagrams indicating the median levels 
(blue). The presented monocyte subset was identified as CD14high (30.31x103), CD16-, with 
intermediary expression of HLA-DR (3.59x103) (Figure 12, C). Expression of additional surface 
markers was determined for a more detailed characterization (Figure 12, D). CD62L, a 
leukocyte antigen responsible for rolling and adhesion of monocytes in blood vessels showed 
an intermediary expression with a median fluorescent intensity of 4.89x103. CD64, the FcγRIII 
receptor and CCR2, a chemokine receptor responsible for chemoattraction of the cells to sites 
of infections likewise showed an intermediary expression with median fluorescent intensities of 
5.28x103 and 3.42x103. Intensities for CD62L, CD64 and CCR2 are presented as single data 
points with the median indicated in blue (Figure 12, D). 
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8.2 Store-operated calcium entry (SOCE) in human melanoma cell 
lines and monocytes 
8.2.1 Activation and features of SOCE in human monocytes 
The characterization of SOCE in the investigated cell types was based on Ca2+ imaging 
experiments. The SERCA blocker Thapsigargin (Tg) was used as activator of SOCE following a 
store-depletion protocol. This protocol triggers SOCE and allows measurement of changes in 
cytosolic [Ca2+], thereby separating the depletion of the internal calcium stores and the influx 
via activated CRAC channels. The protocol is described below (and in 7.2.7.2). and was used 
for all following calcium imaging experiments, unless otherwise indicated.  
Cells were perfused with Ringer solution containing 0.5 mM Ca2+ to generate a base line. After 
250s cells were perfused with buffered Ringer’s solution (0 mM Ca2+) to distinguish pre-
activated cells. The stimulus (Tg or fMLF) was added in buffered 0 mM Ca2+ Ringer’s solution 
750s after start of recording, to empty the internal Ca2+ stores by blockage of SERCA (see 
introduction and Materials for details). The emptying of the stores, leads to an increase in 
intracellular, cytosolic calcium ([Ca2+]i) termed, Tg-Ca2+ release. After another 750 s, Ca2+ was 
re-added to the extracellular solution by perfusion with Ringer’s solution, containing 0.5 mM 
Ca2+ together with the corresponding stimulus. The following rise in [Ca2+]i was mediated by the 
prior activated CRAC channels. This protocol was used to determine the effect of Orai and 
STIM knockdowns on SOCE and hence their contribution to calcium signaling. Initially the 
activation of SOCE was tested in primary human monocytes on day 1-3 after isolation using 
two different stimuli: Tg and fMLF. Tg served as artificial, but well tested and acknowledged 
trigger of SOCE. In contrast, fMLF severed as physiological stimulus; by triggering SOCE via 
binding to a PAMP recognition receptor specific to detect formylated petides deriving from 
bacteria (see also Table 8 for details). The two different stimuli triggered Ca2+ responses with 
distinct features (Figure 13, A). The depletion of internal stores following fMLF stimulation 
resulted in a high, but transient rise in [Ca2+]i with a Ca2+ influx rate of 7.7 nM/s. A lower, but 
prolonged rise in [Ca2+]i with an influx rate of 0.3 nM/s was observed following a Tg stimulation 
(Figure 13, B, Release). The Ca2+ influx via CRAC channels, following the re-addition of 
extracellular Ca2+ showed a rate of 5 and 2.5 nM/s for Tg and fMLF, respectively (Figure 13, B, 
Entry). The Tg stimulation resulted in an increase in [Ca2+]i with a peak Ca2+ of 496.9 nM and 
the development of a plateau phase with 163.3 nM Ca2+ (Figure 12, C). The plateau phase was 
calculated as ∆Calcium between [Ca2+]i at 1500 s (beginning of re-addition phase) and [Ca2+]i 
at 2250 s (end of re-addition phase). FMLF stimulation displayed a smaller peak Ca2+ and 
plateau with 198.4 nM and 23 nM (see quantification in Figure 13, C).  
In addition, the elevation of SOCE using Tg or fMLF was analyzed regarding the response to 
the SOC inhibitor 2-APB. SOCE was measured using Tg or fMLF in Ringer’s solution 
containing 1 mM [Ca2+] (Figure 13, D and E, black traces). Stimulation with Tg and fMLF in the 
presence of 2-APB (Figure 13, D and E, green traces) resulted in the significant decrease in 
peak calcium. [Ca2+]i decreased from 930.6 nM to 130.8 nM under Tg stimulation and from 
1028.7 nM to 410.6 nM under fMLF stimulation (Figure 13, F).  
Regarding the important parameters for characterization of SOCE (peak calcium and 
∆Calcium), Tg stimulation revealed a higher and prolonged signal compared to fMLF 
stimulation (Figure 13 A-C). Based on these results, Tg was the stimulus of choice for further 
calcium imaging experiments (see also 9.1.3 for a detailed discussion of stimuli choice).  
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Figure 13 Activation and inhibition of SOCE in monocytes using two different stimuli.  
Fluorescence based calcium imaging experiments to characterize SOCE in primary human monocytes. (A-C) 
Thapsigargin (Tg) and fMLF triggered SOCE in human monocytes. (A) Comparison of SOCE, triggered by Tg (black) or 
fMLF (grey). Stimuli were applied in Ca2+ -free solution (black arrow) to deplete internal Ca2+ stores (1st rise in [Ca2+ ]i 
and activate CRAC channels. Re-addition of Ca2+ (0.5 mM) allowed SOCE through activated channels (2nd rise in [Ca2+ ]i). 
(B) Quantification of Ca2+ influx rates (slope) of store release (stimulus in Ca2+-free Ringer’s solution) and Ca2+ entry via 
activated channels (stimulus in 0.5 mM Ca2+ Ringer’s solution). (C) Quantification of maximal Ca2+ values (Peak Calcium) 
and height of plateau phase after Ca2+ re-addition (∆Calcium). (D) Tg-triggered SOCE in 1 mM Ca2+ Ringer’s solution in 
absence (black trace) and in presences (green trace) of the store-operated channel inhibitor 2-APB (50 µM). (E) fMLF-
triggered SOCE in 1 mM Ca2+ Ringer’s solution in absence (black trace) and in presences (green trace) of the SOC 
inhibitor 2-APB (50 µM). (D and E) Cells were incubated with buffer (Ø) or 2-APB for 10min before activation of SOCE. 
(F) Quantification of peak Ca2+ in control conditions (black bars) and in presence of 2-APB (green bars). Results are 
presented as means calculated from at least 3 independent experiments with total number of analyzed cells (n): n = 690 
(Tg), n = 602 (fMLF), n = 606/292 (Tg -/+ 2-APB) and n = 803/714 (fMLF -/+ 2-APB). Error bars indicate SEM with 
significance of change in peak calcium by 2-APB treatment indicated as ***, p < 0.001, determined using the unpaired 
student’s t-test.  
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8.2.2 Investigation of the contribution of CRAC channel components to SOCE in 
human monocytes.  
The contribution of the single CRAC channel components (Orai) and the regulator proteins 
(STIM) to Ca2+ signaling in monocytes was analyzed by Ca2+ imaging. RNAi knockdown of the 
single isoforms Orai1-3 and STIM1-2 using specific siRNAs facilitated the investigation of the 
role of the individual channel and regulator molecules in detail. Primary human monocytes were 
isolated from PBMCs, transfected immediately after isolation and measured after 48 h. 
Transfection with NT RNA was performed in all conditions (referred to as control or CTRL 
RNA). The previously described store-depletion protocol (8.2.1) was applied to analyze 
changes in intracellular (cytosolic) Ca2+ concentration ([Ca2+]i). The depletion of the internal ER-
store release by Tg was not-affected by the knockdown of the single Orai and STIM isoforms 
(Figure 14, A-E).  
The siRNA mediated knockdown of Orai1, Orai2, STIM1 and STIM2 (blue traces in Figure 14) 
resulted in a significant decrease in SOCE compared to the corresponding controls (black 
traces in Figure 14). Conversely, the knockdown of Orai3 resulted in a small, though not 
significant, increase in SOCE (Figure 14, C). SOCE was quantified as ∆[Ca2+]i between the end 
of the plateau phase and before re-addition of 0.5 mM Ca2+. The control transfected cells 
showed highly variable Ca2+ responses ranging from 248 nM to 473 nM. Therefore, the effects 
of the knockdown of the different isoforms were presented as percentages of the corresponding 
control measurements (Figure 14, G), providing a more reliable parameter. The knockdown of 
STIM1 resulted in the strongest reduction of SOCE by 54%, while knockdown of STIM2 or 
Orai1 lead to a milder and comparable reduction of 38% and 36%, respectively. The smallest 
reduction was observed with knockdown of Orai2, which resulted in a 25% decrease in SOCE. 
On the other hand, Orai3 down-regulation resulted in a 9% increase in SOCE. 
8.2.3 Investigation of SOCE in human melanoma cell lines SK-MEL-5 and WM3734  
Orai1 and STIM2 were identified as major expressed isoforms in the investigated melanoma 
cell lines (Figure 9, panel B). Therefore, the contribution of these two isoforms in SOCE was 
further investigated using calcium imaging. SOCE was measured in SK-MEL-5 and WM3734 
cell lines not only to characterize Ca2+ signals, but also to determine possible differences due to 
the origins of the cell lines (primary tumor vs. secondary brain metastasis, see 7.1.6). The 
store-depletion protocol was slightly modified compared to monocyte experiments. The initial 
perfusion with Ca2+ containing Ringer’s solution was omitted and 0.25 mM instead of 0.5 mM 
Ca2+ was used for Ca2+ re-addition. The chosen Ca2+ concentrations for re-addition were 
optimal to detect changes in SOCE in the respective cell types (experimental observation). In 
general, a lower Ca2+ concentration is suitable to detect even small effects of a knockdown. In 
the case of monocytes, 0.5 mM Ca2+ was the lowest concentration applicable, regarding overall 
cell responses.  
Thapsigargin stimulation elevated Ca2+ signals in SK-MEL-5 and WM3734 cell lines (Figure 15, 
A and C), that showed a quick run-down after Ca2+ re-addition; hence a plateau phase was not 
definable. Changes in SOCE resulting from knockdown of the different genes were therefore 
estimated from the change in the influx rates (slope) in siRNA treated cells, compared to the 
respective controls (black bar graphs in Figure 15 (B and D).  
The SK-MEL-5 and WM3734 melanoma cell lines displayed differing Ca2+ signals, with obvious 
differences in ER-Ca2+ content and Ca2+-influx rates under control conditions.  
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Figure 14 Contribution of single Orai and STIM isoforms to Store-operated Ca
2+
 Entry (SOCE) in primary 
human monocytes.  
Fluorescence-based calcium imaging to characterize the contribution of single CRAC channel components Orai1-3 and 
STIM-2 to SOCE in primary human monocytes. (A-E) Thapsigargin (Tg) was applied in Ca2+ -free solution (black arrow) 
to deplete internal Ca2+ stores (1st rise in [Ca2+]i) and activate CRAC channels. Re-addition of Ca2+ (0.5 mM) allowed 
SOCE through activated channels (1st rise in [Ca2+]i). Averaged Ca2+ traces for control transfected cells (CTRL, black) and 
siRNA transfected cells (blue) for knockdown of Orai1 (A), Orai2 (B), Orai3 (C), STIM1 (D) and STIM2 (E) measured 48 h 
after transfection. (F) Quantification of SOCE by determination of ∆Calcium on single traces (averaged in A-E), 
calculated from [Ca2+]i at the end of the plateau phase and [Ca
2+]i before Ca
2+ re-addition. (G) Determination of percent 
of change (%) due to knockdown of the single isoforms compared to controls. Traces were averaged from at least three 
independent experiments with number of analyzed cells (n) n = 1132/1178 (CTRL/Orai1), n = 836/740 (CTRL/Orai2), n = 
510/618 (CTRL/Orai3), n = 573/580 (CTRL/STIM1) and n = 685/711 (CTRL/STIM2). Error bars indicate SEM and 
significance of change in SOCE by knockdown of Orai and STIM is indicated with ***, p < 0.001, using the unpaired 
student’s t-test.  
In SK-MEL-5 cells, the increase of cytosolic Ca2+ following external Ca2+ re-addition reached a 
similar level as that observed after store depletion (first and second peak, black trace in Figure 
15, A). In contrast, the activation of CRAC channels in WM3734 cells lead to a significantly 
higher Ca2+ influx compared to the Tg-induced store depletion (first and second peak, black 
trace in Figure 15, B). The influx rates following Ca2+ re-addition were higher in WM3734 than 
in SK-MEL-5 cell lines (3.47 vs. 1.19 nM/s, black traces and bar graphs, Figure 15). The control 
traces present a global average of all control transfected cells, while for the bar graphs 
averages of the single knockdowns are presented with their corresponding controls.  
In contrast to the Ca2+ signals under control conditions, the effect of single and concomitant 
knockdown of Orai1 and STIM2 was comparable between the two cell lines. In SK-MEL-5 cells, 
the down-regulation of Orai1 slowed the calcium influx rate from 1.64 nM/s to 0.18 nM/s, while 
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the knockdown of STIM2 had a less severe impact with a slowdown from 1.04 to 0.55 nM/s. 
The double knockdown of Orai1 and STIM2 showed an intermediary effect by decreasing the 
influx rate to 0.20 nM/s compared to the control value of 1.04 nM/s (Figure 15, B). In the case 
of WM3734, controls were measured in parallel to the three different knockdowns, providing the 
same influx rate of 3.47 nM/s for all conditions. This rate was reduced by down-regulation of 
Orai1 to 0.49 nm/s, of STIM2 to 1.18 nM/s and by the double knockdown to the greatest extent 
to 0.18 nM/s (Figure 15, D).  
 
Figure 15 Contribution of Orai1 and STIM2 to Store-operated Ca
2+
 Entry (SOCE) in human melanoma 
cell lines SK-MEL-5 and WM3734. 
Fluorescence based calcium imaging to characterize the contribution of single CRAC channel components Orai1-3 and 
STIM1-2 to SOCE human melanoma cell lines SK-MEL-5 and WM3734. Thapsigargin (Tg) was applied in Ca2+ -free 
solution (black arrows in A and C) to deplete internal Ca2+ stores (1st rise in [Ca2+]i) and activate CRAC channels. Re-
addition of Ca2+ (0.25 mM) allowed SOCE through activated channels (2nd rise in [Ca2+]i). (A and C) Averaged Ca2+ traces 
for control transfected cells (CTRL, black) and siRNA transfected cells for knockdown of Orai1 (blue), STIM2 (light blue) 
and Orai1/STIM2 (grey) in SKMel-5 (A) and WM3734 (C) cells. (B and D) SOCE was quantified by calculation of calcium 
influx rates (slope) after Ca2+ re-addition for SK-MEL-5 (B) and WM3734 (D). Traces and slopes were averaged from at 
least three independent experiments with total number of cells (n) analyzed: n = 79/94 (CTRL/siRNA Orai1), n = 157/189 
(CTRL/siRNA STIM2) and n = 78/86 (CTRL/siRNA Orai1+STIM2). Error bars indicate SEM and significance of change in 
influx rates by knockdown of Orai and STIM is indicated with ***, p < 0.001, determined using the unpaired student’s t-
test.  
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8.3 Production of reactive oxygen species in primary human 
monocytes 
As professional phagocytes, monocytes are involved in the elimination of intruding pathogens. 
The production of reactive oxygen species (ROS) is an important factor in the immune 
response against the intruders. In addition, certain ROS as H2O2 serve as second messengers 
in cellular signaling. SOCE mediated by CRAC channels is accepted to play an important role 
in phagocytic ROS production, as it is involved in the assembly of NOX. The role of the single 
Orai and STIM isoforms in this context was so far only investigated in neutrophils and 
neutrophil-like cell lines, mainly focusing on the Orai1/STIM1 couple (see 6.5.1 for details). 
Therefore, the ROS production by monocytes regarding the involvement of Ca2+ signaling and 
particularly the role of CRAC channels was analyzed using two different approaches: 
spectroscopic- and fluorescence-based techniques.  
8.3.1 Source and subjection of the production of reactive oxygen species 
8.3.1.1 Measurement of superoxide production using electron paramagnetic resonance 
spectroscopy (EPRS) 
EPRS is a well-established and reliable technique to detect reactive radical species as 
superoxide (•O2-), that is the main initially produced ROS by NOX and mitochondria. Therefore, 
EPRS was applied as first technique to determine the source of ROS production in monocytes, 
as well as the contribution of Ca2+ in general. Tg was used as stimulus to trigger activation of 
SOCE via CRAC channels. The measurement of ROS using EPRS is based on the reaction of 
•O2- with a spin trap. This molecule is oxidized upon encountering a radical, thereby forming a 
stable radical itself, displaying a unique spectroscopic signal. Changes in ROS levels are 
reflected by changes in the intensity of the spectroscopic signal and were converted to •O2- 
concentrations ([•O2-]), based on a calibration of the system (7.2.6.1). Freshly isolated 
monocytes were subjected to EPRS measurements and production of •O2- upon stimulation 
was recorded for 21 min. The changes in ROS levels were plotted over time (Figure 16, A). The 
amount of produced ROS, was calculated as difference in [•O2-] between start (1 min) and end 
(21 min) of the measurements and is presented as ∆•O2- (Figure 16, B).  
Tg stimulation triggered ROS production displaying a sigmoidal kinetic (Figure 16, A, brown 
trace) with significant increase in the amount of •O2- produced from 4 µM to 26.9 µM compared 
to unstimulated cells (Figure 16, A and B, brown and black traces and bars). Two inhibitors of 
known components of enzymatic ROS production were applied to confirm the source of 
measured ROS production. BisGö is an inhibitor of PKC that is involved in phosphorylation of 
the cytosolic NOX2 subunit p47phox and hence the assembly process (see 6.1.2.3 for details). 
DPI targets the NOX core complex and is, in comparison to BisGö, a direct inhibitor of the ROS 
producing enzyme. Inhibition of PKC by application of BisGö (orange trace and bar in Figure 16 
A and B), resulted in a significant decrease in Tg triggered ROS production to base line to 
4.7 µM (after 21 min). Likewise, following application of DPI, •O2- production was significantly 
decreased to 8.04 µM (olive trace and bar in Figure 16 A and B). Elimination of extracellular 
Ca2+ similarly resulted in a significant decrease in ROS production to 2.8 µM •O2- (blue-green 
trace and bar in Figure 16, A and B).  
The effect of the altered extracellular Ca2+ concentrations and NOX inhibitors on Tg-triggered 
ROS production occurred immediately after application. In the inset in Figure 16 (A), providing 
an expanded view of the first 10 min of the measurements, it is shown that kinetics of the 
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treated cells deviate from those of control cells already within 2.5-3 min. The finding that 
several factors can interfere with the ROS production at an early time point within recording 
time was the motivation to analyze kinetics of ROS production in more detail (see below 8.3.1.3 
and 8.3.2).  
 
Figure 16 Dependency of superoxide production by primary human monocytes on SOCE 
Electron paramagnetic resonance spectroscopy (EPRS) recordings using the CMH spin trap, to characterize the source 
and the dependency on SOCE of Tg-triggered superoxide production. Monocytes were isolated from PBMCs and 
subjected to EPRS at day 0 and 1 after isolation. (A) Kinetics of ·O2
- production triggered by Tg (brown), with untreated 
cells as control (CTRL, black), in the presence of the PKC inhibitor BisGö (orange) and the NOX2 inhibitor DPI (olive) and 
under abolishment of external Ca2+ (Ca2+-free Ringer’s solution, Ø, green). All experiments were performed in 1 mM 
Ca2+ Ringer’s solution, despite Ca2+-free condition with n = 14 (CTRL), n = 6 (Tg) and n = 4 (BisGö, DPI and Ca2+-free) 
independent experiments. Cutout of panel A depicts kinetics in the first 10 min for better visualization. (B) 
Quantification of superoxide production as ∆·O2
-, calculated as difference in ·[•O2
-
] at the beginning (1 min) and at the 
end (21 min) of the measurements. For all conditions, 250.00-500.000 cells were used per measurement and superoxide 
production was normalized to a cell number of 10.000. Error bars indicate SEM and significance is indicated with **, p < 
0.01 and ***, p < 0.001, determined using the unpaired student t-test.  
8.3.1.2 Experimental groundwork for measuring H2O2 production using the H2O2-
sensitive dye AmplexUltraRed 
Besides EPRS, a redox-sensitive fluorescent dye was used as second approach to measure 
ROS production and its Ca2+ dependency in more detail. The H2O2-sensitive fluorescent dye 
AmplexUltraRed (AUR) was used to determine the amount of produced ROS when triggered by 
different stimuli in the presence and absence of inhibitors of either Ca2+ signaling or ROS 
producing enzymes (Figure 18). Calibration measurements were performed to convert the 
measured fluorescence intensity into H2O2 concentrations ([H2O2]). Three independent 
experiments were performed, determining the fluorescence intensity of AUR in Ringer’s 
solution in absence of cells and in presence of H2O2 concentrations ranging from 1 nM to 1 µM. 
Measured relative fluorescence intensities were plotted as relative fluorescent units (RFU) 
against the applied [H2O2]. The resulting data showed linear correlation with a regression factor 
of 0.999 (Figure 17, A). The equation describing the linear fit was used to convert obtained 
RFUs from measurements to [H2O2]. 
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Figure 17  Preparatory experiments for fluorescence-based detection of H2O2 and interpretation.  
(A) Calibration of fluorescence based AmplexUltraRed (AUR) measurements to quantify H2O2 concentrations. Linear 
curve fit of fluorescence intensity of AUR in dependency of different concentrations of H2O2 from three independent 
experiments with a regression factor of 0.99. The curve equation was further used to quantify experiments. Cutout of (A) 
shows curve linearity in the low concentration range. (B) Expression profile of NADPH oxidase (NOX) 1-5 and Dual 
oxidase (Duox) 1 and 2 in primary human monocytes. Expression was determined by qRT-PCR, normalized to the 
reference gene TBP and is presented as 2-ΔΔCq values, averaged from five donors. Error bars indicate SEM.  
In EPRS measurements, the unspecific inhibitor of NADPH oxidases, DPI significantly 
decreased Ca2+-dependent ROS production. A qRT-PCR screen was performed to estimate the 
expression level of all seven NOX family members in monocytes and to identify the responsible 
isoform(s), relevant to the measured ROS (7.2.2.4). The expression was estimated from the 
obtained 2-∆∆Cq values, normalized to the reference gene TBP (Figure 17, B). NOX2 showed 
the highest expression level in primary human monocytes with a 2-∆∆Cq value of 26.8. Other 
NOX and Dual oxidase (Duox) isoforms were expressed at much lower levels (2-∆∆Cq ≤ 0,003), 
while NOX3 expression was below the detection limit.  
8.3.1.3 Ca2+ dependency of H2O2 production  
In order to further analyze the Ca2+ dependency of ROS production and in more detail, the 
contribution of the single Orai and STIM isoforms in this process, an additional technique was 
applied. The H2O2 sensitive fluorescent dye AmplexUltraRed (AUR) was chosen due to two 
aspects: First, although superoxide is the initial produced ROS by NOX2, H2O2 is the biological 
most-relevant species (see 6.1.2.2 for details). Secondly, the effect of ROS, and specifically 
H2O2 as signaling molecule, on SOCE was an aspect of the here presented study. It was 
therefore reasonable to choose a species-specific detection method. Measurements using AUR 
were performed on primary human monocytes at day two and three after isolation by adhesion. 
Resulting fluorescence intensities were converted to [H2O2] using Equation 2 (see 7.2.6.2 and 
Figure 17).  
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As in EPRS experiments Tg was used as non-physiological stimulus to activate SOCE. In 
addition, fMLF was used as physiological stimulus that was shown before to activate the 
investigated Ca2+ signaling pathway (Figure 13). In order to confirm a Ca2+-dependency of ROS 
production, measurements were performed in Ca2+-free Ringer’s solution (0 mM [Ca2+]) or 
solution containing 1 mM [Ca2+]. Averaged traces from n = 4 (Tg) and n = 8 (fMLF) independent 
measurements are presented in Figure 18 (A and B). In the presence of Ca2+, Tg and fMLF 
application triggered a production of H2O2 with a mean concentration of 0.344 µM for Tg and 
0.401 µM for fMLF stimulation after 90 min (Figure 18, C). H2O2 concentrations after 90 min 
were obtained by normalization of the change in RFUs to intensities of non-stimulated cells in 
the same conditions. RFUs were further converted to [H2O2] using Equation 2. The results are 
presented as ∆H2O2, calculated from averaged [H2O2] between the end (last five data points) 
and the beginning (first three data points) of each measurement. Kinetics from Tg stimulation in 
1 mM [Ca2+] Ringer’s solution showed a sigmoidal shape, while kinetics from fMLF stimulation 
displayed a logarithmic shape with a rapid increase and a prolonged saturation phase (Figure 
18, A and B, black traces). In absence of external Ca2+, Tg-induced ROS production was 
completely abolished. ROS production triggered by fMLF stimulation was still measurable with 
a similar kinetic as the control condition, but significantly reduced to 0.260 µM H2O2 at the end 
of the recording (Figure 18, B and C, orange trace and bars). The artificial stimulus PMA is 
widely used to trigger ROS production in phagocytes, via activation of PKC. PMA stimulation 
(kinetics not shown) was therefore used as positive control revealing a high ROS production in 
absence or presence of external Ca2+ with concentrations reaching 9 µM and 9.72 µM 
respectively (Figure 18, C). The Ca2+ dependency of the different stimuli was more apparent 
when the percent reduction in ROS production in the absence of external Ca2+ was calculated 
(Figure 18, E). PMA-triggered ROS production was only slightly reduced by 7% due to 
elimination of external Ca2+. FMLF-triggered ROS production was reduced by 44%, while Tg-
triggered ROS production was completely abolished (100% reduction).  
In addition to presentation of the data as mean values, box-plot-whisker-diagrams were used to 
present the data allowing a direct assessment of the variability of ∆H2O2 within independent 
experiments (Figure 18, D). A box plot encloses 25% to 75% of the data points around the 
median in blue with the whiskers indicating minimal and maximal values. The median values 
deviated from mean values by about 40% in the case of Tg stimulation (1 mM [Ca2+]). The 
mean [H2O2] was 0.344 µM, while the median H2O2 concentration was 0.204 µM. With fMLF 
stimulation the median and mean values were more comparable (0.324 µM vs. 0.401 µM) 
displaying a deviation of 20%. In agreement with the above shown results from EPRS 
experiment (Figure 16), AUR measurements showed a reduction of Tg- and fMLF-induced 
ROS production in the presence of DPI (Figure 18, F). Here, inhibition of NOX enzymes 
resulted in a complete abolishment of Tg-triggered ROS production. FMLF-induced ROS 
production was significantly decreased from 331.3 nM H2O2 to 48.29 nM representing a 
reduction of 88%. 
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Figure 18 Analysis of Ca
2+
- dependent ROS production by human monocytes. 
Measurement of H2O2 production by primary human monocytes sing the fluorescent dye AmplexUltraRed (AUR). (A-B) 
Kinetics of measurements in 1 mM Ca2+ Ringer’s solution (black traces) and in Ca2+ free Ringer’s solution (0 mM Ca2+, 
orange traces) using Tg (A) and fMLF (B) as stimuli (1 µM each). Stimuli were applied before starting the measurements 
(black arrows). (C) Quantification of H2O2 production after 90 min (∆H2O2) as means from n = 4 (Tg) and n = 8 (fMLF) 
independent experiments. PMA was used as positive control in n = 5 independent experiments. (D) Box-plot-diagrams 
depict values from Tg and fMLF experiments indicating the median (50%, blue line), the mean (blue square), minimal 
and maximal values (dashes), with boxes enclosing 25% -75% of the data points around the median. (E) Reduction in 
ROS production upon removal of external Ca2+ (0 mM Ca2+) as percentage (%) of Ca2+ containing conditions. (F) 
Quantification of measurement of Tg and fMLF induced ROS production in presence of NOX2 inhibitor DPI (10 µM) 
quantified as ∆H2O2 from n = 7 (Tg) and n = 6 (fMLF) experiments. Error bars indicate SEM and significance of effects of 
treatments is indicated with *, p < 0.05 and ***, p < 0.01, determined using the paired and unpaired (E) standard 
student’s t-test.  
8.3.2 Investigating the role of single Orai and STIM proteins in regulating NADPH 
oxidase activity  
Subsequent to the analysis of the Ca2+ dependency of ROS production by monocytes, the 
particular contribution of the CRAC channels (Orai1 and Orai2) and their regulators (STIM1 and 
STIM2) in regulating ROS production was investigated. Primary human monocytes were 
isolated from PBMCs by adhesion and transfected immediately after isolation with NT RNA 
(CTRL) or Orai1, Orai2, STIM1 or STIM2 siRNA. Fluorescence based ROS measurements 
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were preformed 48 h following transfection. Experiments were performed as described in 
7.2.6.2 using Tg as stimulus. FMLF was used as second stimulus in parallel in all 
measurements and served as an internal control (data not shown). Kinetics of ROS production 
were obtained as described above and in 7.2.6.2. The results of Tg induced ROS production in 
siRNA and NT RNA (CTRL) transfected cells are presented in Figure 19.  
 
Figure 19  H2O2 measurements to determine the contribution of the single CRAC channel components 
to NOX2 activity. 
Fluorescence based detection of external H2O2 production in primary human monocytes to determine the contribution 
of the single Orai and STIM isoforms. Cells were transfected with NT RNA (CTRL, black) and Orai1, Orai2, STIM1 or 
STIM2 siRNA (red). AmplexUltraRed was used to determine kinetics of H2O2 production. Obtained RFU values were 
converted to H2O2 concentrations based on a calibration curve (y = 2.5646x+47.321). Experiments were performed in 1 
mM Ca2+ Ringer’s solution, Tg was used as stimulus to trigger ROS production (black arrow) and depicted kinetics are 
corrected by their specific controls (kinetics of untreated cells). Averaged kinetics were calculated from n = 7 
(CTRL/siRNA Orai1), n = 5(CTRL/siRNA Orai2) n = 5 (CTRL/siRNA STIM1) n = 6 (CTRL/siRNA STIM2) independent 
experiments. Averaged traces of the single knock-downs (red) of Orai1 (A), Orai2 (B), STIM1 (C) and STIM2 (D) are 
presented together with their respective controls (black). Error bars indicate SEM. 
Three parameters were considered in the analysis of the results: 1) the time course of H2O2 
production, 2) the rate of production and 3) the amount of H2O2 that was produced. Alterations 
in time course and productions rates were described based on the averaged kinetics (Figure 
19) and not on single kinetics. This limited descriptive analysis was inevitable, due to a high 
variability within and in between the single measurements and conditions and is related to a 
high donor variability (further discussed below 9.2.4). The kinetics presented in Figure 19 are 
described in the text below and the determined overall effects resulting from siRNA treatment 
are summarized in Table 17.  
Time course. The overall time course of H2O2 production under control conditions (black traces 
in Figure 19, A-D), showed a sigmoidal shape displaying a lag phase with a very slow increase 
in H2O2, followed by a faster main production phase with a steep slope and a prolonged steady 
production phase, ending with saturation in most cases (B-D). This typical shape was most 
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obvious in Orai1 and Orai2 knockdown experiments (A and B). The duration of the lag phase 
varied from a few minutes (STIM1, C) up to 20 min (Orai1, A). The same variability was 
observed for the duration of ROS production till saturation was reached. An increase in ROS 
could be observed from the beginning of the experiments. However, the onset of net H2O2 
production, when the H2O2 concentration exceeded the baseline of not-stimulated cells (DMSO 
treated, dotted lines in A-D), could take several minutes. The onset of net ROS production was 
significantly shifted when Orai1 mRNA was down-regulated (red trace in A). Under control 
conditions, H2O2 levels exceeded the basal level after 13 min (Orai1 control, A), while it took 23 
min (Orai1 siRNA, A) on average under knockdown conditions. Orai2 down-regulation resulted 
in faster onset of net ROS production to start immediately with the recording, while it took 7 min 
under control conditions (B). STIM1 down-regulation resulted in a slight shift from 3 min to 7 
min (C). There was no shift detectable in the case of STIM2 with an onset after 3 min in both, 
knockdown and control condition (D).  
Main production phase. The plotted kinetics revealed a phase with a maximal increase in 
H2O2 production which is referred to as main production phase. The rate of H2O2 production in 
this phase was determined by calculating the slope (nM H2O2/min) of the averaged traces 
(Table 17). The onsets of the main production phase coincide with the onset of net ROS 
production in all experimental sets. When Orai1, STIM1 or STIM2 mRNA was down-regulated, 
the production rate decreased compared to respective controls (compare red to black traces in 
Figure 19, A, C and D) with kinetics from knockdown cells running below their respective 
controls. The production rate was 4.86-fold decreased when STIM1 mRNA was down-regulated 
from 26.43 to 5.44 nM/min. Changes in production rate where less prominent in case of Orai1 
down-regulation with a 1.42-fold decrease from 11.55 to 8.16 nM/min and least effected when 
STIM2 was down-regulated, only showing a 0.57-fold decrease from 39.29 to 22.46 nM/min. In 
contrast to the other isoforms, Orai2 down-regulation resulted in a 4.9-fold increase of the 
production rate from 28.86 nM/min to 110.08 nM/min (Figure 19, B). With exception of the 
Orai1 data set, where a steep increase in H2O2 production could be observer for over 30 min, 
the main production phase did not last longer than 15 min in the other cases. Until saturation 
was reached (see below). A further increase in H2O2 was detectable, but with an obviously 
reduced rate.  
Saturation. Although the main production phase was quite restricted over relatively short time 
(see above), H2O2 was still produced in a prolonged phase for up to 50 min, before saturation 
was reached. In the case of Orai1 saturation was not even reached within 100 min of recording 
(Figure 19, A). A saturation of H2O2 productions was reached after 55 min in the experimental 
set regarding the role of Orai2, both in control and knockdown conditions. Kinetics of STIM1 
and STIM2 knockdowns (red traces in Figure 19, C and D) reached saturation, eight min before 
their respective controls. 
Net production of H2O2. The amount of H2O2 produced upon Tg stimulation under the different 
observed conditions (Figure 20, CTRL – black, siRNA – red) was determined after 90 min of 
recording, from single H2O2 kinetics. The last five values from each kinetic were averaged and 
are presented as single data points in Figure 20. In addition, the results are presented in box-
plot-whisker-diagrams to demonstrate the distribution of the values. Diagrams indicate the 
median (blue lines) and average (blue squares) value, minimal and maximal values (whiskers), 
and boxes enclose 25-75% of the data set around the median. 
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Figure 20 Quantification of H2O2 measurements using AmplexUltraRed based on kinetics.  
Quantification of external H2O2 concentrations determined for control transfected cells (CTRL, black) and cells 
transfected with siRNAs (siRNA, red) targeting Orai1 (A), Orai2 (B), STIM1 (C) and STIM2 (D). Quantification of H2O2 
production from single traces after 90 min (∆H2O2), depicted as box-plot-whisker-diagrams next to single data points. 
Diagrams indicate the median (50 % , blue), minimal and maximal values (whiskers) with boxes enclosing 25 % -75% of 
the data points around the median. Quantification is based on kinetics displayed in Figure 19, from n = 7 (Orai1 
CTRL/siRNA), n = 5 (Orai2 CTRL/siRNA) n = 5 (STIM1 CTRL/siRNA) n = 6 (STIM2 CTRL/siRNA) independent experiments. 
Significance is indicated with *, p < 0.05, determined using the paired standard student’s t-test.  
Table 17 Parameters characterizing kinetics of H2O2 production (presented in Figure 19) 
Presented parameters were collected from averaged kinetics displayed in Figure 19. Main production phase was defined 
as time span in which the steepest increase in H2O2 (min
-1) was detectable. Onset of saturation phase was defined as 
time point when values from kinetics declined the first time, or showed not further increase. Production rate was 
determined from linear fits of data points in the main production phase.  
 
Time point 
exceeding base 
line (min) 
Main production 
phase (min) 
Production rate 
(nM/ min) 
Onset of 
saturation ( min) 
CTRL 13 23-60 11.55 - 
Orai1 23  8.16 - 
CTRL 7 5-20 28.86 55 
Orai2 0  110.08 55 
CTRL 3 <15 26.43 43 
STIM1 7  5.44 35 
CTRL 3  < 15 39.29 39 
STIM2 3  22.46 31 
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Down-regulation of either STIM2 or Orai2 mRNA, resulted in significant, but opposed changes 
in the amount of H2O2 produced after 90 min (Figure 20, B and D). Median H2O2 was 
significantly decreased 3.9-fold from 305.59nM to 77.68nM in the case of STIM2, but was 
increased 5.4-fold from 431.92nM to 2.32 µM in the case of Orai2. Like for STIM2, down-
regulation of STIM1 resulted in an obvious, but statistically non-significant, decrease in H2O2 
levels (Figure 20, C). Median H2O2 was decreased 6-fold from 96.04 to 0 (below base line). 
Noteworthy, compared to the other data sets, the STIM1 set was the only one displaying 
control values below 200nM. The effect of ORAI1 mRNA down-regulation was the least, with a 
1.45-fold decrease in H2O2 from 217.44 to 150.06nM (median values, Figure 20, A).  
 
8.4 Redox regulation of store-operated calcium entry 
SOCE and the contribution of Orai and STIM to Ca2+ -dependent ROS production by 
monocytes were analyzed in separate approaches. The consequential experiments aiming at 
the analysis of the mutual effects of the two processes are presented in this section. The 
impact of produced ROS (H2O2) on SOCE and subsequently on Ca2+-dependent ROS 
production was analyzed. In addition, an equation was introduced to apply the regulatory redox 
mediated mechanism to other cell systems investigated in this study, namely melanoma cell 
lines.  
8.4.1 Analysis of the redox-sensitivity of SOCE in human monocytes  
Initially, the effect of H2O2 on SOCE in human monocytes was investigated in calcium imaging 
experiments as described in 7.2.7. For this data set and also the following data sets presented 
in section 8.4.2, monocytes were isolated using the bead-isolation instead of the adhesion 
method (7.2.1). Method change was the result of changes in overall laboratory organization and 
in terms of time management and efficiency. Monocytes were incubated for 10 min in Ringer’s 
solution containing different concentrations of H2O2 (1 µM, 10 µM, 100 µM, 300 µM, 1 mM, 3 
mM and 10 mM), before Tg addition and activation of SOCE. Averaged traces (except for the 
10 mM condition) are presented in Figure 21 (A-C). The control trace (black), with no H2O2 
applied prior to Tg stimulation, displayed a rise in [Ca2+]i in response to external [Ca2+] re-
addition, as already presented in Figure 13 (D). 
Application of H2O2 resulted in a dose-dependent rise in [Ca2+]i prior to application of Tg (Figure 
21, A). This effect was transient in the case of 10 µM H2O2, but was stable for concentrations 
≥100 µM H2O2 (green and grey traces in Figure 21, B-C). The rise of [Ca2+]i following store 
depletion correlated inversely with H2O2 evoked rise in [Ca2+]i. This correlation was most 
obvious in case of 1 mM and 3 mM H2O2 (Figure 21, C). To quantify the effect of H2O2 on Tg-
triggered SOCE, ∆Calcium was calculated from the single calcium traces as described before 
(8.2.1) and as depicted in Figure 21 (C).  
The obtained ∆Calcium values were plotted against H2O2 concentrations to determine the half-
maximal inhibitory concentration (IC50) of H2O2 (Figure 21, D). The resulting dose-response 
curve displayed two phases and was therefore best described with a second order exponential 
decay equation, instead of the commonly used Hill-equation. Phase 1 showed a nearly linear 
decay of ∆Calcium values in response to treatment with 0-100 µM H2O2, while phase 2 showed 
an exponential decay of ∆Calcium values in response to treatment with 300 µM-10 mM H2O2. 
The IC50 was determined as 155 µM H2O2.  
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Figure 21 Inhibition of store-operated Ca
2+
 entry in human monocytes by H2O2  
Analysis of the inhibitory effect of H2O2 on SOCE in primary human monocytes using fluorescence-based calcium 
imaging. (A-C) Cells were incubated with different H2O2 concentrations or buffer (Ø) (first arrow) before activation of 
SOCE by Tg application (second arrow). Tg was applied in presence of buffer or the respective H2O2 concentration to 
prevent wash-out effects. (A) Averaged traces from measurements in the absence (control, ØH2O2) or presence of 1 µM 
(green) or 10 µM (grey) H2O2. (B) Averaged traces from measurements in the absence (control, ØH2O2) or presence of 
100 µM (green) or 300 µM (grey) H2O2. (C) Averaged traces from measurements in the absence (control, ØH2O2) or 
presence of 1 mM (green) or 3 mM (grey) H2O2. (D) Quantification of SOCE as ∆Calcium calculated from [Ca
2+]i at the 
end of the plateau phase and [Ca2+]i before Tg stimulation. ∆Calcium values plotted against respective H2O2 
concentrations to determine IC50 from a second order exponential decay fit. Kinetics and quantifications were averaged 
from at least three independent measurements with (n) as total number of cell analyzed: n = 606 (control), n = 832 
(1 µM), n = 382 (10 µM), n = 420 (100 µM), n = 101 (300 µM), n = 499 (1 mM), n = 111 (3 mM) and n = 394 (10 mM). 
Error bars indicated SEM.  
8.4.2 The role of Orai3 in modulating redox-sensitivity of SOCE in human monocytes  
As shown above, SOCE was inhibited by H2O2 with an IC50 of 155 µM (Figure 21, D). The 
relatively high expression of the redox-insensitive isoform Orai3 (Figure 9 and Figure 10) 
already indicated a potential role in influencing the observed redox-sensitivity of SOCE.  
The role of Orai3 in redox-regulation of SOCE was analyzed in Ca2+ imaging experiments as 
described above (Figure 21). SOCE was measured with and without pre-treatment with H2O2 in 
NT RNA transfected cells (CTRL) and Orai3 siRNA transfected cells (siRNA Orai3) (Figure 22). 
Monocytes were transfected immediately after bead-isolation. Measurements were performed 
as described in the above section 48 h after transfection. Under control condition, without pre-
treatment with H2O2, down-regulation of Orai3 mRNA resulted in a significant increase in SOCE 
compared to control cells (compare black traces in A and B, Figure 22). Pre-treatment with 
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100 µM H2O2 for 10 min, prior to SOCE activation using Tg (green traces in Figure 22, A and 
B), significantly inhibited SOCE. ∆Calcium was decreased in presence of H2O2 from 540.53 to 
343.50 nM in NT RNA transfected cells and from 635.35 to 292.84nM in siRNA transfected 
cells (green bars in C, Figure 22). Thus, the inhibitory effect of H2O2 on SOCE was significantly 
enhanced in Orai3 silenced cells. SOCE was inhibited by 54%, compared to 38% inhibition in 
control transfected cells (Figure 22, D).  
 
Figure 22  The role of Orai3 in modulating the redox-sensitivity of store-operated Ca
2+
 entry 
Analysis of the role of Orai3 in redox-sensitivity of SOCE in primary human monocytes using fluorescence based calcium 
imaging experiments. (A and B) Cells were incubated with 100µM H2O2 or buffer (Ø) (first arrow) before activation of 
SOCE by Tg application (second arrow). Tg was applied in presence of buffer or H2O2 to prevent wash-out effects. 
(A) Averaged calcium traces from control transfected cells in absence (black) or presence (green) of 100 µM H2O2. 
(B) Averaged traces from cells transfected with Orai3 siRNA in absence (black) or presence (green) of 100 µM H2O2. 
(C) Quantification of SOCE as ∆Calcium calculated from [Ca2+]i at the end of the plateau phase and [Ca
2+]i before Tg 
stimulation. (D) Inhibition (as %) of SOCE by 100 µM H2O2 in control and siRNA treated cells (indicated with grey arrows 
in C and D). Kinetics and quantifications were averaged from at least three independent measurements with (n) as total 
number of cell analyzed: n = 455 (CTRL), n = 496 (CTRL, H2O2), n = 589 (siRNA) and n = 441 (siRNA, H2O2). Error bars 
indicate SEM and significance is indicated with ***, p < 0.001, determined using the unpaired standard student’s t-test.  
8.4.3 The interplay of redox-sensitivity of SOCE and Ca2+- dependent ROS production 
The above described work demonstrates that SOCE in primary human monocytes is inhibited 
by H2O2 with an IC50 of 155 µM (Figure 21). An effect that was significantly enhanced when 
Orai3 mRNA levels were down-regulated using RNAi (Figure 22). In respect to these findings 
and work previously shown by Bogeski and colleagues (Bogeski et al., 2010), redox sensitivity 
of SOCE was analysed in regard of the relative expression of Orai3 and Orai1. Therefore, 
redox-sensitivity of SOCE, indicated by the IC50, was plotted against the relative Orai3/Orai1 
mRNA ratio for naïve and effector T cells and monocytes. The plot revealed a strong correlation 
between the two parameters (Figure 23, A). The resulting plot could be fit to a logarithmic curve 
function with a regression value of 0.998 (Figure 23, A).  
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The curve function is given in Equation 8 and was further used to estimate redox sensitivity of 
SOCE from qRT-PCR data (see below and 8.4.5).  
Equation 8 y = 63.59 ln(x) + 279.42 
In regard of the correlation between the redox-sensitivity and relative Orai3 expression levels 
(Figure 23, A), the effect of H2O2 on SOCE -dependent ROS production in correlation with 
Orai3 expression was next investigated. Internal ROS production in primary human monocytes 
was measured in imaging experiments using the redox-sensitive dye H2-DCFDA as described 
in 7.2.6.2. A scheme of the experimental procedure is given in Figure 23 (C). Monocytes, either 
transfected with NT RNA or Orai3 siRNA were incubated with 300 µM H2O2, prior to stimulus 
application. Tg was applied to determine the role of Orai3 in Ca2+-/SOCE-dependent ROS 
production. Changes in ROS production were calculated from H2O2 treated cells as percent of 
non-treated (no H2O2), Tg stimulated cells (Figure 23, B). Treatment of control transfected cells 
with H2O2 did not reveal a change in Tg-triggered ROS production (CTRL). In contrast, Tg-
triggered ROS production was significantly inhibited by 19% upon H2O2 treatment in Orai3 
knockdown cells (Orai3). These results point to a role for Orai3 not only in modulating SOCE 
under oxidative stress, but also in mediating downstream effect on SOCE-dependent ROS 
production.  
 
Figure 23 Concurrence of Orai3 expression and redox-sensitivity of SOCE and Ca
2+
-dependent ROS 
production in human monocytes. 
(A) Correlation between IC50 of H2O2 on SOCE and the relative Orai3/Orai1 mRNA expression ratios in primary human 
CD4+ naïve and effector T cells and primary human monocytes. Parameter correlation fitted by a logarithmic function 
with a regression value of 0.998. Values for CD4+ cells were already published by (Bogeski et al., 2010) and are 
presented here with permission after re-calculation, for comparison with monocyte data. (B) Analysis of the impact of 
H2O2 on SOCE-dependent ROS production in reliance of Orai3 expression levels. Internal ROS production was measured 
using the redox-sensitive dye H2-DCFDA following H2O2 treatment (300 µM) and Tg stimulation. Inhibition of ROS 
production by H2O2 is calculated as percent ( % ) of Tg stimulated controls for control transfected cells (CTRL, black bar) 
and cells transfected with Orai3 siRNA (Orai3, dark green bar). Values are presented as means from at least 3 
independent experiments with (n) as total number of analyzed cells: n = 842 (CTRL siRNA, H2O2 treatment) and n = 760 
(Orai3 siRNA, H2O2 treatment). (C) Scheme of experimental procedure for results presented in (B). Error bars indicated 
SEM, significance is indicated with ***, p < 0.001, determined using the paired standard student’s t-test.  
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8.4.4 The role of the redox-resistant isoform Orai3 in Ca2+-dependent ROS production  
In preceding experiments, the role of Orai3 for redox-mediated inhibition of SOCE was 
analyzed, as presented in the above sections. The Ca2+-dependent ROS production implied 
further investigation of the contribution of Orai3 in regulating ROS production itself, as already 
analyzed for the other Orai and STIM isoforms.  
AmplexUltraRed was used to measure the produced H2O2 from cells transfected either with 
NT RNA or Orai3 siRNA. Experiments were performed as described in section 8.3.2. Again, the 
three major parameters 1) time course of H2O2 production, 2) the rate of production and 3) the 
amount of H2O2 produced, were considered to further evaluate the role of Orai3 in Ca2+ -
dependent ROS production. Results were quantified based on the average kinetics, with 
exception of the net ROS production that was analyzed for single measurements, due to a high 
variability within and in between the single measurements and conditions. These parameters 
are summarized in Table 18, while average kinetic traces and the quantification of net H2O2 
production are presented in Figure 24.  
Time course. The average time course of H2O2 production determined for NT RNA or Orai3 
siRNA transfected monocytes (black and red in Figure 24, A), did not display a sigmoidal shape 
similar to that observed in Figure 19 (A). The produced H2O2 exceeded baseline within 3 or 5 
min (CTRL and siRNA, respectively), immediately merging into the main production phase 
without running through a further lag phase. From 20 min on, H2O2 produced by cells treated 
with Orai3 siRNA reached a higher level than that produced by control transfected cells. This 
effect was only seen on the averaged trace. Single traces were comparable to control traces, 
with exception of a single event that led to a higher curve run on avaerage. This effect is also 
reflected by the results from calculation of net ROS production (see below and Figure 24, B). 
Both curves did not reach saturation within recording time.  
 
Figure 24 The role of Orai3 in Ca
2+
 -dependent ROS production.  
Fluorescence-based detection of external H2O2 production by monocytes to analyze the role of Orai3 in Ca
2+ -
dependent ROS production. AmplexUltraRed was used to determine kinetics of ROS production. Experiments were 
performed in 1 mM Ca2+ Ringer’s solution. Tg was used to trigger ROS production (black arrow) and depicted kinetics 
are corrected by their respective controls (kinetics of untreated cells). (A) Averaged traces of H2O2 production following 
Tg stimulation (arrow) from NT RNA (CTRL, black trace) and Orai3 siRNA (red trace) transfected cells. H2O2 was 
calculated from RFUs with y = 2.5646x+47.321 (calibration curve,  Figure 17, B). Quantification of  net H2O2 production 
after 90min, depicted as single data points and as box-plot-whisker-diagrams, indicating the median (50%, blue lines) 
and average (blue squares) values, minimal and maximal values (whiskers), with boxes enclosing 25-75% of the data set. 
Kinetics and net H2O2 was calculated from n=11 (CTRL/siRNA Orai3) independent experiments. Error bars in (A) 
indicate SEM.  
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Main production phase. The main production phase lasted from 5 to 20 min for both control 
and siRNA transfected cells. In this phase, the net H2O2 production was slightly increased 
(1.16-fold) in response to Orai3 down-regulation from 14.90 to 12.85 (nM/ min-1). The main 
production phase merged into a prolonged production phase with a decreased slope compared 
to the main phase, without reaching saturation within recording time.  
In contrast, Orai3 down-regulated cells showed continuous production of H2O2 with a high 
production rate for another 22 min before merging into the prolonged phase. However, 
saturation was also not reached in case of Orai3 knock-down.  
Net H2O2 production. The amount of H2O2 produced upon Tg stimulation under the different 
observed conditions (CTRL - black, siRNA - red) was determined after 90 min of recording, 
from single H2O2 kinetics and is presented in Figure 24 (B). Regarding the kinetics and average 
values (blue squares in B), down-regulation of Orai3 seemed to result in an increase in Tg-
triggered H2O2 production from 613.76 to 807.10nM. As already observed in other data sets 
(Figure 20), the single data points showed a broad distribution as illustrated by the box-plot-
whisker diagrams. A single data set (max data point in Figure 24, B (red)) lead to the 
impression of an increased ROS production upon Orai3 down-regulation on average. In the 
majority of the data sets, net ROS production in Orai3 knockdown cells was unaltered or even 
reduced compared to controls.  
Table 18 Parameters characterizing kinetics of H2O2 production (presented in Figure 24) 
Presented parameters were collected from averaged kinetics displayed in Figure 24. Main production phase was defined 
as time span in which the steepest increase in H2O2 (min
-1) was detectable. Onset of saturation phase was defined as 
time point when values from kinetics declined the first time, or showed not further increase. Production rate was 
determined from linear fits of data points in the main production phase.  
 
Time point 
trespassing zero 
base line (min) 
Main production 
phase (min) 
Production rate 
(nM/ min) 
Onset of 
saturation ( min) 
CTRL 5 5-20 12.85  - 
Orai3 3  14.90  - 
 
8.4.5 A theoretical approach to estimate redox-sensitivity of SOCE in different cell 
systems. 
The relative Orai3 to Orai1 expression levels and IC50 values for ROS-mediated inhibition of 
SOCE showed a strong correlation as presented in Figure 23 and Equation 8. This correlation 
was thought to serve as prediction model of redox-sensitivity of SOCE from qRT-PCR data, in 
so far untested cell types. Equation 8 was therefore used to calculate an IC50 value from the 
measured Orai3/Orai1 mRNA ratios determined for melanoma cells lines (presented in Figure 
10).  
As presented in Figure 25, IC50 could be calculated from Orai3/Orai1 ratio values giving an 
estimated IC50 of 154.39 µM H2O2 for SK-MEL-5 and 179.66 µM H2O2 for SK-MEL-28. This 
suggested a redox-sensitivity or resistance of SOCE comparable to that of monocytes. The 
calculated IC50 for WM3734 cells was lower than that of the SK-MEL cell lines and with 
101.28 µM H2O2 more comparable to the redox-sensitivity of effector T cells than monocytes. In 
all cases, H2O2 incubation resulted in the previously observed increase in [Ca2+]i, prior to the 
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activation of SOCE (see also Figure 21). SK-MEL-5 displayed a high Ca2+ influx following the 
addition of H2O2. In contrast, SK-MEL-28 only showed a moderate increase and WM3734 cells 
only displayed a very small and transient rise (green trace, first rise in Ca2+ in Figure 25, A, C 
and D). SOCE was triggered using Tg (black traces in Figure 25, A, C and E) and all 
measurements were performed in 0.25 mM Ca2+ Ringer’s solution.  
.  
  
Figure 25 Theoretical estimation and experimental determination of redox-sensitivity of SOCE in 
melanoma cell lines based on Ora3/Orai1 mRNA ratios.  
Analysis of redox sensitivity of SOCE in melanoma cell lines using fluorescence-based calcium imaging with Fura-2AM 
loaded cells to determine intracellular Ca2+ concentrations [Ca2+]i. (A,C,E) Averaged traces from cells in the absence 
(black), or presence (green) of H2O2. Cells were incubated with buffer (-) or H2O2 (1
st arrow) before activation of SOCE by 
Tg application (2nd arrow). H2O2 concentrations used were assumed as IC50 concentration for the respective cell line, 
calculated from an equation, correlating Orai3/Orai1 mRNA expression ratios to redox-sensitivity of SOCE. H2O2 
concentrations were calculated from Equation 8 (y = 63.59 ln(x) + 279.42) with 154.39 µM for SK-MEL-5 (A and B), 
179.66 µM for SK-MEL-28 (C and D) and 101.28 µM for WM3734 (E and F). (B,D,F) Quantification of peak calcium 
(purple) and slope (orange) of Ca2+ entry following Tg application. ∆Ca2+ (green) calculated from [Ca2+]i at the end of 
the plateau phase (WM373), or after 1750 s of recording (SK-MEL-5 and 28), and [Ca2+]i before Tg application. Kinetics 
and quantification were averaged from 2 independent measurements with total number of analyzed cells (n): n = 34/23 
(-/H2O2) for SK-MEL-5, n = 42/37 (-/H2O2) for SK-MEL-28 and n = 24/19 (-/H2O2). Error bars indicated SEM, significance 
of effects is indicated with ***, p < 0.001 determine using the paired standard student T-Test.  
The treatment of the different melanoma cell lines with the calculated [H2O2] resulted in 
opposite effects on Tg-triggered SOCE. There was no inhibition of SOCE observed in the case 
of SK-MEL-5 and SK-MEL-28. In both cases the calculated parameters to describe SOCE 
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following Tg stimulation were increased rather than decreased. In SK-MEL-5 cells, there was a 
tendency of a reduction in ∆Ca2+ from 421.59 to 339.56 nM. However, the incubation with 150 
µM H2O2 resulted in an obvious, though not significant, increase in peak calcium values 
(583,81 to 841.22 nM) and the corresponding influx rate (3.90 to 4.97 nM/s) (Figure 25, A and 
B). In the case of SK-MEL-28 the promoting effect of H2O2 on SOCE was even stronger. 
Incubation with 180 µM H2O2 resulted in a significant increase of peak calcium (purple) from 
442.20 to 767.35 nM, and from 2.88 to 4.17 nM/s in the corresponding Ca2+ influx rate 
(orange), while ∆Ca2+ (green), calculated at 1750s, was only slightly altered by the incubation 
with H2O2 (260.56 to 271.29 nM) (Figure 25, C and D). In contrast, WM3734 cells showed a 
significant reduction of ∆Ca2+ (green) from 259.97 to 137.04 nM, and peak calcium (purple) 
from 340.91 to 226.76 nM (Figure 25, E and F). The influx rate (orange) also showed an 
obvious, though not significant decrease from 1.26 to 0.99 nM/s upon H2O2 treatment (Figure 
25, F).  
8.5 The Ca2+ and redox environment in regulating cellular functions 
– Preparative adjustment of experimental conditions 
Intracellular processes are not only regulated by the cellular signaling machinery and its 
regulation (here Ca2+ channels), but also by the influence of the extracellular environment. The 
tumor- and inflammatory environment display highly specialized features regarding a plethora 
of factors, as pointed out in the introduction (6.1.3). Therefore, it was also an aim of this work to 
shed light on how the Ca2+ and redox environment regulate monocyte and melanoma function. 
The here described experimental adjustments were used to determine to effects of a changed 
environment on aspects as cell survival and cell proliferation (see below, 8.6 and 8.7).  
To analyze the impact of a changed Ca2+ environment in vitro, the standard culture conditions 
were altered by including the Ca2+ chelator EGTA to adjust the extracellular Ca2+ concentration 
in the medium (referred to as free [Ca2+] or [Ca2+]ext). The resulting free [Ca2+]ext was 
determined using two different methods, as described in 7.2.8. The Ca2+ concentrations were 
determined in three independent measurements per condition and are summarized in Table 
19For analysis of the role of other medium supplements (serum proteins) the Ca2+ 
concentrations in serum free (RPMI) and serum containing medium (RPMI + 10% FCS) were 
determined. Serum supplementation of RPMI medium shifted the free [Ca2+] from 221 µM to 
377 µM Ca2+, an increase of 59% (see Table 19, 0mM EGTA). Ca2+ concentrations depicted in 
the graphs of Figure 26 and Figure 30 represent the numbers given in Table 19.  
Changes in redox environment were achieved by adding different concentrations of H2O2 to the 
standard culture medium. H2O2 was used to mimic a redox environment due to its biological 
relevance and its role as signaling molecule. Final H2O2 concentrations in the medium were not 
further verified. In contrast to Ca2+, H2O2 concentrations were not assumed to be stable over 
time. Although H2O2 is one of the more stable ROS, e.g. compared to superoxide, it is reactive 
with proteins and a decrease of the adjusted concentrations was assumed to inevitably occur 
within a short time. Therefore, the results of the respective experiments reflect the long-term 
effects of an acute exposure.  
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Table 19 Ca
2+
 concentration in RPMI medium supplemented with Ca
2+
chelator EGTA. 
Ca2+ concentrations of EGTA supplemented RPMI medium (-/+10% FCS) were determined in three independent 
experiments per condition. The Calcium Gen.2 Assay (Roche Diagnostic, performed by the Central Clinical Laboratory at 
Universitätsklinikum Saarland), and the Combination Calcium Electrode perfectIonTM (Mettler Toledo) were used to 
determine free Ca2+ concentrations.  
EGTA (mM)  0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 
[Ca2+]RPMI 
+10% FCS (µM) 
377 338 292 224 179 152 93.2 72.7 36.5 0.89 
SEM 28.7 35.5 35.2 39.0 45.4 31.0 38.6 27.4 31.8 0.45 
[Ca2+] RPMI (µM) 221 165 113 67.5 27.4 6.3 0.51 0.37 0.31 0.27 
SEM 29.6 9.54 6.67 6.75 4.45 1.61 0.03 0.03 0.04 0.03 
 
 
8.6 Ca2+ environment and Ca2+ signaling in melanoma progression: 
Proliferation vs. Migration 
8.6.1 The regulation of melanoma proliferation by the extracellular Ca2+ milieu and 
SOCE 
Extracellular Ca2+ concentration plays a critical role in skin barrier formation and differentiation 
of skin cells. This contribution to cell function pointed to a possible role of the Ca2+ environment 
in rendering melanoma progression, by influencing tumor associated features as proliferation 
and migration (see 6.3.2). Several components of the local environment hold the potential to 
alter cellular features. Among these also hormones and peptides, that can bind to receptors 
and subsequent activate intracellular signaling pathways (see 6.3.2). Therefore, the 
dependence of FCS-induced proliferation on extracellular Ca2+ of SK-MEL-5 melanoma cells 
was analyzed in the following section using the CellTiterBlue assay (see 7.2.8). Extracellular 
Ca2+ concentrations were adjusted as described above (8.5) and cells were cultivated for 48 h. 
The influence of serum proteins on proliferation was analyzed by serum (FCS) starvation of the 
cells.  
Proliferation of SK-MEL-5 cells was altered by changes in [Ca2+]ext displaying a unique 
dependency (Figure 26, A and B). In the presence of FCS, SK-MEL-5 cells showed an 
inversely [Ca2+]ext-dependent proliferation. Optimal (or maximal) proliferation was observed at a 
relatively low [Ca2+]ext concentration of 0.15 mM (marked in red in Figure 26, B). Lowering 
[Ca2+]ext below this critical concentration caused dramatic decline in melanoma proliferation and 
also a further increase above 0.15 mM had a, though milder, tendency to decrease 
proliferation. The decrease of [Ca2+]ext from 0.37 mM (Ca2+ concentration under standard 
culture condition) to 0.15 mM resulted in an increase in proliferation of 39% (red marks and 
bars in Figure 26, B and C). Proliferation of cells subjected to FCS starvation was unaffected by 
varying [Ca2+]ext over the range from 0.221 mM down to the critical concentration of 27,4 µM 
(Figure 26, A). Below this critical concentration, SK-MEL-5 cells showed a similar dramatic 
decline in proliferation compared to serum supplied cells. FCS deprivation led to a similar, 
though less pronounced, alteration in proliferation in response to changing [Ca2+]ext. However, 
the absolute proliferation level of serum deprived cells was lower than that of serum supplied 
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cells. In standard culture conditions with 0.22 mM [Ca2+]ext, proliferation was increased by 57% 
upon addition of FCS to the culture medium for 48 h (grey boxes and bar in Figure 26, A-C).  
Observations on Ca2+ dependence of melanoma proliferation implied that a partial reduction of 
SOCE by silencing of Orai1 or STIM2 should increase proliferation. Figure 26 (D) shows that 
Orai1 and STIM2 siRNA-treated SK-MEL-5 cells, indeed, grew faster than control cells (in 
RPMI + 10% FCS, 0.37 mM free Ca2+). These results supported the findings shown in Figure 
26 (B). The increase in cell proliferation 48h after transfection was 43% and 25% compared to 
control transfected cells (CTRL, black), following Orai1 (gold) or STIM2 (brown) siRNA 
treatment (Figure 26, D). This effect was even more pronounced 72 h after siRNA-transfection, 
with an increase in proliferation of 64% when Orai1 mRNA was down-regulated and a 
respective increase of 56% when STIM2 was targeted (Figure 26 E)  
 
Figure 26 Ca
2+
-dependency of melanoma proliferation. 
Analysis of the proliferative capacity of SK-MEL-5 cells in dependency of the extracellular Ca2+ milieu and in dependency 
of CRAC channel components Orai1 and STIM2, using the CellTiterBlue Viability Assay. Different [Ca2+]ext were adjusted 
by adding the Ca2+ chelator EGTA (Table 19) to the respective culture media. The role of Orai1 and STIM2 was 
determined in control or siRNA transfected cells. (A-B) Proliferation of SK-MEL-5 cells 48 h after transfection in standard 
culture medium in the absence (A, black trace) or presence (B, orange trace) of FCS supplementation in dependency of 
[Ca2+]ext. (C) Quantification of change in proliferation in dependency of FCS supplementation calculated at 0.2 mM Ca
2+ 
(grey in A -C) and quantification of change in proliferation in dependency of [Ca2]ext (in the presence of FCS) calculated 
between 0.15 mM and 0.377 mM [Ca2]ext (red in A -C). Results in A-C are presented as means from n = 3 independent 
experiments. (D) Proliferation of SK-MEL-5 cells, transfected with control RNA (CTRL, black) and Orai1 siRNA (gold) and 
STIM2 siRNA (brown) in standard RPMI medium + 10% FCS (0.377 mM [Ca2]ext). Proliferation was measured after 
cultivation for 48 h and 72 h, reflecting 72 h and 96 h after transfection. Results in D are presented as means from n = 
10/9 (CTRL, 48/72 h), n = 10/9 (Orai1, 48/72 h) and n = 4/4 (STIM2, 48/72 h) independent experiments. Error bars 
indicate SEM and significance is indicated with *, p < 0.05 and ***, p < 0.001, determined using the paired standard 
student’s t-test.  
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8.6.2 The migratory potential of melanoma cells in dependency on SOCE 
Migration of melanoma cells in dependency of CRAC channel mediated SOCE was tested 
using the transwell-migration assay as described in 7.2.9 and illustrated in Figure 27 (A). 
WM3734 was the cell line of choice for this set of experiments due to their high migratory 
potential. Non-transfected cells (NT), as well as cells treated with non-targeting RNA (CTRL) 
and cells treated with Orai1 or STIM2 siRNA, were allowed to migrate through the provided 
membranes under standard culture conditions for 24 h. The number of cells migrated was 
determined using a calibration curve obtained from defined cell numbers (see 7.2.9 for details). 
Besides the contribution of Orai1 and STIM2 to regulation of melanoma cell migration, the 
importance of Ca2+ signaling in general was further analyzed using the Ca2+ channel inhibitor 2-
APB. The inhibitor was applied to non-transfected cells, as well as non-targeting RNA and 
siRNA treated cells (green bars in Figure 27, B). Under control conditions the number of cells 
that migrated within 24 h was comparable with 13.400 of 100.000 seeded cells (NT and CTRL, 
black bars in Figure 27, B). On the one hand, down-regulation of Orai1 and STIM2 mRNA 
resulted in a significant decrease in the number of migrated cells to 10.466 and 9236 
respectively. On the other hand, blocking channel activity using 50 µM 2-APB did not influence 
the migratory potential (compare black to green bars in Figure 27, B). When normalized to 
control transfected cells, Orai1 and STIM2 down-regulation resulted in a significant reduction of 
migration with 21% and 29% respectively (Figure 27, C).  
 
Figure 27 CRAC channel -dependent migration of the WM3734 melanoma cell line.  
Determination of the migratory capacity of melanoma cell line WM3734 in dependency on Ca2+-signaling in general 
and CRAC channel components Orai1 and STIM2, using a transwell-migration assay. (A) Schematic overview of 
experimental set-up and performance. (B) WM3734 cells transfected with control RNA and Orai1 and STIM2 siRNA were 
used 24 h after transfection and were allowed to migrate for another 24 h. The number of migrated cells in absence 
(black) and presence (green) of SOC inhibitor 2-APB was calculated from a standard curve based on fluorescence 
signals of defined cell numbers. (C) Quantification of effect of Orai1 and STIM2 down-regulation on migration 
calculated as percentage of control transfected cells. Quantification is based on at least three independent experiments. 
Error bars indicate SEM and significance is indicated with *, p < 0.05 and ***, p < 0.001, determined using the paired 
standard student’s t-test. 
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8.6.3 Molecular mechanisms involved in melanoma progression  
To gain insight into the molecular mechanisms enabling Orai1 and STIM2 to regulate the 
melanoma phenotype, the expression of markers involved in regulating gene expression 
related to proliferation or migration was analyzed by western blot (as described in 7.2.4). 
Lysates were obtained from cells treated with NT siRNA or Orai1 or STIM2 siRNA. In addition, 
cells were transfected with siRNA targeting STIM1 to test for isotype specific effects.  
Microphtalmia-associated transcription factor (MITF) is a Ca2+-dependent master regulator of 
proliferative genes in melanoma. The expression of MITF in cells treated with Orai1, STIM2 and 
STIM1 siRNA was determined to analyze down-stream effects of altered Ca2+ signaling. A 
representative western blot is shown in Figure 28 (A).  
 
Figure 28 Expression analysis of phenotype markers in human melanoma cell line SK-MEL-5.  
Expression of molecular markers was determined by western blot analysis to define a migratory or proliferative 
phenotype. Expression of phenotype markers MITF (TF), JARID1B (histon-demethylase) and Brn2 (TF) was determined in 
SK-MEL-5 cells, transfected with control siRNA (CTRL) and siRNA targeting Orai1, STIM1 and STIM2. (A and C) 
Representative western blots of the detection of expression of MITF (A) and JARID1B and Brn2 (C). (A-E) Protein 
samples were collected from four independent experiments on day 2 after transfection. Expression was quantified in 
relation to loading control GAPDH. Quantification of change in marker expression upon Orai1 and STIM knock-downs 
presented as % of expression in control transfected cells (set to 100 %, black lines) for MITF (B), JARDI 1B (D) and Brn2 
(E). Quantification is based on n= 4 (MITF), n = 4 (JARID1B) and n= 3 (Brn2) independent experiments (western blots). 
Error bars indicated SEM and significance is indicated with *, p < 0.05 and **, p < 0.01, determined using the paired 
standard student’s t-test.  
MITF protein was up-regulated 2.7-, 2.5- and 1.6-fold in SK-MEL-5 cells upon knockdown of 
STIM2, STIM1 and Orai1. This up-regulation is concurrent to an increased proliferation (Figure 
28, B and Figure 26, D). In addition, the effects of down-regulation of Orai1 and STIM2 on 
markers which are typically seen in slow-cycling, pro-metastatic melanoma cell phenotypes 
were analyzed. These markers were the histone demethylase JARID1B (J1B) and the 
transcription factor Brn2. As presented in Figure 28 (D), JARID1B protein was significantly 
reduced by 62%, 46% and 56% in STIM2, STIM1 and Orai1 down-regulated SK-MEL-5 cells. 
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For Brn2 the respective values were 79%, 68% and 41% (Figure 28, E). A representative 
western blot is shown in Figure 28 (C).  
The cytokine IL-8, a member of the CXC-chemokine family, promotes cell proliferation and 
serves as an autocrine growth factor in melanoma progression (see 6.3.3 for details). With 
regard to markers involved in regulating gene expression related to either a more proliferative 
or migratory phenotype (see above), the secretion of IL-8 was determined to further verify the 
role of Orai1 and STIM2 in defining the respective phenotype. IL-8 was measured in an ELISA 
from cell culture supernatants as described in 7.2.10. Supernatants were collected from cells 
either treated with NT RNA or Orai1 and STIM2 siRNA.  
The knockdown of Orai1 mRNA resulted in a significant increase in secreted IL-8 from 
3.12 ng/ml under control conditions (CTRL) to 5.04 ng/ml (Figure 29, A), reflecting an increase 
of 64% (Figure 29, B). The influence of STIM2 mRNA down-regulation was determined in a 
separate data set, with measured IL-8 levels of 0.54 ng/ml under control and 1.53 ng/ml under 
knockdown conditions (Figure 29, A). Although the absolute IL-8 concentration was much lower 
in the STIM2 data set compared to Orai1, the effect of the knockdown was far more distinct, 
reflecting a 190% increase in IL-8 secretion.  
 
Figure 29 IL-8 secretion by SK-MEL-5 melanoma cell line.  
IL-8 production by SK-MEL-5 cells was determined by ELISA to characterize the role of Orai- and STIM-mediated Ca2+ 
signaling on cytokine production. (A and B) IL-8 secretion by cells, transfected with control siRNA or Orai1 and STIM2 
siRNA. Data was averaged from n = 8 (control/siOrai1) and n = 4 (control/siSTIM2) independent experiments. (A) 
Amount of IL-8 secretion upon siRNA treatment, presented as ng/ml. (B) Quantification of effect of STIM2 and Orai1 
down-regulation on cytokine secretion calculated as % of control transfected cells. Error bars indicate SEM, significance 
is indicated with *, p < 0.05, determined using the paired standard student’s t-test.  
 
8.7 Designation of monocyte survival by the extracellular Ca2+ and 
redox environment  
In contrast to melanoma cells, monocytes are non-proliferative cells. It was observed 
throughout the study, that the number of surviving monocytes declined rapidly after isolation 
under standard culture conditions with a loss up to 50% at day 3 (data not shown). Data 
obtained so far concerning the effect of altered Ca2+ concentration on cell proliferation implied a 
potential role of the extracellular Ca2+ milieu for long-term survival effects. In terms of the 
extracellular environment, monocytes contribute to an oxidizing environment by production of 
ROS (see 6.1.3.2 and 6.2.2). Hence, the effects of an altered extracellular milieu on cellular 
survival was analyzed in vitro by changing Ca2+ concentration of the culture medium RPMI or 
increasing the redox stress with supplementation of H2O2 (described above in 8.5). Regarding 
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the results obtained from melanoma experiments, the influence of hormones and serum 
proteins in regulating cell survival was investigated by serum supply or deprivation of the 
culture medium. Survival of non-stimulated monocytes was tested under different conditions 
using the CellTiterBlue viability assay as described in 7.2.8 with summarized results presented 
in Figure 30.  
Redox stress. The presence of increasing concentrations of H2O2 decreased the number of 
viable monocytes with an IC50 of 150 µM, after 24 h in culture (Figure 30, A). The IC50 was 
determined by plotting the resulting intensities from viable cells with the corresponding H2O2 
concentration.  
The data points were fitted with a first order exponential decay fit and the IC50 was graphically 
determined, as already explained in 8.4.2. The determined concentration of 150 µM H2O2 was 
used in further experiments to evaluate the reaction of cells to an external applied redox stress.  
Ca2+ dependency of monocyte survival. While experiments in melanoma cells revealed a 
high impact of the [Ca2+]ext on cell proliferation, monocyte survival was nearly unaffected by a 
decrease in Ca2+ levels under standard culture conditions (orange trace in Figure 30, B and C). 
FCS deprivation rendered the cells, however, sensitive to changes in the [Ca2+]ext (black traces 
in Figure 30, B and C). After 24 h, cell survival rapidly declined when the [Ca2+]ext reached 
levels below 0.07 mM. This effect increased when the duration of cultivation under serum-
deprivation was prolonged to 48 h. In that case, Ca2+ levels below 0.11 mM led to a decline in 
cell survival (black trace in Figure 30, D). At an intermediate [Ca2+]ext of 0.22 mM (grey box in 
Figure 30, B), FCS starvation had no further influence. When [Ca2+]ext was reduced to a level < 
0.001 mM (red box in Figure 30, B), monocytes survival under starvation was significantly 
reduced by 61%. This effect was even more obvious after 48h of cultivation, where a significant 
reduction of survival of 84% was detected (quantified in Figure 30, E). In presence of Ca2+ (0.22 
mM), only a moderate reduction of 8% was detectable. Taken together, in presences of FCS, 
monocyte survival was unaffected by even severe changes in [Ca2+]ext (orange traces in Figure 
30, B and C). Monocytes also displayed a non-significant tendency to a higher survival at 
decreased Ca2+ levels (0.11 mM, Figure 30, C). 
Concurrence of Ca2+ and redox challenges in monocyte survival. Cells were cultured for 
24 h under variable Ca2+ concentrations and in the absence or presence of FCS, prior to the 
incubation with the beforehand determined IC50 of 150 µM H2O2 for another 24 h. On the one 
hand, cultivation for 48 h under altered Ca2+ levels, did not reveal an additional effect to the 
inhibitory effect to the H2O2 treatment over the investigated Ca2+ range (green trace in Figure 
30, C). On the other hand, upon FCS starvation and unaltered [Ca2+]ext of 0.22 mM, monocyte 
survival was decreased about 94% in the presences of H2O2. In the presence of FCS, cell 
survival was only decreased about 39%, revealing a significant difference in the response to 
H2O2 depending on the presence of FCS. A comparable, yet not significant, relation was given 
under reduced Ca2+ levels (< 0.001 mM) with 74% inhibition of cell survival under starvation 
and only 44% inhibition in the presence of FCS (Figure 30, F).  
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Figure 30 Monocyte survival in dependency of the Ca
2+
 and redox environment.  
Analysis of the survival of primary human monocytes in different redox and Ca2+ milieus, using the CellTiterBlue Viability 
Assay. Different [Ca2+]ext were adjusted by adding the Ca
2+ chelator EGTA to the standard culture media (Table 19). (A) 
Survival of monocytes in dependency of increasing [H2O2]ext (1 µM-10 mM) depicted as means, averaged from at least n 
= 3 independent measurements per H2O2 concentration. Determination of IC50 by a first order exponential decay fitting 
of the data set. (B) Survival of monocytes after 24 h in presence (orange) or absence (black) of serum proteins (FCS) in 
dependency of [Ca2+]ext. (C-D) Survival of monocytes after 48 h in presence (C, orange trace) or absence (D, black trace) 
of serum proteins (FCS) in dependency on [Ca2+]ext and in presence (green) or absence (orange and black) of 150 µM 
H2O2. (E) Quantification of change in survival related to FCS supplementation calculated at 0.22 mM and <0.001 mM 
[Ca2+]ext. (F) Quantification of change in survival related to H2O2 treatment calculated at 0.22 mM and <0.001 mM [Ca
2]ext 
in presence (orange) and absence (black) of FCS. For Ca2+-related survival studies (B-F), n = 2 independent experiments 
with n = 6 data points/measurement were performed. First data point in brackets in C identified as significant outlier. 
Error bars indicate SEM and significance is indicated with *, p < 0.05, **, p < 0.01 and ***, p < 0.001, determined by the 
paired standard student’s t-test.  
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9 Discussion 
Intra- and intercellular signaling regulating cellular functions involves and is influenced by the 
extracellular environment. Cellular signaling is not only influenced by the extracellular milieu, 
but also alters and defines the extracellular space by release of signaling molecules and 
enzymes. The immune system and the skin are both considered as organ systems displaying a 
high importance for Ca2+ and reactive oxygen species in regulating cellular (signaling) 
processes. Ca2+ and ROS act on a molecular level as second messengers and as components 
of the cellular environment. The investigation of the regulation of a certain Ca2+ signaling 
pathway, the store-operated Ca2+ entry (SOCE), in the context of the skin and the immune 
system was focus of the here presented study.  
 
9.1 STIM and Orai proteins differentially contribution to SOCE 
9.1.1 Orai1/2 and STIM1/2 contribute to SOCE in monocytes, revealing an important 
role of the so far neglected isoforms Orai2 and STIM2. 
Calcium imaging experiment revealed a contribution of all Orai and STIM isoforms to SOCE, 
though to a different degree. Down-regulation of STIM1 and STIM2 revealed the strongest 
impact and reduction of SOCE. Although the success of down-regulation using siRNA was 
rather limited, especially in the case of STIM2, where only 47% of the respective mRNA was 
targeted. It is likely to assume that full diminishing of STIM1 and/ or STIM2 mRNA will lead to 
an almost complete abolishment of the protein and subsequent SOCE. The strong contribution 
of STIM2 in SOCE, demonstrate the differences in SOCE regulation and gating among different 
cell types. So far, STIM1 was reported to be the dominant isoform in most studied immune 
cells, and for dendritic cells, STIM2 alone was suggested to be the dominant player (see 6.6.1 
for details). In monocytes the two STIM isoforms have an equal contribution to SOCE and, as 
pointed out below, also in Ca2+-dependent ROS production. Orai1 is the dominant Orai isoform 
contributing to SOCE, a finding concomitant with results from other phagocytes (see above, 
6.6.1). The limited contribution of Orai2 to SOCE was surprising, regarding a report from 2011 
presenting Orai2 to be the dominant isoform in dendritic cells that, as monocytes, show a high 
expression level of Orai2 (Bandyopadhyay et al., 2011). The high Orai2 expression though 
pointed to a potential high contribution to SOCE in monocytes, although the insufficient down-
regulation by siRNA (74%) has to be taken into consideration. Orai3 down-regulation resulted 
in the expected rise in SOCE, which can be related to its lower Ca2+ conducting capacity 
compared to Orai1 and Orai2. Based on the results obtained from this study, the expression 
level of Orais and STIMs can be related to their degree of contribution to SOCE, with exception 
of Orai2. To describe this relation, the absolute and relative expression has of the proteins have 
to be considered: Firstly, a high absolute expressed isoform also showed a high contribution to 
SOCE and vice versa. Secondly, and even more important, the relative expression of Orai and 
STIM molecules as determinants. In general, SOCE was shown to have an optimal channel to 
gatekeeper ratio with 1:2 Orai(1) to STIM(1)  (Li et al., 2011). As it was shown in this study for 
monocytes and prior for T cells (Bogeski et al., 2010), the relative Orai3 to Orai1 expression is 
an important parameter in the modulation of redox sensitivity of SOCE. In addition, the ration of 
Orai3 to Orai1 (and Orai2) will impact overall SOCE due to the differences in Ca2+ 
conductance. As it was observed in monocytes, SOCE increases under control conditions in 
the absence of Orai3 (see. Figure 14 Figure 22). The observed increase though was not always 
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significant. In order to analyze the impact of altered Orai3 expression on Ca2+ influx in more 
detail, patch-clamp analysis on Orai3 knockdown cells compared to control cells would be the 
method of choice. Such experiments might provide an insight into altered ICRAC depending on 
the Orai isoform composition. The analysis of the SOCE using calcium imaging only provides 
information on global Ca2+ signals. Since the analysis of ICRAC was not an aim of this study and 
due to difficulties in the performance of patch-clamp on primary human monocytes, the analysis 
was restricted to SOCE.  
The general importance of the SOCE in monocytes is difficult to judge due to lack of full down-
regulation of the components and the lack of information on a monocyte phenotype from 
knockdown mice. The obvious importance for STIM in regulating SOCE implies a potential role 
in regulating other Ca2+ channels also expressed by monocytes. A siRNA screen of TRP 
channel expression in primary human monocytes (one cDNA sample, full data not presented 
here) showed that TRPV2, TRPV6, TRPM2 and TRPM7 are expressed on a comparable, or 
even higher level than Orai and STIM isoforms with 2-∆∆Cq values of 3.85 (V2), 1.00 (V6), 
0.32 (M2) and 0.51 (M7). Especially TRPV6 as Ca2+-selective channel might be an important 
player in monocyte Ca2+ signaling. Furthermore, TRPC and Orai proteins have been suggested 
to associate to mediate SOCE in different cell types and systems (Bréchard et al., 2008; Saul et 
al., 2013). This option might not be the case for monocytes, because TRPC mRNA detection 
was either not possible (TRPC3) or only on marginal levels (TRPC1, 2-∆∆Cq < 0.002). Further 
analysis of TRP expression in these cells and studies on monocytes from STIM (and Orai) 
knockout mice are likely to fill in the gaps in understanding the precise role of the single 
isoforms in this cell type.  
9.1.2 SOCE in melanoma cells lines is mediated by Orai1 and STIM2 
In the two investigated melanoma cell lines, Orai1 and STIM2 were the dominant expressed 
isoforms. Down-regulation of Orai1 and STIM2 resulted in an almost complete reduction of 
SOCE, and the simultaneous knockdown of Orai1 and STIM2 almost completely abolished 
SOCE. Orai1 and STIM2 therefore can be considered as essential components in the SOCE 
signaling cascade of melanoma cells. As for monocytes the expression profile reflects the 
contribution to SOCE. The results from melanoma cell lines are further in line with the findings 
from primary melanocytes, where Orai1 and STIM2 were previously shown to be the dominant 
isoforms (Stanisz et al., 2012). Despite the fact, that Orai1 and STIM2 regulate SOCE in the 
two different cell lines investigated in this study, they also displayed obvious differences. In SK-
MEL-5 cells the Ca2+ elevations following store release were as high as the Ca2+ influx 
mediated by activated CRAC channels, while the store release from WM3734 cells was much 
smaller compared to SK-MEL-5 and smaller than the Ca2+ influx. These results suggest 
substantial differences in size and capacity of the internal Ca2+ stores. Also the influx rates 
differed between the cell lines, where WM3734 showed a fast and steep influx after Ca2+ re-
addition, while the rates in SK-MEL-5 cells displayed lower influx rates. These overall 
differences in Ca2+ signal shape might be of importance in the regulation of downstream Ca2+-
dependent functions, or might be an adaption to their respective environment. Regarding the 
regulation of down-stream effects, there were intensive investigations on how distinct Ca2+ 
signal modulations trigger different Ca2+--dependent responses in cells, as for example the 
regulation of different transcription factors or activation of signaling cascades (eg. MAPK) (see 
6.1.1 and 6.3.3 for details).  
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9.1.3 Additional aspects – The differences and similarities regarding SOCE in different 
cell systems  
Dominance of Orai and STIM isoforms. This study emphasized the importance of STIM2 in 
respect to the so far more thorough investigated isoform STIM1. In the investigated cell types 
STIM2 was shown to be either the main expressed isoform (melanoma) or it was shown to act 
together with STIM1 and contribute to SOCE to the same degree (monocytes). Orai2 was not 
targeted in melanoma cell lines in this study. It’s relative low expression (compared to Orai1 
and Orai3) might be an indicator for only a marginal contribution to SOCE, or it might contribute 
to specialized functions. The little contribution or Orai2 to SOCE in monocytes and the clear 
dominant role of Orai1 in all investigated cell types of this study, confirms the dominance of 
Orai1 in regulating SOCE in many cell types, such as immune and skin cells.  
Physiological versus non-physiological stimulation. In a recent study analyzing the role of 
SOCE in melanocyte function (Stanisz et al., 2012), endothelin-1 (ET-1) was used as 
physiological stimulus to trigger SOCE via binding to its cognate receptor. However, ET-1 
stimulation of melanoma cell lines failed to activate SOCE. Thus, the widely accepted drug Tg 
was used to trigger the activation of the CRAC channel signaling cascade. Although the 
presences of SOCE in melanoma cells is indisputable, the identification of a physiological 
stimulus will be the next step to take, in order to further analyze the role of SOCE in tumor 
progression and to target the signaling cascade for therapeutic means. An example would be 
ligands of the metabotropic glutamate receptor, that are expressed in melanoma and were 
shown to trigger IP3 release and ER Ca2+ store depletion (Lee et al., 2008). The physiological 
ligand, glutamate, could be used as physiological stimulus to trigger SOCE, but also other 
signaling cascades in melanoma. In monocytes Tg was used to carefully analyze the effects of 
Orai and STIM down-regulation on SOCE and Ca2+-dependent ROS production. In addition, the 
physiological stimulus fMLF was applied, since it was shown to successfully activate CRAC 
channels by binding to its receptor FPR1 (Li et al., 2008; Bréchard et al., 2008). The existence 
of SOCE following Tg and fMLF stimulation could be shown by its abolishment in the presence 
of the SOCE inhibitor 2-APB. As representative shown for the analysis of Ca2+ dependency of 
SOCE in monocytes (Figure 18), the observed effects under Tg stimulation were also 
detectable under fMLF stimulation, but were usually less pronounced and subject to even 
higher fluctuations. Regarding this, and the differences in Ca2+ signal shape under fMLF and Tg 
stimulation in store-depletion protocols (see Figure 13), Tg was the more suitable stimulant to 
carefully detect an impact of Orai and STIM down-regulation on Ca2+ signals and Ca2+-
dependent ROS production (see also 9.2.2).  
9.2 ROS production in monocytes is dependent on Ca2+ signaling 
with a particular role for Orai and STIM mediated SOCE 
9.2.1 NOX2 is the source for enzymatic ROS production in monocytes 
In the immune system, NOX2 is the predominant expressed isoform, as it is responsible for 
ROS production by phagocytes and was shown to be expressed in neutrophils, macrophages, 
monocytes, and several immune-cell derived cell-lines (see 6.1.2.3 and 6.6.1). The recent 
suggestion that NOX4 is an additional source of ROS (especially H2O2) (Lee et al., 2010a; 
Ullevig et al., 2012), could not be verified or confirmed by the here presented study. Although 
the experimental set up in this study could clearly show NOX as the source of ROS in response 
to simulation, the inhibitors used were rather unspecific. DPI is a known inhibitor of NADPH 
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oxidases, but cannot be used to distinguish between different NOX isoforms. The PKC inhibitor 
Bis/Gö instead is more specific, since it activates PKC, a key step in the assembly process of 
the NOX2 (see also Table 8). Activation of NOX4 does not require the activation of PKC, 
because NOX4 activity is not dependent on the recruitment of cytosolic subunits. A step 
regulated by phosphorylation of the mentioned subunits by PKC in the case of NOX2. The most 
convincing evidence for the sole presence of NOX2 in monocytes was the qRT-PCR screen of 
NOX and DUOX family members that did not show the presence of NOX4 mRNA (Figure 17). 
The functionality of the used NOX4 primers was confirmed by internal positive controls, and 
was in addition successfully used to detect NOX4 expression in melanoma cell lines (data not 
sown).  
9.2.2 NOX2 activation is dependent on the elevation of Ca2+ signals  
The applied methods used to determine ROS production upon activation of SOCE both 
confirmed the dependency of ROS production (superoxide and H2O2) on the influx of Ca2+ from 
the extracellular space. Independent on the measuring technique, the removal of extracellular 
Ca2+ caused complete abolishment of ROS production under Tg stimulation. However, under 
fMLF stimulation the production of H2O2 was only reduced to 50 %, leaving the initial rise in 
H2O2 following stimulus application unaltered (see panel B in Figure 18). An explanation of the 
different effect of Ca2+ removal depending on the stimulus is the difference in the activation of 
NOX2 using Tg or fMLF. As pointed out in the introduction and above, Ca2+ elevation is an 
important step in the assembly process of NOX2 (6.4.2). Under the use of Tg this Ca2+ 
elevation is the only activation step in the elsewise complex process. With the physiological 
stimulant fMLF, Ca2+ elevation is only one aspect of the signaling cascade, as the receptor 
engagement also leads to the activation of PKC not only by Ca2+, but also by the generation of 
DAG (6.2.2). The Ca2+ released from internal stores, usually fails to activate NOX2 alone. In the 
case of fMLF the concomitant activation of PKC by DAG seems to be sufficient to activate 
NOX2 in the absences of external Ca2+, though in a limited manner.  
9.2.3 Orai and STIM are differentially involved in regulating NOX2 activity  
9.2.3.1 Orai1, STIM1 and STIM2 provide a Ca2+ influx necessary for ROS production  
The influx of extracellular Ca2+ to the cytosol required for proper ROS production was shown to 
be mediated mainly by Orai1, STIM1 and STIM2. The reduction of the amount of H2O2 
produced following Tg stimulation in Orai1, STIM1 and STIM2 siRNA treated cells, could be 
correlated to the degree of reduction of SOCE. The contribution of Orai1 and STIM1 in 
phagocyte ROS production has already been demonstrated for neutrophils (see 6.6.1) and 
could be confirmed for monocytes in this study.  
Regarding the role of STIM molecules in phagocyte ROS production, a contribution of STIM2 
was so far either ruled out or not the topic of investigations (see 6.6.1). The comparable 
expression levels and the equal effect of STIM1 and STIM2 down-regulation on SOCE implied 
a contribution of not only STIM1 but also STIM2 in monocyte ROS production. Regarding the 
impact of down-regulation one can assume that STIM2 might even play a dominant role. STIM1 
down-regulation, though more efficient than STIM2, did not result in a stronger reduction in 
H2O2 production compared to STIM2. In line with the effects on SOCE, it is likely that a full 
down-regulation of STIM2 (and STIM1) will lead to a complete abolishment of H2O2 production. 
On the basis of this study, the gating of the CRAC channels, rather than the channel 
components itself seem to be the major players in regulating Ca2+-dependent ROS production. 
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In a broader scope, additional functions of STIM molecules are possible, as for example in 
regulating other Ca2+ channels, thereby influencing ROS production (compare to 9.1.1). A Ca2+-
independent context is likewise possible, as it will be discussed below in the additional aspect 
section (see 9.2.4).  
9.2.3.2 Kinetic analysis  
The kinetics of H2O2 production displayed high donor and experimental variability regarding 
overall shape and production rates. In most cases two phases could be observed: a main 
production phase, where a constant increase in net H2O2 production could be observed, and a 
prolonged or saturation phase, in which no additional H2O2 was produced, or with a clearly 
reduced rate. Due to high donor dependent variations, the overall kinetic analysis was limited to 
be descriptive (see Table 17 and Table 18). Differences in production rates were obvious, 
though a standardized definition of a phase and its production rate would have been highly 
subjective and was therefore not further analyzed.  
Anyway, the tendencies observed might be a first indication for implications and further 
analysis. For example, the differences in reaching saturation might dependent on the 
inactivation of the CRAC channels. Therefore, different composition of Orai and STIM isoforms 
in the machinery and the mode of inactivation are likely determinants of the period of ROS 
production. The same accounts for changes in production rates, in response to down-regulation 
of Orai and STIM (see Table 17). Time scale and production rates are possible modulators of 
redox signaling, that could result in different cellular responses, as it was shown for the 
modulation of Ca2+ signals (see 6.1.1). Overcoming the issue of high donor dependency using 
an appropriate cell line, might be a possibility to analyze ROS production kinetics in a more 
objective manner.  
9.2.3.3 Something new: Orai2 
Regarding the strong evidence for Orai1 and STIM1/2 mediating the necessary Ca2+ influx for 
ROS production, the results of Orai2 down-regulation on H2O2 production were surprising. 
Although Orai2 down-regulation resulted in reduced SOCE, H2O2 production was severely 
increased instead of decreased. This contrary effect was also the most stable one, compared to 
the effect of Orai1 or STIM1/2 down-regulation. While the data sets of Orai1 and STIM1/2 
displayed a huge variety and donor dependent fluctuations, the increase in H2O2 production in 
Orai2 knockdown cells was stable and nearly free of instabilities. With the intensive studies 
conducted in neutrophils and respective cell lines and the results of this study, there is no doubt 
for the dependency of ROS production on Ca2+ signaling and a contribution of SOCE (see 6.5. 
for details). This and the fact that the impact of Orai2 down-regulation on SOCE was mild 
compared to the impact on H2O2 production implies a Ca2+-independent mechanism underlying 
the observed events.  
Based on the obtained results it is possible to hypothesize that Orai2 is an inhibitory modulator 
of NOX2 activity with the purpose to prevent overshooting responses. As presented in the 
scheme below (Figure 31) the assembly process of the different subunits of NOX2 depends on 
various protein-protein and protein-lipid interactions between the different cytosolic subunits 
and the membrane residing core unit as well as the plasma membrane. To act as modulator, 
Orai2 might be a competitor in binding of NOX2 subunits, thereby limiting the number of fully 
assembled holoenzymes and the amount of ROS produced by the cells. However, two factors 
restrict the hypothesis. Firstly, the binding of NOX2 subunits has to take place via a unique 
binding site not present in Orai1 and Orai3 or underlying a specific binding affinity to be limited 
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to Orai2. This binding site is in addition supposed to be an PRR or an SH3 domain to properly 
bind NOX2 subunits in competition to the cytosolic subunits. Based on the ongoning research 
to identify the exact structural basis of the SOCE machinery, one could suggest a potential 
NOX-binding sit in the cytosolic regions of Orai2. This region are the C- and N-terminal regions 
as well as the cytosolic loop between the trans-membrane domains 2 and 3 (Stathopulos & 
Ikura, n.d.). However, there is no valid information so far available, that would explain a unique 
binding of Orai2 (instead of Orai1 or Orai3). Secondly, the observed effect, though strong and 
stable, is limited to Tg stimulation. While in all other investigated cases, fMLF stimulation 
displayed the same tendency as Tg, fMLF-induced ROS production is not altered in Orai2 
knockdown cells. Therefore, a verification of the suggested hypothesis requires intensive 
molecular analysis of the binding properties of all Orai proteins with the potential NOX2 targets 
and a careful analysis of the activation pathway and the chosen stimulant.  
 
Figure 31 Interaction and binding within the assembly process of NADPH oxidase 2 
Scheme of protein-protein interactions among the different subunits in the assembly of NOX2 and a potential 
involvement of Orai2 binding sites. Dotted lines indicate protein-protein interactions and dashed lines indicate 
interaction of proteins with membrane lipids. The AIR of p47phox is bound to (SH3)2 when not phosphorylated. 
Phosphorylation (red dots) exposes SH3 domains for binding to p22phox. Domain nomenclature and explanations: PX – 
Phox homology domain, SH3 – SRC Homology 3 Domain, SRC – Proto-oncogene tyrosine-protein kinase Src (sarcoma), 
AIR – auto-inhibitory region, PRR - proline-rich region, PB1 – Phox and Bem1p protein domain (involved in protein-
protein-interactions), TRP - tricodecapeptide repeat (TPR) domains, AD – activation domain. Information taken from 
(Lambeth, 2004; Kerkhoff et al., 2005; Bedard & Krause, 2007; El-Benna et al., 2009). 
9.2.4 Additional aspects – Potential and limitation to the interpretation of ROS 
production by monocytes 
Potential for interpretation: Orai and STIM molecules in the NOX2 assembly process. As 
suggested for Orai2 above, also STIM proteins hold potential to be involved in regulation of 
NOX2 assembly in a Ca2+-independent context. STIM1 and STIM2 were shown to bind 
phosphatidylinositol phosphates (PIPs). PIPs are important anchors in the plasma membrane 
to bind the modulator and organizer subunits p40phox and p47phox, thereby stabilizing the NOX2 
complex (see Figure 31). STIM2 binds the PIP metabolites PIP2 and PIP3, while STIM1 is 
limited to PIP3 binding (Ercan et al., 2009). STIM1 and STIM2 could therefore be involved in 
stabilizing the NOX complex, or could be involved in the physical and functional coupling of 
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NOX and Orai channels to provide local Ca2+ signals, as shown for STIM1 in neutrophils 
(Nunes et al., 2012). 
Limitations to interpretation: Fluctuations in monocyte ROS production. Limitations in cell 
numbers restricted knockdown experiments to fluorescent methods and the analysis of the 
amount of ROS produced under different conditions revealed high fluctuations, even between 
control conditions (see black data points in Figure 20). The high fluctuations can partially be 
explained by general donor dependency usually observed using primary cells and by 
fluctuations in the expression of NOX2 (see high SEMs in Figure 17). Due to the high 
fluctuations the results were presented showing both the mean and the median values (Figure 
20). In optimal distributed data sets, median and mean values show no or only limited deviation 
as for example in the Orai2 and STIM2 data sets. In a more diverse picture as the data sets for 
Orai1 and STIM1, there is a high deviation between the two parameters. Although in all cases 
the tendency of the result of the knockdown was obvious, statistical analysis only showed 
significance in the case of Orai2 and STIM2.  
9.3 Redox-regulation of CRAC channels  
9.3.1 In Monocytes Orai3 is a redox-insensitive isoform, that serves as modulator of 
SOCE-dependent ROS production in monocytes 
Orai3 defines redox-sensitivity of SOCE. H2O2 inhibits SOCE in monocytes with an IC50 of 
155 µM, displaying a higher redox-resistance than other mammalian cells. Naïve and effector T 
cells were shown to be more redox-sensitive, with an IC50 of 10 and 83 µM respectively (altered 
calculations from (Bogeski et al., 2010)). The importance of Orai3 in regulating the redox-
sensitivity of CRAC channels in T cell differentiation was demonstrated by Bogeski and 
colleagues (Bogeski et al., 2010) and pointed towards a role of Orai3 in redox-challenged cells 
such as phagocytes. These findings could be confirmed by this study, as down-regulation of 
Orai3 resulted in an increased inhibition of SOCE. This study showed that the modulatory role 
of Orai3 is not a T cell specific, but rather a general mechanism of immune cells to protect their 
Ca2+ signaling pathway by up-regulation or general high expression levels of Orai3. RNAi 
mediated down-regulation of Orai3 did not reveal an active contribution to NOX2 activity (8.4.4). 
However, the redox-insensitive isoform indeed holds an important function as modulator of 
redox-sensitivity of SOCE in monocytes. The presence of Orai3 defines the redox-sensitivity of 
CRAC channels, while the other isoforms mediate and regulate SOCE thereby defining the 
amount of ROS produced. The analysis of overall redox-sensitivity of SOCE revealed a 
biphasic effect of H2O2 (see two phases in Figure 21, D). This might be an indication for 
differences in the mode of redox-regulation of the CRAC channel. It is possible, that different 
concentrations of the oxidant results in different oxidation modes (indirect vs. direct), or 
different oxidation states of the target cysteine residues (see 6.1.2.2  for details).  
A regulatory feedback loop. In monocytes Orai3 is not only a modulator of redox sensitivity of 
SOCE, but is also part of a feedback loop in the interplay between CRAC channels and NOX2 
activity. The suggested feedback loop (Figure 32, A) describes the restriction of overshooting 
ROS production by NOX2 via a feedback of the produced H2O2 on the CRAC channels that 
provide the required Ca2+ signal. By partial inhibition of the SOCE, NOX2 activity is reduced but 
prolonged. Calcium imaging and ROS measurements provided evidence for dependency of 
NOX2 activity on Orai and STIM mediated Ca2+ signals and on the inhibitory effect of H2O2 on 
SOCE (8.3.2 and 8.4.1). Further experiments aimed to analyze the impact of Orai3 down-
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regulation on Tg triggered, hence Ca2+-dependent, ROS production (see Figure 23, B). The 
experiments revealed an inhibition of Tg-triggered ROS production only in the absence of 
Orai3. Taken together, these experiments were the basis for the suggested feedback loop. A 
regulatory feedback loop is of physiological relevance due to the importance of restriction and 
regulation of ROS production. This regulation is a necessity and prerequisite to prevent 
pathological effects of ROS and to serve as signaling molecules (see also 6.1.2).  
Channel constitution and its effect on redox sensitivity and SOCE. As pointed out in the 
introduction the actual confirmation state of activated CRAC channel is not fully elucidated (see 
6.4.1). Based on the results from T cell studies and the results from monocytes, an increasing 
number of channels containing Orai3 subunits, can be linked to overall decreased Ca2+ 
permeability, hence smaller SOCE. In parallel, higher Orai3 expression leads to a gain in 
redox-resistance (Figure 32, B). The overall channel confirmation will also depend on the 
expression level of the single Orai subunits. As illustrated in the upper part of Figure 32 (B) one 
can assume how the channel confirmation might occur depending on the abundance of the 
single isoforms in different immune cell types. In T cells, Orai1 is the dominant expressed 
isoform, while in monocytes Orai2 is expressed at comparable levels. It is therefore to assume, 
that Orai1 and Orai2 subunits are equally abundant in the CRAC channels of monocytes. 
Unpublished data from Dr. Dalia Alansary (Niemeyer/Hoth group, Biophysics, Homburg), 
revealed that one Orai3 subunit per channel is sufficient to gain redox-resistance while further 
insertion of Orai3 does not enhance this effect. One can conclude that it is the number of 
channels containing an Orai3 subunit that defines the overall sensitivity of SOCE, rather than 
the number of Orai3 subunits per channel. These observations also imply the favor of 
heteromeric channels rather than homomeric ones.  
9.3.2 An equation describes the correlation between Orai3/Orai1 expression profiles 
and the redox sensitivity of SOCE  
Regarding the expression of Orai3 it is important to note that not the absolute Orai3 expression, 
but rather the relative Orai3 to Orai1 ratio defines redox sensitivity of SOCE. These relative 
ratios were determined for all investigated cell types in this study revealing similarities and 
differences between monocytes and melanoma and in between melanoma cell lines. WM3734 
showed the lowest Orai3/Orai1 expression ratio of the tested cell lines. This might be ascribed 
to the different origin of this cell line that derives from brain metastasis compared to cell lines 
deriving from primary melanoma (see 7.1.6).  
As differences in Ca2+ signaling, differences in gene expression can be considered as result of 
adaption to a certain specialized environment. High Orai3 levels can be ascribed to adaption to 
a redox-challenging environment as effector T cells or phagocytes encounter in inflammation. 
In the case of melanoma the high absolute Orai3 expression levels as well as the high 
Orai3/Orai1 ratios might be an adaption to both, high UV-induced redox stress in the skin and a 
cancerous environment. The role of Orai3 in tumor progression was so far intensively 
investigated in the context of breast cancer and recently also prostate cancer (Motiani et al., 
2010, 2013; Faouzi et al., 2011; Holzmann et al., 2013). Increased levels of Orai3 were 
observed in breast cancer cell lines, supporting the idea of Orai3 adapting to a cancerous 
environment. In contrast, Holzmann and colleagues reported decreased Orai3 levels in 
cancerous tissue compared to healthy controls (Holzmann et al., 2013). The difference in Orai3 
expression ratio in melanoma and healthy tissue was not analyzed in a direct comparison in the 
here presented study. The contradictory observations regarding Orai3 levels in cancer 
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emphasize the importance to regard relative, rather than absolute expression values, when 
comparing different cell types.  
 
Figure 32 Orai3 as modulator in the interdependency of SOCE and ROS production  
(A) Scheme describing the regulatory feedback loop between Ca2+-dependent ROS production and the activity of CRAC 
channels. NOX2 activity requires Ca2+ signals mediated by CRAC channels. H2O2 produced by NOX2 feeds back on the 
CRAC channels by inhibiting Orai1 and Orai2, but not Orai3. This loop might prevent overshooting ROS production, by 
dampening Ca2+ elevations. (B) Suggested channel configuration of T cells and monocytes in regard to SOCE and the 
redox resistance of CRAC channels, defined and modulated by the amount of channels holding an Orai3 subunit. This 
scheme is based on findings from this study and from Bogeski and colleagues (Bogeski et al., 2010). 
The observed correlation between the relative Orai3/Orai1 expression ratio and redox 
sensitivity of SOCE was determined by relating the Orai3/Orai1 ratios to IC50 values of H2O2 
induced inhibition of SOCE. The logarithmic dependency from redox sensitivity on the relative 
Orai3 level was in line with the mechanism of Orai3 insertion to CRAC channels as described 
above. In a linear correlation, additional Orai3 units would result in a constant increase of redox 
sensitivity. The logarithmic correlation instead implies a limitation to insertion, when additional 
Orai3 units will not result in further increased redox sensitivity. Instead, the relative abundance 
of Orai1 and Orai2 channels in the case of monocytes, containing one Orai3 subunit is likely to 
define the overall redox sensitivity.  
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9.3.3 Can an equation be used to estimate redox-sensitivity of SOCE in different cell 
types? 
The equation described, correlating redox sensitivity of SOCE to the relative Orai3/Orai1 
expression ration, was thought to serve as prediction method to estimate the redox sensitivity 
for a cell type from qRT-PCR data. The benefit of such a prediction method, if applicable, would 
be to avoid the time consuming experiments to determine an IC50, by accessing the easier and 
faster obtainable PCR data. Using the model biased IC50 concentrations in calcium imaging 
experiments for the three investigated melanoma cell lines, limitations and advantages of such 
a prediction method became obvious (see Figure 25). In the case of WM3734 the calculated 
IC50 concentration of 100 µM H2O2 indeed resulted in 53% reduction of SOCE in imaging 
experiments. This close fit of estimated and measured values seemed to be a proof of principal 
for the suggested method. However, in the case of the SK-Mel cell lines the method showed its 
limitations. In both cell lines, with more pronounced characteristics observed in SK-MEL-28, the 
calculated H2O2 concentration did not result in a reduction of SOCE. In contrast, all determined 
parameters: ∆Ca2+ (reflecting SOCE), peak Ca2+ values and the influx rates after channel 
activation (slope) were increased. These results showed that although the equation seems to 
apply to certain cell types and Orai3 is indeed a modulator of Ca2+ sensitivity in T cells and 
monocytes, it is not the only defining parameter. The interpretation of the complete lack of an 
inhibition of SOCE by H2O2 and the opposed augmentation of the Ca2+ signal, requires further 
analysis. The redox regulation of SOCE, thus a clear picture in so far analyzed immune cells, is 
different in melanoma cell lines, probably underlying different or additional regulatory 
components. It is also to be considered, that other groups reported an elevation of SOCE in the 
presence of H2O2 (Grupe et al., 2010). The repeatedly observed difference between WM and 
SK-Mel cell lines again, might be explained by adaption to the specific environment of their 
origin.  
9.3.4 H2O2 induces an initial increase in Ca2+ signals in human monocytes and 
melanoma cells with so far unknown function  
The treatment of cells with different concentrations of H2O2 resulted in an initial rise in Ca2+ in 
all investigated cell types. This effect, here referred to as initial effect, has early been reported 
by others (Bogeski et al., 2010). The elevation of Ca2+ can partially be explained by activation 
of the IP3 receptor and the release from internal stores. It was shown, that thiol modification of 
the IP3R lead to Ca2+ store depletion (Hilly et al., 1993; Parekh & Penner, 1995). More recently, 
Zheng and colleagues showed H2O2 to be an activator of the IP3 receptor (Zheng & Shen, 
2005). The initial effect is subject to modulation and is measurable via patch clamp suggesting 
a channel underlying the observed effect (observation, unpublished data, (Bogeski et al., 
2010)). Some groups have suggested TRPM2 as the channel in charge (Kolisek et al., 2005; 
Ishii et al., 2006; Grupe et al., 2010). Though not representative, the qRT-PCR screen 
performed to analyze the expression of TRP channels in monocytes was also performed on a 
cDNA sample from the monocyte/macrophage cell line THP-1 (see 9.1.1). In both cases, 
TRPM2 mRNA was expressed with the same 2-∆∆Cq values, but THP-1 cells lack the initial 
effect in calcium imaging experiments even under high H2O2 concentrations (observation, data 
not shown). These observations do not support TRPM2 as potential channel mediating the 
initial effect. The unaltered presence of the initial effect in Orai3 knockdown cells also rules out 
the protein as potential target. Still, based on the experiments conducted in this study and 
without further precise analysis, it is not possible to conclude on a molecular mechanism of the 
observed initial effect.  
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9.3.5 Additional aspects – Orai3 and other players in redox regulation of SOCE 
The data obtained from monocytes and melanoma cell lines, with respect to data from T cell 
studies, pointed towards two statements regarding redox regulation of CRAC channels: 1.) 
Orai3 acts as modulator of redox sensitivity in so far analyzed immune cells, but this 
mechanism is not fully transferable to other cell systems such as melanoma cell lines. 2.) 
Opposed results from different melanoma cell lines regarding redox regulation of CRAC 
channels implies other and additional components involved in in the response of Ca2+ signals to 
oxidative signals or stress.  
A potential player other than Orai3 involved in redox regulation of CRAC channels is STIM2. 
Cysteine residues are the major target in proteins for H2O2 induced redox modification. STIM2 
with 15 determined cysteine residues holds a high potential of being regulated by H2O2 (see 
6.1.2.2). Especially in systems displaying a high STIM2 expression such as melanoma, H2O2 
induced cysteine modification might influence protein function, thereby regulating or influencing 
CRAC channel activity.  
9.4 A phenotype switch in melanoma cell lines is dependent on 
Orai1 and STIM2  
9.4.1 Orai1 and STIM2 in proliferation vs. migration  
Orai1 and STIM2 were shown to be the molecular players underlying the regulation of the Ca2+-
dependent switch in melanoma from a migratory/invasive to a rather proliferative phenotype. 
High Orai1 and STIM2 expression levels were shown to favor an invasive phenotype, while a 
down-regulation of the two isoforms resulted in increased proliferation and a decreased 
migratory capacity (Figure 26 and Figure 27). The modulatory function of Orai1 and STIM2 was 
not only proven by the chosen read outs, migration and proliferation analysis, but was also 
supported on a molecular level. The change in expression of transcription factors following the 
down-regulation of Orai1 and STIM2, confirmed the switch from a migratory to proliferative 
phenotype (see Figure 28). The master regulator of melanoma function MITF was shown to 
promote cell proliferation (see 6.3.3 and (Levy et al., 2006)) and displayed a significant up-
regulation in Orai1 and STIM2 down-regulated cells. Brn2 is involved in the transcriptional 
regulation of melanoma progression and fulfills various functions in regulating basic gene 
expression (see 6.3.3 and (Goodall et al., 2008)). The TF binds to promoter regions close to 
binding sites of MITF, thereby repressing its function. This repression of MITF is diminished 
under low Brn2 expression levels, as observed in Orai1 or STIM2 siRNA treated cells, again 
supporting a more proliferative phenotype by increasing MITF activity. The histone-
demethylase Jarid1B was initially described to be up regulated in slow-cycling melanoma 
subpopulations (Roesch et al., 2010). The significant down-regulation of Jarid1B under Orai1 
and STIM2 siRNA treatment supports the switch to a fast-cycling, speaking highly proliferative, 
phenotype.  
As it was pointed out in the introduction, major signaling pathways as MAPK signaling 
cascades are highly Ca2+-dependent. Targets of MAPK as MITF, Brn2 or NFkB are involved in 
regulation of proliferation in melanoma (see 6.3.3). The activity of the TFs (see above) and the 
expression of their target genes (see below) is therefore highly Ca2+-dependent, providing a 
high potential for Orai1 and STIM2 in their regulation. For example, the expression of IL-8, the 
marker cytokine of melanoma, involved in the promotion of proliferation and tumor progression 
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is mainly regulated by the Ca2+-dependent TF NFkB. This cytokine is therefore potentially 
regulated by Orai1/STIM2 mediated Ca2+ signaling. IL-8 secretion was increased upon the 
down-regulation of Orai1 and STIM2 (see Figure 29). Hence, IL-8 levels severed as additional 
proof of the stated phenotype switch. Though it is to consider, that increased expression and 
secretion of IL-8 and its cognate receptors CXCR1 and CXCR2 have been associated not only 
to an enhancement of proliferation and cell growth of melanoma, but also a promotion of 
vertical growth and metastasis (reviewed by (Singh et al., 2010)). IL-8 results upon down-
regulation of Orai1 and STIM2 therefore have to be interpreted in the context of the results from 
transwell-migration experiments presented in this study (8.6.2) and results from spheroid 
assays presented in (Stanisz et al., 2014). Since both types of experiments revealed an 
attenuation of the migratory potential and invasion, the increased IL-8 secretion can be 
accounted as indicator for an enhanced proliferation and the stated phenotype switch. One can 
assume, that the observed IL-8 increase is not sufficient to cause pro-invasive effects in 
melanoma and is outweigh by the influence on proliferation. In addition, the complex activity of 
IL-8 in melanoma progression was usually observed in the background of changes in the 
expression of CXCR1/2 (Venkatakrishnan et al., 2000; Waugh & Wilson, 2008). Orai1 and 
STIM2 down-regulation might not affect the expression of the respective receptors, resulting in 
a sole consequence of enhanced proliferation. In order to verify this assumption and to further 
elucidate the role of Orai1/STIM2-mediated Ca2+ signaling for cytokine expression, additional 
experiments on CXCR expression are required. In contrast to melanoma, down-regulation of 
Orai1 or STIM2 in primary melanocytes, the origin of malignant melanoma, resulted in reduced 
proliferation (Stanisz et al., 2012). This opposed results might speak for a tumor specific 
mechanism of Orai1 and STIM2 shaping the melanoma phenotype.  
9.4.2 General vs. specific effects of the cellular environment and Ca2+ signaling on 
proliferation and migration 
Regarding proliferation of melanoma, both the extracellular Ca2+ environment and Orai1- and 
STIM2-mediated signaling were shown to regulate cellular functions, thereby determining the 
cell phenotype. A reduced Ca2+ availability, either by lowering [Ca2+]ext. or by reducing 
Orai1/STIM2-mediated SOCE, resulted in an enhanced proliferation. In contrast to proliferation, 
migration seems to be specifically regulated by Orai1 and STIM2 and not by Ca2+ signals in 
general. The use of the unspecific Ca2+ channel blocker 2-APB did not result in a reduced 
migration in untreated and control transfected cells (Figure 27, A). However, the knockdown of 
Orai1 or STIM2 significantly reduced the migratory capacity. Hormones and peptides in vivo, or 
fetal calf serum (FCS) in vitro, stimulate the proliferation of cancer cells including melanoma by 
the engagement of membrane-bound receptors. The subsequent activation of transcription 
factors involves Ca2+ signaling as important player in this process (Roderick & Cook, 2008; 
Prevarskaya et al., 2011). The reduced proliferation observed under serum deprivation 
supports the important general role of the local environment in shaping the melanoma 
phenotype.  
9.4.3 Additional aspects – Orai1 and STIM2 in the context of melanoma onset and 
progression  
Orai1 and STIM2. The general role of Ca2+ for melanoma proliferation might be related to the 
regulatory function of the Ca2+ gradient in the epidermis that has already been shown to be 
involved in keratinocyte differentiation and skin barrier formation (see 6.3.1). Melanocytes can 
cope with very low [Ca2+]ext., as they reside in the basal epidermal layer, displaying the lowest 
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Ca2+ concentration within the gradient. The experimentally determined low Ca2+ concentrations 
for optimal melanoma proliferation, suggests that melanoma cells reside in an optimal 
environment for proliferation in the basal epidermal layer. The enhanced proliferation following 
Orai1 or STIM2 down-regulation might lead to intracellular Ca2+ levels that promote 
proliferation. This levels might also match the actual Ca2+ levels melanocytes and melanoma 
cells hold in an environment with a low [Ca2+]. 
It is still not fully understood how melanoma cells acquire their enormous metastatic potential. 
Apparently, subpopulations of melanoma cells possess a considerable migratory capacity while 
still retaining the potential to switch into a highly proliferative phenotype after arriving at the 
metastatic niche (Pinner et al., 2009). The mechanisms that control this phenotypic switch are 
largely unknown but most likely involve extracellular signals from the tumor environment and 
complex intracellular signal transduction (Hoek et al., 2006, 2008; Hoek & Goding, 2010). 
Based on the identification of Orai1 and STIM2 in the regulation of the phenotype it is likely to 
assume that changes in Orai1 and STIM2 expression in response to environmental or local 
triggers define tumor invasion and spreading. A future project might focus on the identification 
and analysis of potential triggers responsible for changes in Orai1 and STIM2 expression. The 
determination of different Ca2+ concentrations in metastatic niches will give further insight into 
the role of the environment for phenotype shaping. It is further worth to analyze whether 
melanoma subpopulations show differences in Orai and STIM expression, and whether the 
balance between these subpopulations defines the overall tumor phenotype, as it was shown 
for Jarid1B (Roesch et al., 2010).  
A possible function for STIM1 in melanoma. Initially, STIM1 was tested in several 
experiments to serve as isoform control. Although STIM2 is indeed the higher expressed STIM 
isoform, STIM1 down-regulation also showed an impact on the expression of molecular 
markers (see Figure 28). Therefore, STIM1 might also contribute to SOCE and other cellular 
functions. However, since a concomitant down-regulation of Orai1 and STIM2 already resulted 
in an almost complete abolishment of SOCE, an essential role for STIM1 is not likely.  
9.5 Monocytes in an altered redox and Ca2+ microenvironment  
9.5.1 Monocytes react to changes in their environment, but are moderately insensitive 
to changes in the extracellular Ca2+ concentration 
In comparison to T cells, monocytes display a stronger resistance towards the impact of an 
oxidative milieu in both, Ca2+ signaling and overall survival. Still, an oxidative milieu, with H2O2 
as observed parameter, results in a reduced survival rate of monocytes with an IC50 of 150 µM. 
The redox resistance and stability in an oxidizing environment of the cells became more 
obvious under further challenging conditions, when the impact of the IC50 concentration of 
150 µM was stable with no regard to the external Ca2+ concentration. The presented data in 
Figure 30 (C) shows one data point not coherent with the remaining results. Although the 
measured survival under 150 µM H2O2 did not show a decrease in survival, compared to the 
non-treated condition, it was not further considered because it was identified as significant 
outlier (indicated by brackets and dotted line). In all other cases, a concentration of 150µM 
indeed resulted in an obvious decrease of survival (see also Figure 30, A). Monocytes do not 
proliferate under standard culture conditions and are considered as non-proliferative cells. The 
effect of a changing environment was therefore analyzed based on the survival of the cells over 
time.  
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As well as melanoma cell lines, serum protein deprivation resulted in severe changes in cell 
survival rates. Although the effect of H2O2 was stable in the absences or presence of serum 
proteins, the cells reacted to alteration in the Ca2+ environment after serum deprivation for 24 
and 48 h. Taken together, although monocytes as highly versatile cells are in general strongly 
influenced by their environment, they displayed a strong resistance to Ca2+ and redox 
challenges.  
9.5.2 Additional aspects – What additional parameters define redox sensitivity of 
monocytes? 
In order to fully understand and reveal the mechanisms underlying the strong redox resistance 
of Ca2+ signaling and overall survival of monocytes, it is important to understand the 
contribution and adaption of the antioxidant systems. The presence of antioxidant systems is 
detectable either by mRNA or protein analysis. It is far more complicated to analyze the activity 
of the different systems or enzymes. The standard assays require a destruction of the cells and 
simply detect the activity of the enzyme in a cell lysate. These approaches are limited in their 
informative value, because they do not monitor enzyme activity in intact cells. An initial 
approach was therefore to determine mRNA levels of two players of the most abundant 
antioxidant enzymes/systems dealing with H2O2: namely catalase and glutathione reductase 
(GR) (data not shown but briefly described here). The analysis of mRNA levels in untreated 
monocytes and monocytes challenged with fMLF revealed minor, though unstable and non-
significant, changes to acute induction of increased redox levels. Possible changes in the 
context of Orai and STIM down-regulation were also analyzed. It became obvious, that catalase 
and GR expression displayed a general strong donor dependency and were prone to 
fluctuations as observed for NOX2 expression. Catalase mRNA levels showed a tendency of 
reduction in Orai3 knockdown cells, while they were increased following the knockdown of 
Orai1. GR mRNA levels were meanwhile increased under STIM1 down-regulation. Further 
analysis of expression levels of other enzymes as SOD, in parallel to additional methods, is 
required to interpret the regulation of anti-oxidative systems by Orai and STIM mediated Ca2+ 
signaling.  
A physiological approach to determine the actions and reactions of the antioxidant system to 
changes in the Orai/STIM machinery or the environment is the use of genetically encoded 
redox sensors. Examples are redox-sensitive GFP constructs (roGFP) or the H2O2-sensitive 
sensor HyPer. These constructs can be targeted to different subcellular compartments and are 
used to analyze real-time, single cell biased oxidative processes in intact living cells (Belousov 
et al., 2006; Gutscher et al., 2008). Different roGFP derivatives have been established and are 
applied in revealing oxidative processes of the immune and the cardiovascular system (Pal et 
al., 2013; Ezeriņa et al., 2014). In the here presented study, the limitations of the analysis of 
real-time ROS production on single cell level was based on two issues. On the one hand, the 
overexpression rates of the constructs at hand were either limited (HyPer, 5-10%) or nearly not 
detectable (roGFP). On the other hand, the expression of GFP constructs in monocytes turned 
out to be inapplicable, due to the high autofluorecence of the cells at 470nm excitation. Using 
optimized constructs, further analysis might give insight into the function of antioxidant systems 
of primary phagocytes and their adaption to altered Ca2+ and redox signaling processes. A 
recent improved HyPer-Red construct is currently under investigation, and will be suitable to 
analyze intracellular H2O2 concentrations in cells such as monocytes (work by Belousov et al. 
unpublished to date).  
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9.6 Regulation of NOX and CRAC channel activity as therapeutical 
application in inflammatory and cancerous diseases: A clinical 
outlook  
9.6.1 Regulation of CRAC channel activity as therapeutical application in melanoma 
treatment  
Aberrant Ca2+ signals have early been correlated to cancer (Monteith et al., 2012; Schwarz et 
al., 2013), due to their multiple roles in regulating cellular functions, as proliferation and 
migration that are related to cancer development (Qu et al., 2011). Several Ca2+ mediating 
channels have therefore been a target of investigation, among these the CRAC channels and 
their components. So far, several reports correlated aberrant Orai and STIM expression levels 
to cancerous diseases (reviewed by (Hoth & Niemeyer, 2013)). There are contradictory results 
and observations regarding the correlation of, for example, increased or decreased STIM2 
expression levels to disease outcome. This implies a rather specific than general role of STIM 
molecules in cancerogenesis and progression. McAndrew and colleagues reported the 
STIM1/STIM2 expression ratio as critical parameter in breast cancer prognosis with the poorest 
survival rate of patients displaying a STIM1(high) to STIM2(low) expression (McAndrew et al., 
2011). Also in prostate cancer, a low STIM2 expression was related to an increased Gleason 
grade, hence a poor therapeutical prognosis (Ashida et al., 2012). In glioblastoma, high STIM2 
expression was determined and designated as potential target (Ruano et al., 2006). With the 
results from the here presented study, it is obvious, that the effects of aberrant STIM2 levels 
are highly specific to the type of cancer and have to be interpreted in the context of other 
parameters. For example, while in melanoma a high STIM2 level is related to an invasive and 
migratory phenotype, Aytes and colleagues reported high STIM2 levels to favor a less invasive 
phenotype and an augmented cell growth in colorectal cancer (Aytes et al., 2012).  
Although STIMs were initially identified as tumor suppressor genes (see 6.4.1), STIM2 (and 
Orai1) can be partially considered as tumor promoters in melanoma, due to their contribution to 
migration and invasion. The use of siRNAs targeting Orai1 and STIM2 expression in melanoma 
could be a therapeutical approach to render the tumor to a proliferative status to increase the 
susceptibility to conventional radiation and chemotherapy. Given that STIM2 has been shown 
to have no or minor effects in cells with predominant expression of STIM1 (Peel et al., 2006; 
Potier et al., 2009; Mancarella et al., 2013), the possibility arises to target SOCE by modulators 
of STIM2. The potentially big advantage of such a STIM2-targeted therapy is based on the fact 
that immune cells depend more on STIM1 and may thus not be significantly affected by 
interfering with STIM2 function. Hence, manipulations of STIM2 function will very likely have 
minor effects on the antitumor immune response, that mainly relies on T cell and NK cell 
activity (Stanisz et al., 2014). 
9.6.2 Regulation of NOX and CRAC channel activity as therapeutical application in 
inflammatory diseases  
Targeting NADPH oxidases and monocyte function. NOX enzymes are active in signaling 
pathways and immune responses and their aberrant activity can be a cause for different 
disease patterns or are related to them. Their implication in inflammatory and cancerous 
diseases made them a potential therapeutical target (Bonner & Arbiser, 2012; Weyemi et al., 
2012). Several molecules were identified as NOX inhibitors over the years and also found their 
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way into clinical application (reviewed by (Jaquet et al., 2009)), but the search for new NOX 
inhibitors and new approaches to diminish NOX activity is ongoing (Di Marco et al., 2014). 
Regarding the different NOX isoforms, NOX2 is the most prominent target, although most 
inhibitors lack isotype specificity (Cifuentes-Pagano et al., 2014). Results from the here 
presented study questions the role of NOX4 in monocytes. Nevertheless. it is to mentioned that 
Tavakoli and colleagues also discussed and suggested NOX4 derived ROS as new and 
potential target in the treatment of atherosclerosis (Tavakoli & Asmis, 2012). As pointed out 
before, not only overshooting but also insufficient ROS levels and mutations in NOX subunits 
impairing a sufficient enzyme assembly can be the cause of inflammatory and autoimmune 
diseases (see 6.1.2.2). Hultqvist and colleagues have previously demonstrated the protective 
role of ROS in autoimmune diseases (Hultqvist et al., 2009). Very recently the group 
approached the identification and analysis of NOX2 activators, instead of inhibitors, in the 
treatment of inflammatory and autoimmune diseases (Hultqvist et al., 2014).  
Targeting specific CRAC channel components as novel approach in the treatment of 
inflammatory diseases. The results from this study highlight the interdependency of CRAC 
channels and NOX2 activity. This points to an indirect regulation of ROS signaling in 
monocytes in inflammatory diseases, by targeting CRAC channels. In this approach, STIM2 
and Orai3 are the most promising targets to modulate NOX2 activity, meanwhile limiting 
unwanted side effects. By targeting the modulatory subunit Orai3, NOX2 activity can be altered, 
without complete loss of physiological relevant ROS production. As it was shown in this study, 
targeting Orai3 will in addition only have minor effects on overall Ca2+ signaling in monocytes 
and on other immune cells. The same argumentation accounts for STIM2 as potential target. 
The equal contribution of STIM1 and STIM2 will allow augmenting ROS levels by partially 
decreasing SOCE, without affecting Ca2+ signaling in neighboring immune cells as T cells (see 
also 9.6.1).  
9.6.3 Influencing cellular fate and survival by altering the extracellular environment  
Regarding the influence of the environment to the here investigated cell types, artificial induced 
changes of the Ca2+ and redox environment hold a high potential to influence cell function 
instead of a direct targeting of CRAC channels and NOX enzymes. Chance of success of the 
mentioned approach might be higher in melanoma rather than in a monocyte related diseases. 
Changing the extracellular matrix composition is challenging, but likewise effective to render 
melanoma more proliferative and hence more susceptible to conventional treatments. In 
addition, the high dependency of melanoma proliferation on [Ca2+]ext. in comparison to the 
remarkable resistance of monocytes, points to melanoma as most promising system. Interfering 
in the local environment of the skin provides the advantage of a less invasive method and the 
reduction of systemic side effects. In contrast to skin, altering the local redox environment at 
sites of inflammation bears the high risk of systemic side effects and seems to be more 
challenging. However, instead of a direct targeting of the inflammatory environment, new 
approaches consider monocytes and macrophages as potential tool to alter the local 
environment via a cellular back door. Addressing this issue, monocytes and macrophages have 
evolved as such cellular tools in the treatment of atherosclerosis. Lee and colleagues recently 
described an elegant way of targeting overshooting ROS levels in atherosclerotic lesions, 
providing a new approach in regulating a local redox environment. Monocyte recruitment, as 
characteristic step in lesion formation, was exploited as shuttle to traffic stabilized catalase, 
usually prone to degradation, to the site of inflammation, thereby reducing local ROS levels 
(Lee, 2014).  
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9.7 Concluding Remarks  
The analysis of SOCE and the role of the single CRAC channel components was conducted in 
primary human monocytes and melanoma cell lines and revealed several major findings. Ca2+ 
signaling plays an important role in the immune system. It was shown to regulate essential 
T cell functions and is an important factor in innate immune responses. It was shown, that 
monocytes, in contrast to other phagocytes as neutrophils, express all five Orai and STIM 
isoforms that contribute to SOCE. In addition, both STIM proteins equally contribute to SOCE 
and Ca2+ -dependent ROS production in human monocytes. These results emphasized an 
active contribution for STIM2 in different cellular functions that seem to be a unique monocytes 
feature compared to other phagocytes. NOX2 was the only noteworthy expressed NOX isoform 
in primary human monocytes. NOX2 activity was shown to be dependent on CRAC channel 
activity to generate sufficient amounts of ROS. The redox-insensitive isoform Orai3 is a 
modulator in the interdependence of CRAC channels and NOX2 activity and defines redox 
sensitivity of SOCE in monocytes. These results showed that the strategy of high Orai3 
expression as protective mechanism in an oxidative milieu is not only present in CD4+ T helper 
cells, but also monocytes. The skin, is another organ were Ca2+ and redox signaling hold a high 
potential to regulate cellular functions. In a prior study, Orai and STIM were shown to regulate 
melanocyte function. It could be shown in the here presented study, that also under 
pathological skin conditions, as melanoma, SOCE and its molecular components regulate 
cellular features that define the tumor phenotype. Orai1- and STIM2-dependent calcium entry 
was shown to inversely regulate melanoma proliferation and migration in the observed 
phenotype switch. Cellular functions are not only defined by intracellular signaling pathways but 
also by specific environments. The Ca2+ and redox environment was shown to differentially 
regulate SOCE and cell behavior of monocytes and melanoma cells. In a broader scope, the 
findings on the role of the single Orai and STIM proteins in regulating cellular features of 
monocytes and melanoma, might provide new therapeutical applications for the treatment of 
skin cancer and innate immunity-associated inflammatory diseases. In this regard, a distinctive 
role might come in for the isoforms STIM2 and Orai3.  
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